Regulation of Phosphatidylinositol 4-kinase Activity in Rat Pancreatic Acini by Conway, Bruce R.
Virginia Commonwealth University
VCU Scholars Compass
Theses and Dissertations Graduate School
1992
Regulation of Phosphatidylinositol 4-kinase
Activity in Rat Pancreatic Acini
Bruce R. Conway
bconwaylll@yahoo.com
Follow this and additional works at: http://scholarscompass.vcu.edu/etd
Part of the Medicine and Health Sciences Commons
© The Author
This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in
Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/etd/4504
Virginia Commonwealth University 
School of Basic Health Sciences 
This is to certify that the dissertation prepared by 
Bruce R. Conway entitled "REGULATION OF PHOSPHATIDYLINOSITOL 
4-KINASE ACTIVITY IN RAT PANCREATIC ACINI" has been approved 
by his committee as satisfactory completion of the 
dissertation requirement for the degree of Doctor of 
Philosophy. 
Suzam�e G. Laychock, asic Health Sciences 
& School of Biomedical Sciences, S.U.N.Y. at Buffalo 
Date 
School of Basic Health Sciences 
Health Sciences 
of Basic Health Sciences 
/972-
Basic Health Sciences 
Graduate Committee 
REGULATION OF PHOSPHATIDYLINOSITOL 4-KINASE ACTIVITY 
IN RAT PANCREATIC ACINI 
A dissertation submitted in partial fulfillment of the 
requirements for the degree of Doctor of Philosophy at 
Virginia Commonwealth University. 
By 
Bruce R. Conway 
B.S., Philadelphia College of Pharmacy and Science, 1987 
Director: Ronald P. Rubin, Professor 
Department of Pharmacology & Toxicology, M.C.V. 
& 
Chairman, Department of Pharmacology & 
Therapeutics, S.U.N.Y. at Buffalo 
Virginia Commonwealth University 
Richmond, Virginia 
December, 1992 
ii 
ACKNOWLEDGEMENTS 
I am grateful to Dr. Ronald Rubin for his guidance 
throughout all aspects of this project, and to Dr. Suzanne 
Laychock, who provided useful discussion regarding 
experimental design and the interpretation of data. I wish 
to thank Drs. Franson, Grider, and Ellis for serving as 
members of my Graduate Committee, and Dr. Freer for his 
evaluation of this manuscript. I am also grateful to 
Maureen Adolf and Matthew Withiam-Leitch for their 
invaluable assistance during various phases of this study, 
and Dr. Stephen Soltoff (Tufts University) for the HPLC 
analysis of the reaction products. 
I would also like to express my gratitude to Denise 
Litz, Donna Litz, Bob Miller, Diana Kania, and Jean 
McFarland, whose wonderful friendships and continued support 
made graduate school a much more enjoyable experience. 
· . .  
.:·.:.\ 
DEDICATION 
To Ray and Jeanette Conway for their unwavering 
willingness to make personal sacrifices so that I could 
continue to pursue this degree. 
iii 
iv 
TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS .......................................... ii 
DEDICATION ............................................... iii 
TABLE OF CONTENTS ......................................... i v 
LIST OF FIGURES ......................................... viii 
LIST OF TABLES ............................................. x 
LIST OF ABBREVIATIONS ..................................... xi 
ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  xiii 
INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
I. Morphology of the Exocrine Pancreas . . . . . . . . . . . . . . . . . . .  2 
A. Acinus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... . . . . . . . . . .  2 
B. Acinar Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 
1. Subcellular Organization of the 
Acinar Cell . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . .  3 
A. Plasma Membrane . . . . . . . . . . . . . . . . . . . . . . . . . 6 
B. Golgi . . . . . . . . . . . .. . . . . .... . . . . . . . . . . .. . .  6 
c. Zymogen GranulesjExocytosis . . . . . . . . . . . . . 6 
II. Regulation of the Pancreatic Acinar Cell ... . . . . . . . . . . .  7 
A. Calcium-mobilization and 
Cellular Regulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 
1. Historical Perspectives . . . . . . .. . . . . . . . . . . . . .  10 
2. Muscarinic Receptor coupling to PLC 
v 
in the Pancreas . . . . . . . . . . . . . . . . . . . . . . . . . . . .  17 
A. Identification of the Muscarinic 
Receptor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  17 
B. Phospholipase C ....................... 18 
3. InsP3 Generation and Intracellular 
ca2+ -release . . . . . . . • . . . . . . • . . . . . . . . . . . . . . . .  19 
4. DAG Generation and Activation of PKC ........ 21 
B. The Role of Cyclic AMP in Cellular Regulation .... 23 
1. Receptors coupled to Adenylate Cyclase ...... 25 
2. Protein Kinase A ............................ 2 6 
c. PKC- and PKA-mediated Phosphorylation ............ 27 
D. Regulation of Cell Function by Epidermal 
Growth Factor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 8 
1. Cellular Events Associated with 
EGF Treatment .............................. 2 9 
2. Biological Effects of EGF on the Exocrine 
Pancreas ................................... 3 1 
III. Principles of Phosphoinositide Synthesis ............ 32 
A. Synthesis and Interconversion of 
Phosphoinositides . . . . . . . . . . . . . . . • . . . . . . . . . . . . . . .  33 
1. Ptdins Synthase ............................. 3 4 
B. Polyphosphoinositide Synthesis . . . . .. . .. . . .. . . . . . .  35 
1. Substrate Cycling . . . . . . . . . . . • . . . . . . . . . . . . . . .  38 
2. Phosphatidylinositol 4-kinase ............... 40 
A. Subcellular Distribution of 
Ptdins 4-kinase ....................... 44 
vi 
3. Phosphatidylinositol(4)phosphate 5-kinase ... 46 
C. Regulation of Polyphosphoinositide Synthesis ..... 47 
IV. Rationale For Project ................................ 50 
MATERIALS AND METHODS ..................................... 53 
I. Materials . . . . . . . . . • • . . . • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  53 
II. Methods .............................................. 53 
A. Preparation of Dispersed Acini ................... 53 
B. Preparation of homogenates and 
subcellular fractions ........................... 55 
c. Measurement of Ptdins kinase Activity ............ 58 
D. Linearity of Ptdins(4)P formation ................ 60 
E. Determination of Ptdins(4)P stability ............ 60 
F. Identification of Phosphoinositides .............. 61 
G. HPLC analysis of deacylated 
reaction products ............................... 63 
H. Kinetic Analysis of Ptdins 4-kinase Activity ..... 64 
I. Preparation of Triton X-100/Ptdins 
Mixed Micelles .................................. 66 
J. Measurement of Ptdins(4)P 5-kinase Activity ...... 67 
K. Polyphosphoinositide Metabolism Studies .......... 68 
L. Measurement of cAMP levels in 
Pancreatic Acini ................................ 69 
M. Statistical Analysis ............................. 69 
RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  70 
I. Characterization and localization of Ptdins kinase .... 70 
II. Regulation of Phosphoinositide metabolism by 
vii 
Muscarinic Agents ................................... 84 
A. Carbachol-mediated r32P]Ptdins(4,5)P2 
hydrolysis . . . . . . . . . . . . . . . . . . . . . . . . . • . . . • . . . . . . . .  84 
B. Mediation of Ptdins(4)P synthesis by 
Muscarinic Agents . . . . . . . . . . . . . . • . . . . . . . . . . . . . . . .  89 
c. Kinetic Properties of the CCh-stimulated 
Ptdins 4-kinase ................................ 101 
D. Modulation of Ptdins(4,5)P2 Synthesis 
by Carbachol ................................... ·105 
E. Role of Protein Kinase c in 
Ptdins 4-kinase Regulation ..................... 108 
III. Role of cAMP-dependent Protein Kinase in 
Ptdins 4-kinase Regulation ........................ 115 
A. Kinetic analysis of the cAMP-mediated 
stimulation of Ptdins 4-kinase activity ........ 117 
IV. Regulation of polyphosphoinositide synthesis by 
Epidermal Growth Factor ............................ 120 
DISCUSSION ............................................... 13 0 
I. General Properties of Acinar Ptdins 4-kinase ......... 130 
II. Regulation of Ptdins 4-kinase Activity .............. 135 
III. cAMP-dependent modulation of 
Ptdins 4-kinase activity .......................... 146 
IV. Regulation of Ptdins 4-kinase Activity by 
Epidermal Growth Factor ............................ 148 
REFERENCES ............................................... 157 
VITA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  187 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
viii 
LIST OF FIGURES 
Schematic representation of a pancreatic 
acinar cell ........................................... 5 
Schematic representation of the 
"phosphatidylinositol-phosphatidic acid"cycle ........ 13 
Enzymatic pathways involved in the synthesis 
and breakdown of polyphosphoinositides ............... 37 
Time-course of [32P]Ptdins(4)P formation 
in acinar homogenates and purified zymogen granule 
membranes .......................... , ................. 7 2 
E��ect of excess unlabeled ATP on 
[ P]Ptdins(4)P formation ............................ 74 
Protein-Dependence of [32P]Ptdins(4)P 
formation ............................................ 77 
The pH dependence of Ptdins 4-kinase activity 
in homogenates and purified zymogen granule 
membranes ............................................ 79 
Ptdins and ATP dependence of Ptdins 4-kinase 
activity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  81 
Effect of CCh on [32P]Ptdins(4,5)P2 levels . . . . . . . . . . .  86 
C�2centration-dependent effect of CCh on 
[ P]Ptdins(4,5)P2 levels . . . . . . . • . . . . . . . . . . . . . • . . . . . .  88 
Time-dependent effect of CCh on 
Ptdins 4-kinase activity measured in 
acinar homogenates ................................... 91 
Concentration-dependent effect of CCh on 
Ptdins 4-kinase activity ............................. 93 
Concentration-dependent effect of muscarine 
on Ptdins 4-kinase activity .......................... 95 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24 0 
25. 
Blockade of the CCh-mediated increase in Ptdins 
4-kinase activity by the muscarinic receptor 
ix 
antagonist, n-methyl-scopolamine ..................... 98 
HPLC analysis of the deacylated product of 
CCh-regulated Ptdins kinase . . • . . . . . . . . . . . . . . . . . . . . . .  100 
Effect of CCh on the kinetic properties of 
Ptdins 4-kinase . . . . . . . . . . . . . . . • • • . . . . . . . . . . • . . . . . . . .  104 
Time-course of [32P]Ptdins(4,5)P formation 
in acinar homogenates and inhibifory effect 
of Triton X-100 • • . . . . • • . . . . . . . . • • • . . . . . . . . . . . . . . . . . .  107 
Time-dependent effect of CCh on Ptdins(4)P 
5-kinase activity ................................... 110 
Concentration-dependent effects of cell 
permeable diglyceride analogues on 
Ptdins 4-kinase activity ............................ 112 
Blockade of the Dies-mediated increase in 
Ptdins kinase activity by pretreatment with 
staurosporine ....................................... 114 
The effect of monobutyryl cAMP on the kinetic 
properties of Ptdins 4-kinase ....................... 119 
Concentration-dependent effect of EGF on 
Ptdins 4-kinase activity ............................ 122 
HPLC profile of the deacylated product of 
EGF-regulated Ptdins kinase ......................... 124 
Effects of EGF and CCh on [32P]Ptdins(4,5)P2 
levels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . • . . . . . . . . . . . . .  128 
Proposed model for the regulation of Ptdins 
4-kinase activity in the exocrine pancreas .......... 155 
1. 
2. 
3. 
4. 
5. 
X 
LIST OF TABLES 
Subcellular distribution of Ptdins 4-kinase 
in pancreatic acini . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  83 
The ef�ect of ex��enous Ptdins on . CCh-stlmulated ( P]Ptdins(4)P formatlon ............. 102 
Effect of cAMP analogues and PKA catalytic 
subunit on Ptdins 4-kinase activity .................. 116 
The effects of C�h and EGF alone and in 
combination on ( 2P]Ptdins(4) formation .............. 125 
Inability of EGF to elevate cAMP levels 
in rat pancreatic acini .............................. 129 
LIST OF ABBREVIATIONS 
ACh - acetylcholine 
ATP - adenosine triphosphate 
BSA - bovine serum albumin 
ca2+- calcium 
cAMP - adenosine 3':5'-cyclic monophosphate 
CCh - carbachol 
cpm - counts per min 
DAG - diacylglycerol 
Dies - dioctanoylglycerol 
EDTA - Ethylenediamine-tetraacetic acid 
EGF - epidermal growth factor 
EGTA - Ethylene glycol bis-(P-aminoethyl ether) N,N,N',N'­
tetraacetic acid 
HEPES - (N-[2-hydroxyethyl)piperazine-N'­
[2-ethane sulfonic acid]) 
HPLC - high performance liqid chromatography 
InsP3 - inositol(l,4,5)trisphosphate 
InsP4 - inositol(l,3,4,5)tetrakisphosphate 
KHB - Krebs-Henseleit buffer 
MES - (2-[N-Morpholino)ethane sulfonic acid) 
OAG - 1-oleoyl-2-acetylglycerol 
PKA - cAMP-dependent protein kinase 
PKC - protein kinase C 
xi 
PLC - phospholipase C 
Ptdlns - phosphatidylinositol 
Ptdlns(3)P - phosphatidylinositol 3-phosphate 
Ptdlns(4)P - phosphatidylinositol 4-phosphate 
Ptdlns(4,5)P2 - phosphatidylinositol-4,5-bisphosphate 
PtdOH - phosphatidic acid 
VIP - vasoactive intestinal peptide 
xii 
Regulation of phosphatidylinositol 4-kinase activity in rat 
pancreatic acini. 
ABSTRACT 
A dissertation submitted in partial fulfillment of the 
requirements for the degree of Doctor of Philosophy at 
Virginia Commonwealth University. 
Bruce R. Conway 
Advisor: Ronald P. Rubin, Ph.D. 
Virginia Commonwealth University 
The present report describes the characteristics and 
regulatory properties of phosphatidylinositol (Ptdlns) 4-
kinase activity in rat exocrine pancreas. The membrane-
associated Ptdlns 4-kinase displayed a broad pH profile with 
optimal activity at neutral to alkaline pH. Carbachol (CCh) 
elicits a concentration- and time-dependent increase in 
Ptdlns 4-kinase activity in homogenates derived from 
agonist-stimulated acini. This effect was blocked by N-
methylscopolamine and mimicked by muscarine. The enzyme had 
an apparent � for Ptdlns and ATP of 4 and 60 uM, 
respectively. CCh caused no discernible change in the Km for 
either Ptdlns or ATP, but did produce a modest increase in 
the Vmax· The cell permeable diacylglycerol analogues 
dioctanoylglycerol (DiCS) and oleoyl acetylglycerol (OAG) 
xiv 
also produced a concentration-dependent increase in Ptdins 
4-kinase activity which was blocked by the protein kinase c 
inhibitor, staurosporine. Cell permeable monobutyryl cAMP 
caused an increase in Ptdins 4-kinase activity when added to 
intact acini. This agent caused a significant decrease in 
the apparent Kro for ATP but had no effect on Ptdins utiliza­
tion or the Vmax of the reaction. Moreover, pretreatment of 
the acinar homogenate with the catalytic subunit of protein 
kinase A (PKA) produced a concentration-dependent increase 
in enzyme activity suggesting that phosphorylation may be 
involved in the regulation of Ptdins 4-kinase. Epidermal 
growth factor (EGF) elicited a concentration-dependent 
increase in Ptdins 4-kinase activity in homogenates derived 
from agonist-stimulated pancreatic acini. The combination 
of CCh and EGF produced a response which was not synergistic 
or additive. EGF, unlike CCh, failed to cause 
[32P)Ptdins(4,5)P2 breakdown, suggesting different mechan­
isms for the increase in Ptdins 4-kinase activity induced by 
EGF and CCh. Furthermore, exposure of pancreatic acinar 
cells to EGF failed to elevate cyclic AMP levels, suggesting 
that a third pathway exists for the regulation of Ptdins 4-
kinase activity in the exocrine pancreas. We conclude that 
Ptdins 4-kinase represents a key component of the signaling 
pathways utilized by various receptor agonists and that 
phosphoinositide synthesis is under direct and tight regula­
tion by PKC- and PKA-dependent pathways. 
INTRODUCTION 
The exocrine pancreas, with the acinar cell as its 
functional unit, has become a model system for studying 
secretory mechanisms. The exocrine functions of the 
pancreas include the synthesis and secretion of digestive 
enzymes, fluids, and electrolytes necessary for digestion. 
Digestive enzymes (and zymogens) such as amylase and 
chymotrypsinogen are produced in acinar cells, whereas 
electrolyte and fluid secretions are produced in duct cells 
(Sewell & Young, 1975) and to a lesser extent centroacinar 
cells (Hollander & Birnbaum, 1952). Following a meal, the 
stored secretory products are released into the pancreatic 
duct system and ultimately the duodenum, where they 
facilitate digestion. 
Although the relationships between the morphologic 
features and the physiologic functions of the pancreas are 
still being elucidated, numerous investigations at the 
subcellular level have provided insight into the basic 
mechanisms regulating cellular function. This section is 
divided into three subsections, the first of which contains 
a general morphologic overview of the pancreas. The second 
section describes the physiology of the pancreatic acinar 
cell. In particular, the effects of various secretagogues 
l 
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and the second messenger systems involved in the regulation 
of pancreatic function will be presented. The final section 
describes in some detail, the enzymes involved in the 
synthesis of the polyphosphoinositides. In particular, this 
section describes the characteristics and regulatory proper­
ties of Ptdins 4-kinase, the enzyme responsible for the 
synthesis of Ptdins(4)P, the immediate precursor for 
Ptdins(4,5)P2. 
I. MORPHOLOGY OF THE EXOCRINE PANCREAS 
The pancreas, a retroperitoneal organ, is comprised of 
exocrine and endocrine tissue, with the exocrine portion of 
the gland forming approximately 90 % of the mass of the 
pancreas (Bolender, 1974). Endocrine cells account for 2-4 
% of the tissue mass depending on the species studied 
(Kempen et al., 1977). Blood vessels and ductular cells 
also comprise approximately 4 % of the tissue mass (Case, 
1978). 
A. Acinus 
The basic subunit of the exocrine pancreas, the acinus, 
is composed of acinar cells grouped around a narrow lumen. 
It has long been accepted that the exocrine pancreas is 
organized into acini, the actual size of which is still a 
topic of debate. Langerhans (1903) first reported a single 
acinus to contain six to eight acinar cells; however, more 
recently, morphological and electrophysiological studies 
have suggested that the acinus is comprised of approximately 
500 cells (Brockman, 1978; Peterson, 1982). 
B. Acinar Cells 
3 
The ultrastructure of the pancreatic acinar cell has 
been studied extensively (Ekholm et al., 1962; Palade et 
al., 1962; Hermodsson, 1965; and Motta et al., 1977). These 
cells are pyramidally shaped with the apex facing the lumen 
of the acinus (Fig. 1). The morphology of acinar cells 
reveals that they are specialized for protein synthesis. 
Their most striking feature is the abundance of zymogen 
granules which appear to be restricted to the apical 
cytoplasm of the cell and vary in size and number depending 
on the stage of development (Doyle & Jamieson, 1978). 
Acinar cells have a uniform appearance throughout the 
pancreas with the exception of those cells located near the 
islets of Langerhans. These periinsular cells have larger 
nuclei and possess more zymogen granules thus creating a 
"halo" appearance (Hellman et al., 1962). In addition to 
the morphologic distinctions, differences in the relative 
concentrations of digestive enzymes in the periinsular cells 
also exist (Malaisse-Lagae et al., 1975; Bendayan & Ito, 
1979). 
1. Subcellular Organization of the Acinar Cell 
The major subcellular organelles involved in the formation 
and storage of secretory proteins are arranged in the acinar 
cell in a highly polarized manner, imparting functional 
specialization to different regions of the acinar cell (Fig. 
1). A description of the subcellular components participat­
ing in the synthesis, storage, and release of digestive 
Figure 1. Schematic representation of a pancreatic acinar 
cell. 
Redrawn from Case (1978) with permisssion. 
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enzymes will be presented below. 
A. Plasma Membrane 
6 
The plasma membrane of the acinar cell is divided into two 
structurally and functionally distinct regions: the basolat­
eral and apical membranes. Several differences exist bet­
ween these specialized regions which reflect their function­
al relationship. For example, only the basolateral membrane 
possesses receptors for the pancreatic secretagogue, chole­
cystokinin (Rosenzweig et al., 1983). Another example of 
the heterogeneity of the plasma membrane sterns from the 
findings of Motta et al., (1977), who demonstrated that only 
the apical plasma membrane possesses microvilli. Although 
the functional significance of this observation has not been 
defined, it would appear that the structural specializations 
of the apical and basolateral plasma membranes may have a 
functional correlate during stimulus-secretion coupling. 
B. Golgi 
The Golgi complex appears as a few stacks of flattened 
cisternae of varying size together with numerous smooth­
surfaced vesicles of varying dimensions. These vesicles 
have membranes characteristic of immature zymogen granules 
or condensing vacuoles (CV). This suggests that the 
cisternae manufacture vesicles which, after reaching a given 
size, break free to form cv, the immediate precursor of 
zymogen granules. 
c. Zymogen Granules/Exocytosis 
According to the scheme of intracellular transport 
described thus far, the composition of the CV membranes is 
largely determined by the activity of the Golgi complex. 
Likewise, the composition of the mature zymogen granules 
appears to be a direct reflection of that of the CV. 
Following their formation in the Golgi complex, secretory 
granules move by undefined mechanisms to the apical region 
of the acinar cell until the appropriate stimulus triggers 
exocytosis. 
Although the exact mechanisms involved in the movement 
of granules to the site of exocytosis remain undefined, it 
is evident that the zymogen granule membrane specifically 
recognizes only the apical portion of the plasma membrane. 
In addition, marked similarities in the composition of 
zymogen granule membranes and plasma membranes are known to 
exist; however, the importance of these similarities in the 
fusion process remains poorly defined. 
7 
Although the molecular details of the final step in the 
exocytotic event remain unclear, continuity between the two 
membrane bilayers is achieved. The zymogen granule contents 
are released into the alkaline lumen where dissolution of 
the secreted products occurs. 
II. REGULATION OF THE PANCREATIC ACINAR CELL 
Secretion by the pancreas is regulated physiologically 
by the autonomic nervous system and by circulating hormones. 
The ability of pancreatic acinar cells to respond to a given 
stimulus with the highly orchestrated release of granule 
contents implies the existence of intracellular messengers 
capable of transducing the external signal into an 
accelerated rate of secretion, a process referred to as 
stimulus-secretion coupling (Douglas & Rubin, 1961) . 
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Secretagogues that act on pancreatic acinar cells 
stimulate enzyme secretion by activating one of two 
functionally distinct pathways, leading to an increase in 
either cytosolic free calcium (Ca2+) or cellular cyclic 
adenosine monophosphate (cAMP) (Gardner & Jensen, 1987). 
Although the initial steps in these pathways are func­
tionally distinct, at some presently undefined step these 
pathways become functionally coupled, resulting in the 
potentiation of amylase secretion. Therefore, pancreatic 
secretagogues have classically been subdivided into two 
categories based upon which intracellular messenger they 
utilize to transduce their signal. A third category exists 
for agonists such as epidermal growth factor (EGF) and 
insulin, which fail to elicit an acute secretory response 
but appear to modify pancreatic function by interacting with 
the ca2+-mobilizing agonists (Korc et al., 1983). 
In this section, I will attempt to outline the major 
signaling pathways described above. In the case of agonists 
working through the ca2+ or cAMP pathways, the membrane­
transduction machinery consists of three major components: 
(a) a receptor, (b) a guanine nucleotide-binding protein (G 
protein), and (c) an effector, either phospholipase c (PLC) 
or adenylate cyclase. The transduction mechanism for the 
third category of receptors involving growth factors has 
9 
been less rigorously characterized in the exocrine pancreas, 
but may involve a receptor tyrosine kinase. Several indi­
vidual receptor agonists and their respective transduction 
processes as they relate to acinar cell function will be 
discussed. Emphasis will be placed on the cellular and 
biochemical changes which occur in response to stimulation 
with carbachol (CCh}, a muscarinic receptor agonist. 
A. Calcium-mobilization and Cellular Regulation 
Several different agonists are capable of increasing 
enzyme secretion from pancreatic acini both in vivo and in 
vitro. Muscarinic agonists produce a marked increase in 
phosphoinositide metabolism resulting in the generation of 
diacylglycerol (DAG) and inositol(l,4,5} trisphosphate 
(InsP3). DAG activates protein kinase C (PKC), whereas 
InsP3 causes the release of ca
2+ from the endoplasmic 
reticulum. InsP3 also serves as the precursor for 
inositol(1,3,4,5) tetrakisphosphate (InsP4), which may 
function as a second-messenger in the cell (see below). In 
addition, occupation of the muscarinic receptor causes the 
liberation of free arachidonic acid (Halenda & Rubin, 1982); 
however, an in-depth description of this pathway is beyond 
the scope of this investigation. 
The initial investigations which defined the critical 
role of phospholipid metabolism in cellular regulation will 
be presented below. In addition, the functional 
implications of second-messengers generated in response to 
polyphosphoinositide breakdown will be discussed as they 
pertain to pancreatic acinar cell function. 
1. Historical Perspectives 
10 
Early studies aimed at the elucidation of cellular 
regulation focused on the turnover of membrane 
phospholipids. Many cell types show changes in phospholipid 
metabolism in response to the activation of plasma membrane 
receptors (Michell, 1975). One such response involves the 
net loss of phosphatidylinositol (Ptdins}, perhaps due to 
PLC, and subsequent synthesis of phosphatidic acid (PtdOH). 
This response, measured initially as increased labeling of 
phospholipids with (32P)P04 following stimulation with 
acetylcholine (ACh) was first described in pigeon pancreas 
slices by Hokin and Hokin in 1953. This effect was blocked 
by the muscarinic receptor antagonist atropine and appeared 
to be specific for phospholipids in that incorporation of 
(32P)P04 into other phosphorus-containing fractions was not 
similarly increased. Since the initial studies examined the 
incorporation of c32P)P04 into the total phospholipid frac­
tion, this phenomenom became known as the "phospholipid 
effect". 
Shortly thereafter (1954), Dawson developed a method 
for separating individual phospholipids, thus making it 
possible to determine which phospholipids exhibited an 
increase in c32P)P04-content after stimulation. Using 
pigeon pancreas slices, Hokin & Hokin (1955) subsequently 
demonstrated a 15-fold and 3-fold increase in the incorpora­
tion of c32P)Po4 into Ptdlns and PtdOH, respectively. 
11 
Similar results were obtained when myo-[3H)inositol was 
utilized to label Ptdins and PtdOH in the pancreas and brain 
(Hokin & Hokin, 1958 a,b). These studies also demonstrated 
that stimulation with ACh resulted in a 5-fold increase in 
the incorporation of [14c)glycerol into Ptdins, which indi­
cates that a certain degree of de novo synthesis is also 
occurring. 
Investigations employing the avian salt gland 
demonstrated that [32P]P04-incorporation into Ptdins and 
PtdOH was also markedly enhanced by ACh (Hokin & Hokin, 
1960). Furthermore, if ACh was added to [32P)P04-prelabeled 
salt gland slices, only a fraction of the PtdOH continued to 
turnover and become labeled (Hokin & Hokin, 1964). Under 
these conditions, only a small increase in [32P]Ptdins could 
be detected, presumably due to simultaneous breakdown of 
prelabeled Ptdins. Pretreatment with atropine resulted in 
the disappearance of ACh-stimulated [32P]P04-labeling of 
PtdOH and a reciprocal rise in [32P]Ptdins. If atropine was 
washed out and the slices subsequently stimulated with ACh, 
the reverse was observed. That is, the [32P)Ptdins formed 
upon atropine addition rapidly disappeared and was accompa­
nied by a marked increase in [32P]PtdOH. 
These observations led to the proposal of a "Ptdins-
PtdOH cycle" (Fig. 2) (Hokin & Hokin, 1959). This model 
predicted that stimulation with ACh causes the PLC-mediated 
breakdown of Ptdins, producing inositol 1-phosphate and DAG, 
which is subsequently phosphorylated to form PtdOH. 
Figure 2. Schematic representation of the 
"phosphatidylinositol-phosphatidic acid" cycle. 
The original model proposed by Hokin & Hokin in 1964. 
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According to this model, removal of ACh, causes the 
conversion of PtdOH to Ptdlns by the sequential actions of 
CTP-PtdOH cytidyl transferase and Ptdlns synthase (Agranoff 
et al., 1958; Paulus & Kennedy, 1960). 
Support for the proposed model was afforded by the 
observations of Jones & Michell in 1974. These 
investigators observed a decrease in the mass of Ptdins 
following stimulation of parotid-gland fragments with ACh. 
Similarly, Hokin-Neaverson (1974) demonstrated that ACh­
stimulation of mouse pancreas in vitro caused a decrease in 
the mass of Ptdlns and a reciprocal increase in the mass of 
PtdOH, further supporting the model proposed by Hokin & 
Hokin in 1964. 
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In addition to the pancreas, brain, and avian salt 
gland, ACh-stimulated phospholipid effects were observed in 
a variety of secretory systems including the adrenal medulla 
(Hokin et al., 1958; Trifaro, 1969), submaxillary gland 
(Eggman & Hokin, 1960) , and the parotid gland (Hokin & 
Sherwin, 1957). Thus, it appeared that the phospholipid 
effect was not unique to a particular system but instead 
represented a general characteristic among a variety of cell 
types. 
The realization that the phospholipid effect is a 
widespread occurrence in biology, together with the 
observation that ca2+ is a critical mediator of exocytosis 
in a variety of systems (Douglas, 1968), prompted several 
laboratories to explore the possibility that a link exists 
between these phenomena. Early investigations demonstrated 
that omission of ca2+ from the incubation medium caused a 
complete inhibition of secretion from pigeon pancreas 
(Hokin, 1966) and bovine adrenal medulla (Trifaro, 1969). 
In contrast, the incorporation of [32P]P04 into Ptdins and 
PtdOH was only partially inhibited by the removal of ca2+, 
which suggested that the phospholipid effect was only 
loosely coupled to secretion. 
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Interest in the phospholipid effect began to wane until 
several years later when Michell (1975) noted that this 
phenomena was associated exclusively with ca2+-mobilizing 
receptors. He suggested that Ptdins breakdown may be 
directly coupled to receptor activation and in some way to 
the mobilization of ca2+. However, several studies by 
Farese et al. (1982 a and b) demonstrated that the ACh-
mediated decrease in Ptdins mass could be dissociated from 
the increase in [32P]P04-labeling of PtdOH and Ptdins in rat 
pancreas. The differential ca2+ sensitivities of these 
responses cast doubt on the assumption that a decrease in 
Ptdins mass, and its presumed hydrolysis, is important as 
the initiating event for the phospholipid effect. 
At this time, investigators shifted their attention to 
the polyphosphoinositides as possible mediators of the 
phospholipid effect. Although several early studies demon­
strated significant decreases in [32P]PtdinsP and 
[32P]Ptdins(4,5)P2 levels following ACh stimulation (Brock­
erhoff & Ballou, 1962; Santiago-Calvo et al., 1964), the 
significance of these findings was not fully recognized 
until 1977, when analysis of the time course revealed that 
breakdown of the polyphosphoinositides occurs prior to that 
of Ptdins (Abdel-Latif et al., 1977). This study was car-
ried out using rabbit iris smooth muscle and provided the 
first convincing evidence that a receptor agonist could 
bring about a rapid breakdown of polyphosphoinositides. 
However, the hydrolysis of Ptdins{4,5)P2 was reported to be 
ca2+-dependent {Akhtar & Abdel-Latif, 1978; 1980), which 
suggested that polyphosphoinositide breakdown is a conse­
quence of ca2+-mobilization. However, a similar ca2+_ 
dependence has not been observed in other systems (Weiss et 
al., 1982; Creba et al., 1983). Moreover, the results in 
the iris smooth muscle have been attributed to the inhibi-
tion of release of an endogenous neurotransmitter. There­
fore, it appears that ca2+-gating is not a prerequisite for 
polyphosphoinositide breakdown. 
16 
Shortly thereafter, several laboratories demonstrated 
agonist-induced changes in the metabolism of the 
polyphosphoinositide, Ptdins(4,5)P2 (Kirk et al., 1981 a; 
Weiss et al., 1982; Berridge, 1983). Moreover, Putney et 
al. (1983) demonstrated that stimulation of pancreatic 
acinar cells with CCh caused a rapid and pronounced decrease 
in [32P]Ptdins(4,5)P2 levels. Collectively, these results 
suggest that Ptdins{4,5)P2, rather than Ptdins, is likely to 
be the primary phospholipid involved in receptor-mediated 
signaling processes. 
Now that the concept of phosphoinositide turnover has 
been introduced, a description of the muscarinic receptor 
and the evidence suggesting that this receptor couples to 
phospholipase C (PLC) and ca2+-mobilization in the pancreas 
will be presented. 
2. Muscarinic Receptor Coupling to PLC in the Pancreas 
A. Identification of the Muscarinic Receptor 
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Several laboratories have successfully employed 
radiolabeled antagonists such as [ 3H] quinucl idinyl benzyl·ate 
([3H]QNB) and [3H]N-methylscopolamine ([3H]NMS) to 
demonstrate the existence of muscarinic receptors on 
pancreatic acinar cells (Appert et al., 1981; Larose et al., 
1981; Dehaye et al., 1984). Analysis of the concentration­
response curves for various CCh-mediated events including 
InsP3 formation, ca
2+-mobilization, and amylase secretion 
suggests the presence of either (A) a single receptor which 
changes properties upon agonist binding or (B) two distinct 
muscarinic receptor populations (Larose et al., 1981; Rubin 
et al., 1984; Merritt et al., 1986). studies of the 
abilities of muscarine and CCh to inhibit binding of [3H]NMS 
to pancreatic acini also show biphasic inhibition curves 
further suggesting the existence of spare receptors. 
Molecular cloning of the muscarinic receptor has shown 
the existence of a family of proteins designated m1 to m5 
(Levine & Birdsall, 1989); however, Peralta et al. (1988) 
demonstrated that the exocrine pancreas contains only the m3 
subtype. This receptor has a topological orientation within 
the plasma membrane similar to that proposed for receptors 
known to couple G proteins (Hall, 1987; Ashkenazi et al., 
1989). Indeed, the involvement of a G protein (Gq) in 
coupling receptor activation to phosphoinositide breakdown 
has been observed in a variety of cell types including 
pancreatic acinar cells (Merritt et al., 1986). These 
investigators demonstrated that muscarinic receptors couple 
to a novel Gq that is insensitive to either cholera or 
pertussis toxins. In addition, Schafer et al. (1988) de­
scribed a cholera toxin-sensitive G protein coupled to 
cholecystokinin receptors in the rat exocrine pancreas. 
Thus, it appears that pancreatic acinar cells possess at 
least two distinct G proteins which function to coordinate 
signals originating from multiple receptors into an in­
tegrated response - the activation of PLC. 
B. Phospholipase c 
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The phospholipid-specific PLC is a family of isozymes 
that hydrolyze Ptdins and its polyphosphate derivatives, 
Ptdins(4)P and Ptdins(4,5)P2. Together, they comprise 
approximately 5-10 % of the total cellular phospholipids 
(Michell et al., 1970). More than seven PLC isozymes have 
been purified to homogeneity from several tissues, four of 
which have been cloned and sequenced (Crooke & Bennett, 
1989; Rhee et al., 1989). The identification of multiple 
PLC isoforms has raised the question of their functional 
implications. The simplest explanation is that each isozyme 
is selectively coupled to one of several agonists working 
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through a common pathway. An alternative explanation for 
the existence of multiple PLC isozymes involves differential 
substrate specificities. For example, three PLC isozymes 
purified to homogeneity from bovine brain (Ryu et al., 1987) 
hydrolyze Ptdins and Ptdins(4,5)P2 in a ca
2+-dependent 
manner (Rhee et al., 1989). However, at low ca2+ concentra-
tions, Ptdins(4,5)P2 was the preferred substrate for all 
three isozymes. Similar results were obtained using 
isozymes purified from sheep seminal vesicles (Wilson et 
al., 1984) and guinea pig uterus (Bennett & Crooke, 1987). 
In contrast, four PLC isozymes have been purified from human 
platelets, all of which appear to preferentially hydrolyze 
Ptdins(4)P rather than Ptdins(4,5)P2 (Low et al., 1984; Low 
et al., 1986). Four PLC isozymes which preferentially 
hydrolyze Ptdins have also been purified from porcine 
lymphocytes (Carter & Smith, 1987). Therefore, it seems 
likely that specific tissues may require different modes of 
PLC regulation which may be afforded by the presence of 
distinct PLC isozymes. 
Unfortunately, little is known regarding the PLC 
isozymes present in other tissues. To date, there are no 
published reports addressing which isozymes of PLC are 
present in the exocrine pancreas. 
3. InsP3 Generation and Intracellular ca
2+-release 
Although the PLC-mediated hydrolysis of Ptdins(4,5)P2 
appeared to be a characteristic response to the ca2+­
mobilizing agonists, the relationship between Ptdins(4,5)P2 
breakdown and the elevation of cytoplasmic ca2+ remained 
unclear. However, in a pioneering experiment utilizing 
permeabilized pancreatic acinar cells, Streb et al. (1983) 
demonstrated that InsP3 caused the release of ca
2+ from a 
non-mitochondrial source, thus establishing for the first 
time, a link between Ptdins(4,5)P2 hydrolysis and the 
elevation of intracellular ca2+. Moreover, this effect was 
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specific for InsP3 in that Ins(1,4)P2 and other inositol 
phosphates failed to promote ca2+ release. Using fractions 
derived from acinar cell homogenates, Streb et al., (1984) 
subsequently demonstrated that InsP3 released ca
2+ from a 
fraction enriched in rough endoplasmic reticulum (RER) . 
Indeed, a saturable high affinity binding site for InsP3 was 
localized to the RER in permeabilized hepatocytes and 
neutrophils (Spat et al., 1986), suggesting that this 
intracellular organelle provides a reservoir of readily­
releasable ca2+ upon cell activation. The direct 
measurement of InsP3 accumulation in response to CCh 
provided definitive proof that ca2+-mobilizing agonists were 
capable of causing the PLC-mediated hydrolysis of 
Ptdins(4,5)P2 in pancreatic acinar cells (Hokin-Neaverson & 
Sadeghian, 1984; Rubin, 1984; Rubin et al., 1984; Streb et 
al., 1985). 
The similar concentration-response curves for CCh­
mediated InsP3 formation and ca
2+-mobilization, suggests 
that these two events are intimately linked (Merritt et al., 
1986; Muallem et al., 1988); however, InsP3 may have other 
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functions within the cell. For example, InsP3 serves as the 
precursor for the synthesis of InsP4, a molecule which may 
regulate the ca2+-content of the InsP3-releasable pool 
(Irvine et al., 1986). Due to the close apposition of the 
plasma membrane and the endoplasmic reticulum (ER) , Putney 
(1986) proposed a "capacitance theory" for the refilling of 
the InsP3-sensitive pool. According to this model, when the 
ca2+ level in the ER is reduced, ca2+ enters through a pore 
in the plasma membrane to refill the agonist-sensitive pool. 
InsP4 has been suggested to fuse these membranes in a manner 
similar to a gap junction (Irvine & Moor, 1987); however, 
direct evidence supporting either the capacitance theory or 
a role for InsP4 in calcium gating is still controversial. 
4. DAG Generation and Activation of PKC 
The hydrolysis of Ptdins(4,5)P2 also results in the 
formation of DAG, a neutral lipid that remains within the 
plane of the plasma membrane (Berridge & Irvine, 1984). The 
second messenger role of DAG was discovered by Nishizuka and 
his colleagues, who observed that this molecule dramatically 
increases the affinity of PKC for ca2+, thus fully 
activating the enzyme without a change in intracellular ca2+ 
concentration (Kikkawa & Nishizuka, 1986). The activation 
of this ubiquitous enzyme is widely recognized as playing a 
crucial role in signal transmission for a variety of 
hormones and growth factors, thus warranting a description 
of the factors known to regulate its activity. 
As described above, PKC is a ca2+- and phospholipid-
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dependent enzyme that has been implicated in the control of 
several physiological processes, including exocytotic 
secretion, ion channel conductance, cell growth, and gene 
expression (Kikkawa et al., 1989). Although the molecular 
mechanisms governing PKC activation are poorly understood, a 
highly specific lipid-protein interaction appears to be 
involved. For example, diacylglycerols with the 1,2-sn 
configuration bind to PKC with a 1:1 stoichiometry, thus 
activating the enzyme (Castagna et al., 1982). Furthermore, 
the ability of diacylglycerols to activate PKC is largely 
dependent on the nature of the fatty acid moieties (Ganong 
et al., 1986). Molecular cloning of PKC has led to the 
identification of at least seven distinct enzymes with 
different phospholipid and ca2+ requirements (Akita et al., 
1990); however, the function and physiological substrates 
for each isozyme remain unresolved. 
Despite the complexity of this family of proteins, 
several aspects relevant to PKC activation have been 
established. (A) Tumor promoting agents, such as 12-0-
tetradecanoylphorbol, 13-acetate (TPA), can substitute for 
DAG, bind to, and activate PKC (Castagna et al., 1982). (B) 
Receptor-mediated DAG production or stimulation with TPA 
causes the ca2+-independent translocation of PKC from the 
cytosol to the membrane (Kraft & Anderson, 1983; Drust & 
Martin, 1985) and (C) both phorbol esters and cell permeable 
diacylglycerols trigger a persistent stimulation of 
exocytosis at resting ca2+ levels (Kikkawa & 
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Nishizuka, 1986). 
With respect to the exocrine pancreas, the presence of 
a ca2+;phospholipid-dependent protein kinase was first 
described by Wrenn et al. (1981). Enzyme activity is half­
maximal in the presence of 1 to 10 uM ca2+ and is markedly 
potentiated by DAG (Wrenn, 1983). In addition, TPA and 
synthetic diacylglycerols cause the phosphorylation of 
several proteins in pancreatic acini (Burnham et al., 1986), 
one of which has been localized to the zymogen granule 
membrane (Wrenn, 1984). Finally, several investigators 
demonstrated that stimulation of pancreatic acini with TPA 
or CCh caused the translocation of PKC from the cytosol to 
the membrane {Wooten & Wrenn, 1984; Ishizuka et al., 1987). 
These studies also demonstrate PKC activation in response to 
very low CCh concentrations, presumably due to the 
generation of DAG from the hydrolysis of 
polyphosphoinositides, as well as phosphatidylcholine 
(Matozaki & Williams, 1989; Komabayashi et al., 1990; Rubin 
et al., 1992). Collectively, these results further 
emphasize the importance of PKC-dependent signals in the 
regulation of pancreatic acinar cell function (see below). 
B. The Role of Cyclic AMP in Cellular Regulation 
As outlined above, many cellular responses involve the 
mobilization of intracellular ca2+, however, a second 
pathway involving the generation of cAMP also appears to 
play a central role in cellular regulation. Receptors, such 
as those for Vasoactive Intestinal Peptide (VIP) and 
secretin, couple to adenylate cyclase via a distinct G 
protein (Gsl . Occupation of these receptors by the agonist 
results in the elevation of cAMP levels and subsequent 
activation of cAMP-dependent protein kinase (PKA) . The 
changes in cellular function associated with agonist­
mediated cAMP generation will be presented below. In 
addition, the interrelationship between PKA- and PKC­
dependent pathways will be discussed as it pertains to 
cellular regulation. 
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Although the influence of cAMP on a number of secretory 
systems has been observed, a unifying theory regarding the 
role of cAMP has not been established. In fact, the role of 
cAMP in the regulation of cell function is dependent on the 
tissue and species being examined. For example, cAMP serves 
as the primary signal for enzyme secretion from the rat 
parotid gland (Butcher & Putney, 1980); whereas, cAMP has 
little or no effect on catecholamine release from the 
adrenal medulla (Jaanus & Rubin, 1974). With regard to the 
species variation, Robberecht et al. (1977) demonstrated 
that secretin and VIP elevate cAMP in pancreatic fragments 
from mouse, dog, cat, rat, and guinea pig; although 
augmented amylase secretion occurs only in pancreatic 
fragments from rat and guinea pig. The basis of this dis­
crepancy is unknown; however, a critical examination of VIP 
and secretin receptors for each species may be useful in 
establishing the relationship between cAMP production and 
cell function. In any event, the role of cAMP in the regu-
lation of acinar cell function has been well documented in 
the rat (for review see Hootman & Williams, 1987). 
1. Receptors coupled to Adenylate Cyclase 
As mentioned previously, several polypeptides of the 
secretin-VIP-glucagon family modulate pancreatic 
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function, due presumably to the elevation of cAMP levels. A 
review of the biochemical evidence demonstrating that these 
peptides are, in fact, working through receptors coupled to 
adenylate cyclase is presented below. When possible, this 
discussion will highlight those results obtained using rat 
pancreatic acinar cells to circumvent confusion spawned by 
the high degree of species variability. 
In the rat exocrine pancreas, at least four classes of 
receptors are required to account for the actions of VIP and 
secretin (Bissonnette et al., 1984). Of these receptor 
subclasses, at least two are coupled to adenylate cyclase 
and produce a rise in cAMP levels, which in turn modulates 
cellular function. Indeed, both VIP and secretin stimulate 
a hormone-responsive adenylate cyclase present on the plasma 
membrane of rat pancreatic acinar cells (Rutten et al., 
1972; Svoboda et al., 1978; Robberecht et al., 1982). 
Cholera toxin and forskolin, known activators of adeny1ate 
cyclase, mimic the effects of VIP and secretin on cAMP 
accumulation and amylase release (Singh, 1982; Dehaye et 
al., 1985). In addition, cell permeable cAMP analogues, 
such as dibutyryl cAMP, induce secretion from the rat pan­
creas (Gardner & Jackson, 1977). Collectively, these data 
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suggest that VIP and secretin regulate pancreatic 
function through a cAMP-dependent pathway possibly involving 
PAA. 
2. Protein Kinase A 
With few exceptions, all known cAMP-responsive events 
require the activation of PAA (Hockberger & Swandulla, 1987; 
Scott, 1991). PKA has been described in a number of 
mammalian systems including the rat exocrine pancreas 
(Cenatiempo et al., 1975; Lewis & Ronzio, 1979). Little is 
known regarding the subcellular distribution of this enzyme 
in the pancreas, although activity has been localized to the 
cytosolic fraction (Burnham & Williams, 1984). Enzyme 
activity has also been localized to the zymogen granule 
membrane (Lambert et al., 1974); however, the endogenous 
substrate remains unidentified. 
Hormone-mediated activation of PKA in situ can be 
assessed by homogenizing cells and measuring enzyme activity 
in the absence of cAMP (Soderling et al., 1973). Studies of 
this type have shown that VIP and secretin activate the 
kinase in rat pancreas (Holian et al., 1980). Furthermore, 
Burnham et al. (1988) demonstrated that a correlation exists 
between the ability of VIP and cell permeable cAMP analoges 
to increase cellular cAMP and PKA-dependent phosphorylations 
of several proteins in pancreatic acini. These data in­
dicate that pancreatic acinar cells are subject to regula­
tion by an agonist-sensitive FAA-dependent pathway. 
Phosphorylation of substrate proteins by the catalytic 
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subunit of PKA triggers an array of physiological responses. 
In addition, the analysis of specific cellular responses in 
various tissues, including the exocrine pancreas, suggests 
the existence of a complex relationship between the cAMP 
and ca2+-dependent processes (Rasmussen, 1981). The exact 
mechanisms underlying this interaction remain poorly 
defined; however, an alteration in the availability of 
either messenger or the function of their respective 
effectors, including PKC and/or PKA, may be involved. 
c. PKC- and PKA-mediated phosphorylation 
Although considerable data exist for changes in the 
phosphorylation of regulatory proteins involved in hormone 
stimulation ( for review see Walaas & Greengard, 1991) , the 
physiologic substrates for PKC and PKA in the pancreas are 
largely unknown. Due to the lack of information regarding 
specific enzymes or regulatory proteins involved in 
exocytosis, a more general approach has been to determine if 
secretagogues induce changes in protein phosphorylation. 
The ability of agonists to cause a change in phosphorylation 
in the rat pancreas was described as early as 1973 by 
Lambert and colleagues. These investigators demonstrated a 
small increase in [32P)P04 incorporation into several 
proteins localized to a crude zymogen granule fraction. 
More recently, studies have utilized one- and two­
dimensional gel electrophoresis to identify phosphoproteins. 
For example, a major regulated phosphoprotein with a 
molecular weight of approximately 29 kilodaltons (kDa) has 
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been described in a crude particulate fraction isolated from 
rat pancreas (Freedman & Jamieson, 1982; Vandermeers et al., 
1984). Phosphorylation of this protein is increased 
following exposure to CCh and secretin; however, its 
subsequent identification as the ribosomal S6 protein makes 
it an unlikely candidate for participation in the acute 
secretory response (Jahn & Soling, 1983). Freedman & 
Jamieson (1982) have also reported the phosphorylation of a 
number of pancreatic proteins following exposure to various 
secretagogues. In addition, Burnham et al. (1988) reported 
altered phosphorylation of at least ten proteins in response 
to CCh. One subset was similarly altered by phorbol esters, 
whereas another distinct subset was altered by VIP and a­
bromo cAMP. These results suggest that both PKC and PKA are 
responsible for the phosphorylation of similar as well as 
distinct proteins in the pancreas. These authors also 
concluded that the similar phosphorylation profile may 
underlie the synergistic action of VIP on CCh-induced amy­
lase secretion; however, the identification of these pro­
teins will be necessary to either support or refute this 
hypothesis. 
D. Regulation of Cell Function by Epidermal Growth Factor 
In addition to the muscarinic and peptidergic receptors 
described above, many mammalian cells, including pancreatic 
acinar cells, possess a third class of receptors which 
regulate growth and differentiation. These receptors have 
intrinsic tyrosine kinase activity, which appears to be 
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essential for the initiation of the signaling cascade. This 
family of receptors mediates the signaling processes of a 
diverse group of biologically active peptides including EGF, 
insulin, and fibroblast growth factor. Although each growth 
factor has a trophic effect on the pancreas (Logsdon, 1986) , 
only EGF appears to interact with the ca2+-mobilizing 
agonists to augment protein synthesis and amylase secretion 
(Logsdon & Williams, 1983a) . Therefore, this discussion 
will be limited to the signaling events associated with EGF­
receptor occupation and their interrelationship with PKC­
and PKA-dependent processes. 
EGF was initially purified from the mouse salivary 
gland by Carpenter & Cohen in 1979. In addition, high 
concentrations of EGF are also present in the pancreas, 
liver, and kidney (Hirata & Orth, 1979). Various fluids 
including saliva, pancreatic juice, bile, and urine also 
contain high concentrations of EGF (Joh et al., 1989). 
Available evidence indicates that EGF is produced locally 
and secreted directly into the fluids mentioned above 
(Hirata et al., 1982), thus setting the stage for possible 
paracrine effects on neighboring cells. 
1. Cellular Events Associated with EGF Treatment 
The EGF receptor is a transmembrane glycoprotein with a 
molecular weight of approximately 170 kDa (Massague, 1982). 
As described earlier, this receptor possesses intrinsic 
tyrosine kinase activity which plays a key role in signal 
transduction. Many investigators have utilized A431 human 
epidermoid carcinoma cells to study the cellular events 
associated with EGF receptor activation. These cells 
overexpress EGF receptors, thus representing a model system 
to study the biochemical alterations following exposure to 
EGF. Activation of the EGF receptor in this system 
initiates a series of early responses including activation 
of the receptor tyrosine kinase and autophosphorylation of 
the EGF receptor (Schlessinger, 1987; Carpenter, 1987). 
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Other investigators have utilized this system to demonstrate 
that exposure to EGF results in DAG production (Macara, 
1986), InsP3-mediated ca
2+ release (Hepler et al., 1987), 
and the opening of ca2+ and K+ channels (Peppelenbosch et 
al., 1991). A variety of enzymes including PLc-r1 (Wahl et 
al., 1987), phospholipase A2 (Margolis et al., 1988), and 
Ptdins 4-kinase (Walker & Pike, 1987) are activated by the 
occupied EGF receptor. In the case of PLC-r1, treatment 
with EGF causes a rapid increase in the phosphorylation of 
tyrosine and serine residues, thereby increasing the cataly-
tic activity of the enzyme (Goldschmidt-Clermont et al., 
1991) . Whether other enzymes are similarly regulated by 
direct phosphorylation remains to be determined. 
stimulation with EGF also results in the generation of 
various second-messenger molecules which may function to 
regulate the enzyme activities described above. For 
example, the activation of PLc-r1 results in the generation 
of DAG and activation of PKC (Susa et al., 1989). 
Furthermore, EGF has been shown to stimulate PKC activity in 
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thyroid (Kasai et al., 1989) and A431 cells (Sahai et al., 
1982). Finally, Ahn and her colleagues (1990) identified at 
least seven EGF-stimulated serine/threonine kinases in 
fibroblasts. This finding demonstrates that EGF stimulates 
a variety of tyrosine and serine/threonine phosphorylations 
which, in turn, may initiate a host of cellular responses. 
EGF is also capable of modulating cAMP levels in several 
systems including parotid acinar cells (Nakagawa et al., 
1991), A431 cells (!washita et al., 1990), and ovarian 
granulosa cells (Knecht & Catt, 1983). In addition, EGF has 
been shown to modulate PKA activity in thyroid cells (Roger 
et al., 1991). Therefore, it appears that recruitment of 
PKC andjor PKA activities may account for the diversity of 
biological effects observed following exposure to EGF. 
2. Biological Effects of EGF on the Exocrine Pancreas 
As alluded to earlier, EGF has a trophic action on the 
exocrine pancreas (Dembinski et al., 1982). EGF also ap­
pears to be necessary for the maintenance of pancreatic 
acinar cells in short-term culture (Logsdon & Williams, 1983 
b). Although pancreatic acini possess EGF receptors, the 
signaling events following EGF binding remain elusive. 
Short-term exposure of pancreatic acini to EGF fails to 
elicit amylase secretion (Korc et al., 1983); however, a 
complex interaction between the growth factor and ca2+­
mobilizing agonists has been suggested. For example, CCh 
and CCK block EGF-receptor internalization subsequent to the 
elevation of cytosolic ca2+ (Logsdon & Williams, 1983 c; 
Korc et al., 1984). In addition, long-term treatment with 
EGF elicits amylase release and prevents caerulein-induced 
desensitization of secretion (Morisset et al., 1989). 
Recently, Chandrasekar & Korc (1991) demonstrated that EGF 
fails to promote a significant increase in InsP3 formation 
or cytosolic ca2+ levels, suggesting that the interaction 
between EGF and the ca2+-mobilizing agonists does not in­
volve the activation of PLC. In addition, EGF and ca2+­
mobilizing agonists have been shown to interact with the 
same Gi- and Gs-proteins in plasma membranes of pancreatic 
acinar cells (Profrock et al., 1991 a). However, the func­
tional correlate of this interaction was not defined. 
Therefore, the precise role of EGF in the exocrine 
pancreas remains unresolved. Due to the myriad of cellular 
responses initiated by EGF-receptor activation, formulation 
of a hypothesis explaining the interaction with ca2+­
mobilizing agonists is difficult. However, one possible 
explanation may involve the convergence of multiple 
signaling pathways on a single effector protein, the 
identity of which remains unknown. 
III. PRINCIPLES OF PHOSPHOINOSITIDE SYNTHESIS 
Mammalian cells contain at least three inositol-
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containing phospholipids- Ptdins, Ptdins(4)P, and 
Ptdins(4,5)P2- which undergo rapid interconversions cata­
lyzed by specific kinases and phosphatases. As described 
above, many cell surface receptors elicit their responses by 
stimulating the PLC-mediated hydrolysis of Ptdins(4,5)P2, 
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thus generating DAG and InsP3. In addition to serving 
important second-messenger functions within the cell, these 
second-messengers play a critical role in the resynthesis of 
Ptdins. This resynthesis pathway involves a series of 
enzymatic reactions, some of which appear to be regulated. 
Similarly, the replenishment of Ptdins(4,5)P2 following 
agonist-mediated breakdown requires two separate enzymatic 
processes. Ptdins(4)P and Ptdins(4,5)P2 are synthesized 
from Ptdins by specific kinases that phosphorylate the D-4 
and D-5 position of Ptdins and Ptdins(4)P, respectively. 
In this section, the current knowledge regarding 
inositol phospholipid synthesis will be reviewed. Although 
Ptdins synthesis will be described, emphasis will be placed 
upon the enzymes which catalyze the synthesis of 
polyphosphoinositides. In particular, the properties and 
characteristics of Ptdins 4-kinase will be examined. 
Finally, a review of the experimental evidence suggesting 
that Ptdins 4-kinase may be regulated by receptor agonists 
will be presented. 
A. synthesis and Interconversion of Phosphoinositides 
The biosynthetic routes to the major glycerophospho­
lipids were elucidated during the 1950's, primarily through 
the work of Eugene Kennedy and his colleagues. In particu­
lar, these investigators identified cytidine nucleotide­
linked intermediates as being responsible for the transfer 
of phosphoryl-base headgroups to a 1,2-diacylglycerol accep­
tor. Agranoff and his colleagues (1958) demonstrated that 
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the cytidine nucleotide-activated precursor responsible for 
Ptdins biosynthesis was a novel "liponucleotide", CMP­
phosphatidate. This is sometimes referred to as COP-diacyl­
glycerol, although CMP-phosphatidate is the preferred term 
since it supplies an entire phosphatidyl moiety to the D-1 
hydroxyl of free myo-inositol. 
Several possible routes exist for the incorporation of 
P04 into the phosphatidyl residue destined for Ptdins: a) 
formation of sn-3-glycerophosphate, followed by acylation to 
PtdOH; b) phosphorylation of glycerol by glycerokinase, 
followed by acylation to PtdOH; and c) direct ATP-dependent 
phosphorylation of DAG by DAG kinase. The latter process, 
which involves the recycling of DAG, provides the rapid 
incorporation of phosphate into PtdOH and ultimately Ptdins, 
thus partially explaining the rapid labeling of Ptdins with 
[32P]P04 that occurs in most cells (see also section II). 
1. Ptdins Synthase 
As described above, Ptdins can be resynthesized from 
PtdOH and inositol via the high-energy intermediate, CMP­
phosphatidate. This reaction is believed to occur in the 
endoplasmic reticulum prior to extensive remodeling of 
phospholipids by deacylationjreacylation reactions (Holub, 
1978). However, accumulating evidence suggests the occur­
rence of Ptdins synthase in distinct subcellular compart­
ments including the plasma membrane (Harden et al., 1987; 
Helms et al. , 1991). Thus, it appears that the synthesis of 
Ptdins may occur directly in the compartment where utiliza-
tion will occur. In addition, newly synthesized Ptdins can 
be transferred between intracellular membranes, probably 
aided by an exchange protein (McMurray & Dawson, 1969; Kirk 
et al., 1981 b). In this way, Ptdins is readily available 
for the synthesis of polyphosphoinositides. 
B. Polyphosphoinositide synthesis 
35 
The net flux of Ptdlns through Ptdins(4,5)P2 depends 
upon a balance of specific kinase and phosphomonoesterase 
activities (Fig. 3). The reservoir of Ptdins(4,5)P2 in 
cells is very small (approximately 1/lOOth of that of ATP), 
and its rate of synthesis is regulated to meet the increased 
demand for Ptdins(4,5)P2 during cell activation (Downes et 
al., 1989). Two types of mechanisms may account for a net 
increase in the synthesis of Ptdins(4)P and Ptdins(4,5)P2 
during stimulation. The first entails a rise in the rate of 
either one or both of the lipid kinase activities. This may 
involve an allosteric modulator or a change in either sub­
strate concentration or availability. A second mechanism 
may involve a decrease in the activity of Ptdlns(4)P andjor 
Ptdins(4,5)P2 phosphomonoesterases, assuming that all of 
these enzyme activities are expressed in the unstimulated 
cell. The process responsible for maintaining a balance 
between various intermediates of the Ptdins cycle has been 
referred to as "substrate cycling" and will be described 
below. 
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Figure 3. Enzymatic pathways involved in the synthesis and 
breakdown of polyphosphoinositides. 
37 
kinase kinase 
Ptdlns Ptdlns(4)P .,. Ptdlns(4,5)P 2 
PLC PLC PLC 
l phosphomonoesterase l phosphomonoesterase l 
lnsP lnsP 2 lnsP 3 
t 
inositol 
38 
1. Substrate Cycling 
Several decades ago, Brockerhoff & Ballou (1962) demon­
strated that [32P)P04 was rapidly incorporated into the 
monoester phosphate groups of polyphosphoinositides. These 
workers further demonstrated the existence of a phosphomo­
noesterase activity capable of hydrolyzing Ptdins(4,5)P2, 
thus spawning the concept of substrate cycling for the 
polyphosphoinositides. However, as these authors pointed 
out in their discussion, the precision of non-equilibrium 
[32P)P04-labeling experiments is severely limited for 
several reasons. In most cells the pool of Ptdins is at 
least 100 times larger than the pools of Ptdins(4)P and 
Ptdins(4,5)P2; therefore, the polyphosphoinositides will 
turn over much more rapidly in proportion to their size. 
This results in a disproportional approach to isotopic 
equilibrium for the monoester and diester phosphate groups, 
thus making interpretation of steady-state polyphosphoinosi­
tide concentrations difficult. A further complication of 
this type of analysis involves the relatively slow exchange 
of [32P)P04 with the r-phosphate of ATP during the pre­
stationary phase (Reich, 1968). In this phase, the specific 
radioactivity of ATP is still reaching a steady-state, thus 
hampering quantitative data evaluation. 
Using intact human platelets, Muller et al. (1986) 
measured [32P]P04 flux into the polyphosphoinositides to 
address whether substrate cycling occurs. Using Reich's 
model for [32P)P04 flux into the r-phosphate of ATP during 
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the dynamic phase, these authors fit their data to the 
metabolic model of Brockerhoff and Ballou (1962). This 
strategy yielded flux rates best explained by the presence 
of phosphomonoesterase activities in vivo, thus representing 
the most convincing evidence to date that polyphosphoinosi­
tides undergo substrate cycling. 
The best available data regarding the influence of the 
various reactions following hormonal stimulation are those 
of Palmer et al. (1986) who utilized isolated hepatocytes. 
In this system, desensitization of InsP3 accumulation does 
not occur for at least 10-15 min (Thomas et al., 1984); 
therefore, a net increase in the levels of Ptdins(4,5)P2 
must occur during stimulation. Using a protocol similar to 
that of Muller et al. (1986), Palmer and his colleagues 
(1986) demonstrated that the net rise in Ptdins(4)P and 
Ptdins(4,5)P2 levels is largely produced by the increased 
rate of synthesis of the polyphosphoinositides. Whether a 
decrease in the rate of one or both phosphomonoesterases 
provides a minor contribution to the rise in net synthesis 
under these conditions is not known. Using similar tech­
niques in which the specific activity of ATP was measured, 
Verhoeven et a1. (1987 a) demonstrated that the monoester 
phosphate groups on the polyphosphoinositides are in close 
equilibrium with the pool of metabolic ATP. Moreover, these 
authors subsequently demonstrated that thrombin stimulation 
of platelets caused a rapid increase in the labeling of 
metabolic ATP and a concomitant increase in [32P]P04 
incorporation into Ptdins(4)P and Ptdins(4,5)P2 (Verhoeven 
et al., 1987b). 
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Although valid investigations which address the futile 
cycling of polyphosphoinositides have been few in number, 
the available evidence points to the lipid kinases as 
possible targets for regulation by receptor agonists. A 
description of the general properties and characteristics of 
these enzymes is presented below. 
2. Phosphatidylinositol 4-kinase 
Until very recently the pathways involved in the syn­
thesis of polyphosphoinositides were thought to be relative­
ly simple: Ptdins is phosphorylated on the D-4 and D-5 
positions of the inositol ring by Ptdins 4-kinase (E.C. 
2.7.1.67) and Ptdins(4)P 5-kinase respectively, resulting in 
the generation of Ptdins(4,5)P2. However, the complexity of 
the Ptdins cycle has increased with the recent discovery of 
Ptdins 3-kinase and its novel phospholipid products (Whitman 
et al., 1988). 
Two monophosphorylated phosphoinositides are now known 
to exist, Ptdins(4)P and Ptdins(3)P. In addition, two novel 
diphosphoinositides have been described, Ptdins(3,4)P2 and 
Ptdins(3,5)P2 (Auger et al., 1989). Although the discovery 
of this class of inositol phospholipids has created substan­
tial interest among investigators, their physiological 
significance remains unclear. Numerous attempts to locate a 
phospholipase capable of hydrolyzing these lipids have 
failed (Lips et al., 1989; Serunian et al., 1989). Unlike 
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Ptdins(4)P and Ptdins(4,5)P2, which are present in signifi­
cant concentrations in the resting cell and generally de­
cline in response to hormone-stimulation, Ptdins(3,4)P2 and 
Ptdins(3,5)P2 are undetectable in quiescent cells and are 
produced upon stimulation (Auger et al., 1989). Thus, these 
lipids are likely to be directly involved in the signaling 
event rather than serve as precursors for signals. In any 
event, this class of phospholipids and the enzymes responsi­
ble for their synthesis will be discussed only when appro­
priate for the purpose of direct comparison with the more 
classical pathways involved in the synthesis of Ptdins(4)P 
and Ptdins(4,5)P2. 
Although the experiments by Brockerhoff & Ballou (1962) 
demonstrated the phosphorylation of Ptdins, it was not until 
several years later that Ptdins kinase activity was first 
described in rat liver (Michell & Hawthorne, 1965) and rat 
brain (Colodzin & Kennedy, 1965). Harwood & Hawthorne 
(1969) subsequently described two types of Ptdins kinase in 
plasma membranes and endoplasmic reticulum, based upon 
differential activation by non-ionic detergents. More 
recently, Whitman et al. (1987) identified two types of 
Ptdins kinase in swiss 3T3 fibroblasts. One form (designat­
ed as type 2 Ptdins kinase) had a � for ATP of 35 uM and 
was activated by non-ionic detergents. In addition, the 
type 2 Ptdins kinase was markedly inhibited by adenosine. 
In contrast, type 1 Ptdins kinase had a somewhat lower � 
for ATP (10 uM), was inhibited by detergents, and appeared 
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to be insensitive to the inhibitory affect of adenosine. 
The type 2 Ptdlns kinase was subsequently shown to 
phosphorylate the D-4 position of the inositol ring, whereas 
the type 1 enzyme phosphorylated the D-3 position. Thus, 
type 1 and type 2 Ptdlns kinases are not isozymes but cata­
lyze distinct enzymatic reactions. 
With respect to Ptdins 4-kinase, multiple isozymes from 
bovine brain have been separated by sucrose gradient 
centrifugation of detergent-solubilized membranes (Endemann 
et al., 1987). One isozyme has an apparent molecular weight 
of 55 kDa and exhibits properties similar to the type 2 
Ptdlns kinase described by Whitman. Proteins with similar 
properties to those of the fibroblast and brain type 2 
Ptdlns 4-kinase have been purified from a variety of sources 
including bovine uterus (Porter et al. , 1988), porcine liver 
(Hou et al. , 1988), erythrocyte plasma membranes (Jenkins et 
al., 1991; Wetzger et al., 1991}, A431 cells (Walker et al., 
1988), adipocytes (Del Vecchio & Pilch, 1991), and chromaf­
fin granules (Husebye et al., 1990). 
The second isozyme described by Endemann et al. (1987) 
has properties unlike both fibroblast Ptdlns kinase 
activities and is designated as type 3 Ptdlns kinase. This 
enzyme has an approximate molecular weight of 230 kDa and a 
much higher Kro for ATP (742 uM). In addition, the type 3 
isozyme is resistant to inhibition by adenosine. An enzyme 
with similar properties has been purified from bovine uterus 
(Li et al., 1989). This protein has a molecular weight of 
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200 kDa and, like the brain type 3 enzyme, is relatively 
insensitive to adenosine. Furthermore, this enzyme has a Kro 
for ATP of 250 uM, which is much higher than that reported 
for the type 2 isozymes. Yamakawa and Takenawa (1988) 
purified a membrane-bound enzyme from rat brain that is 
similar to type 3 Ptdlns kinase, in that it is relatively 
resistant to inhibition by adenosine and is activated by 
non-ionic detergents. This enzyme has an apparent Kro for 
ATP of 150 uM which is intermediate between previously 
characterized type 2 and type 3 enzymes; however, this 
apparent disparity is probably a result of the higher degree 
of purification (11,000- versus 1,000-fold for bovine uterus 
type 3 enzyme) . The question as to whether this enzyme 
catalyzes the phosphorylation of the D-3 or D-4 position of 
inositol was not investigated; however, its ability to be 
activated by detergents suggests that it is a Ptdlns 4-
kinase. Further substantiation that this protein is, in 
fact, a Ptdlns 4-kinase was provided by the molecular clon­
ing of the eDNA which encodes this enzyme (Yamakawa et al., 
1991). A specific antibody raised against the protein 
expressed in Escherichia coli successfully immunoprecipitat­
ed rat brain Ptdlns 4-kinase activity. 
In addition to the type 2 and type 3 Ptdlns 4-kinases 
described above, a related Ptdlns 4-kinase has been de­
scribed. Belunis et al. (1988) purified a Ptdlns 4-kinase 
from the membrane fraction of Saccharomyces cerevisiae which 
is activated by non-ionic detergents. This enzyme has a 
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molecular weight of 35 kDa which is similar to that reported 
for the type 2 isozymes. However, this protein has a rela­
tively high � for ATP (300 uM) and is insensitive to adeno­
sine inhibition. Based upon these data, it appears that 
this protein represents a third subclass of Ptdlns 4-kinase 
isozymes. 
A. Subcellular Distribution of Ptdlns 4-kinase 
Various investigations of the subcellular distribution 
of Ptdlns 4-kinase activity in mammalian tissues have found 
that this enzyme is almost exclusively membrane associated. 
Studies which employ [32P]Po4-labeling techniques indicate 
that the majority of [32P]Ptdlns(4)P resides in the plasma 
membrane fraction (Seyfred & Wells, 1984). Although several 
studies have demonstrated the existence of Ptdlns 4-kinase 
activity in plasma membranes (Payrastre et al., 1990; Wetzg­
er et al., 1991), other studies have found the majority of 
activity residing on intracellular membranes including those 
of the endoplasmic reticulum (Lundberg & Jergil, 1988), 
Golgi (Jergil & Sundler, 1983; Cockcroft et al., 1985 a), 
and mitochondria (Hajra et al., 1968; Stubbs et al., 1988). 
Ptdlns kinase has also been found on nuclear membranes 
isolated from rat liver cells (Smith & Wells, 1983), Friend 
erythroleukemic cells (Cocco et al., 1987), and the nuclear 
matrix of fibroblasts (Payrastre et al., 1992). In addi­
tion, granule membranes isolated from mast cells (Kurosawa & 
Parker, 1986), adrenal chromaffin cells (Husebye et al., 
1990), parotid acinar cells (Oren et al., 1978), and islets 
of Langerhans (Tooke et al., 1984; Rana & MacDonald, 1986) 
all possess Ptdlns kinase activity. 
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The apparent disparities with regard to the distribu­
tion of the enzyme can be reconciled if Ptdins kinase is 
differentially regulated in various membranes, or if 
Ptdins(4)P is transported to other membranes, especially the 
plasma membrane, shortly after synthesis. A second possible 
explanation stems from the studies of Campbell et al. (1985) 
who found Ptdins kinase on the exterior face of coated 
vesicles isolated from bovine brain, rat liver, and chick 
embryo skeletal muscle. These vesicles are involved in the 
intracellular transport of macromolecules. This raises the 
possibility that these structures modulate Ptdins(4)P cont­
ent of plasma membranes by regulating the amount of Ptdins 
kinase activity therein. Moreover, the presence of Ptdins 
4-kinase on the exterior surface of the vesicle would corre­
spond to a location on the cytoplasmic face of the plasma 
membrane. 
Recently, Del Vecchio & Pilch (1991) have characterized 
a type 2 Ptdins kinase associated with glucose transporting 
vesicles isolated from rat adipocytes. These authors con­
tend that this enzyme may be involved in maintaining the 
unique structure of the vesicle or perhaps, the production 
of Ptdins(4)P necessary for the process of membrane fusion 
(see also Eberhard et al., 1990). There are, as yet, no 
further data on either of these intriguing possibilities, 
consequently an explanation for the ubiquitous nature of 
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Ptdins 4-kinase awaits further investigation. 
3. Phosphatidylinositol(4lphosphate 5-kinase 
Ptdins(4)P 5-kinase (E.C. 2.7.1.68) catalyzes the 
phosphorylation of Ptdins(4)P at the D-5 position of the 
inositol ring to form Ptdins(4,5)P2. This enzyme appears to 
be equally distributed among the cytosolic and particulate 
fractions (Van Dongen et al., 1984; Imai et al., 1986); 
however, only the latter form has been studied in detail. 
Ling and her colleagues (1989) have purified a membrane­
associated Ptdins(4)P 5-kinase from human erythrocytes, 
which specifically recognizes Ptdins(4)P as the substrate. 
Furthermore, this enzyme has an apparent � for ATP 
utilization of 2 uM and a molecular weight of approximately 
150 kDa. This enzymatic activity, like the cytosolic form 
previously purified from rat brain (Cochet & Chambaz, 1986), 
is enhanced in the presence of phosphatidylserine. 
Similar findings have also been reported for Ptdins(4)P 
5-kinase purified from bovine brain (Moritz et al., 1992). 
These authors also demonstrated a 20-fold increase in enzyme 
activity in the presence of exogenous PtdOH. In addition, 
some species of Ptdins(4)P 5-kinase appear to be subject to 
feedback inhibition by the product, Ptdins(4,.5)P2 (Van 
Rooijen et al., 1985; Imai et al., 1986; Ling et al., 1989). 
In contrast, Ptdins(4)P 5-kinase activity in the particulate 
fraction of pituitary cells appears to be activated by 
Ptdins(4,5)P2 (Van Rooijen et al., 1985). The reliability 
of results concerning the lipid dependence of this enzyme 
remains in question due to the unknown nature of the sur­
rounding phospholipid environment. 
Cell fractionation studies have shown that most of the 
membrane-associated Ptdins(4)P 5-kinase activity is 
localized to the plasma membrane (Benistant et al., 1990; 
Uromow & Wieland, 1990 a). Ptdins(4)P 5-kinase has also 
been found in membranes of nuclei (Cocco et al., 1987), 
lysosomes, and Golgi (Cockcroft et al., 1985 a). 
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Since the cytosolic and membrane-associated Ptdins(4)P 
5-kinases have similar properties, one may speculate that a 
translocation process occurs in response to hormonal 
stimulation. To date, there are no published reports to 
either support or refute this hypothesis. In addition, the 
partial purification of a low-molecular weight GTP-binding 
protein capable of activating the soluble form of Ptdins(4)P 
5-kinase has recently been reported (Urumow & Wieland, 1990 
b); however, realization of the putative regulatory 
implications of this observation awaits further purification 
of this protein. 
C. Regulation of Polyphosphoinositide Synthesis 
A rise in the rate of synthesis of Ptdins(4)P and 
Ptdins(4,5)P2 must occur through one of several proposed 
mechanisms, including: an allosteric modification of the 
kinases; a change in substrate availability; or removal of 
end-product inhibition. Despite several reports of product 
inhibition of Ptdins and Ptdins(4)P kinases (Van Rooijen et 
al., 1985; Imai et al., 1986; O'Shea et al., 1986), it is 
unlikely that this mechanism would account for the complete 
recovery of Ptdins(4)P and Ptdins{4,5)P2 levels during 
prolonged stimulation of PLC {Thomas et al., 1984). There­
fore, an increase in the net synthesis of the polyphosphoi­
nositides appears likely. 
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One possibility may involve the direct receptor­
mediated activation of Ptdins or Ptdins(4)P kinases. 
Currently, there is very little positive evidence in the 
literature for receptor-mediated activation of lipid kinases 
during stimulation. A clear indication that stimulation 
does indeed occur would be the demonstration that hormones 
increase (32P]P04-labeling of the monoester phosphates of 
phosphoinositides in cells incubated with [32P]Po4. 
Unfortunately, the complexities associated with this type of 
non-equilibrium labeling study (see section III B.1) have, 
for the most part, precluded any attempt to measure agonist­
induced changes in Ptdins(4)P or Ptdins(4,5)P2 synthesis. 
Nonetheless, there have been several reports of hormone­
mediated increases in (32P]P04-labeling of Ptdins(4)P and 
Ptdins{4,5)P2 under these conditions. For example, EGF 
stimulation of A431 cells caused an increase in poly­
phosphoinositide labeling, which may be largely explained by 
a corresponding increase in the [32P]P04-specific radioac­
tivity of [r-32P]ATP (Macara, 1986). Similar increases in 
specific [32P]P04-labeling of metabolic ATP and poly­
phosphoinositides have been observed in platelets (Verhoeven 
et al., 1987b) and GH3 pituitary cells (Imai & Gershengorn, 
1986) following stimulation with thrombin and thyrotropin­
releasing hormone, respectively. 
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Several studies conducted on various fractions isolated 
from treated cells have also provided useful information 
regarding the ability of certain receptor agonists to 
modulate lipid kinase activities. Walker & Pike (1987) 
demonstrated that Ptdins 4-kinase activity was increased in 
membranes derived from A431 cells pretreated with EGF. 
Analysis of the time course indicates that activation of 
Ptdins kinase was maximal after 2 min. Kinetic analysis 
revealed that EGF caused a decrease in the Kro for Ptdins 
utilization, with no change in the Vmax· Similarly, che­
moattractants and leukotriene B4 cause a rapid stimulation 
of Ptdins(4)P 5-kinase activity in a particulate fraction 
derived from intact neutrophils (Pike et al., 1990). Line­
weaver-Burk analysis showed that this effect was due to an 
increase in the Vmax of the reaction, with no change in the 
Kro for ATP. Surprisingly, these are the only published 
reports demonstrating agonist-mediated regulation of lipid 
kinase activities. 
Several studies have indicated that G proteins may be 
involved in the regulation of Ptdins 4-kinase (Chahwala et 
al., 1987) and Ptdins(4)P kinase activities (Uromow & Wie­
land, 1986; Smith & Chang, 1989); however, the validity of 
these results has been questioned (Benistant et al., 1990). 
These investigations relied upon the use of stable GTP 
analogues which were subsequently shown to cause 
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stabilization of [r-32P)ATP in the kinase assay system 
(Benistant et al., 1990). Therefore, the role of G proteins 
in regulation of polyphosphoinositide synthesis remains 
unclear. 
Accumulating evidence suggests that Ptdins kinase may 
be regulated by second messengers including diacylglycerol 
(de Chaffoy de Courcelles et al., 1984) and cAMP (Holland et 
al., 1988; Kato et al., 1989). Furthermore, regulation may 
involve PKC- and PKA-dependent pathways (Giraud et al., 
1988; Quist et al., 1989; Yamamoto & Lapetina, 1990). 
However, convincing evidence favoring a PKC or cAMP-mediated 
activation of Ptdins 4-kinase is still fragmentary. 
Small molecules and peptides have also been shown to 
directly interact with these kinases. For example, 
trifluoperazine and polyamines are capable of increasing 
Ptdins kinase activity (Husebye & Flatmark, 1988; Vogel & 
Hoppe, 1986). Mastoparan and cardiotoxin also modulate 
Ptdins kinase activity (Eng & Lo, 1990; Walker & Pike, 
1990); however, the exact mechanisms underlying these 
interactions remain undefined. 
IV. RATIONALE FOR PROJECT 
Although the polyphosphoinositides constitute only a 
minor fraction of the total cellular phospholipids, their 
essential role in the regulation of pancreatic acinar cell 
function has been well documented. 
Secretagogues of the exocrine pancreas such as CCh 
exert their primary action on the surface of the acinar cell 
51 
to promote the breakdown of Ptdins(4,5)P2, giving rise to 
the second messengers, DAG and InsP3• Clearly, the con­
tinued generation of these molecules is dependent upon the 
availability of the agonist-sensitive pool of Ptdins(4,5)P2. 
Although the mechanisms underlying the PLC-mediated hydroly­
sis of Ptdins(4,5)2 have been thoroughly elucidated, those 
mechanisms responsible for the replenishment of 
Ptdins(4,5)P2 following stimulation have not been adequately 
defined. 
The synthesis of Ptdins(4,5)P2 from Ptdins is mediated 
by Ptdins 4-kinase and Ptdins(4)P 5-kinase, both of which 
represent possible targets for regulation. Our 
understanding of polyphosphoinositide synthesis is in its 
infancy; however, there are several published reports 
demonstrating that recepter-agonists (Walker & Pike, 1987; 
Pike et al., 1990) and second-messengers (Kato et al., 1989; 
Quist et al., 1989) are capable of modulating lipid kinase 
activities. 
The primary objective of this study is to evaluate 
whether secretagogues of the exocrine pancreas regulate the 
synthesis of polyphosphoinositides; and if so, what are the 
mechanisms involved. Therefore, this investigation will 
describe the localization and characterization of Ptdins 4-
kinase activity in pancreatic acinar cells, as well as its 
modulation by muscarinic-receptor agonists. The regulation 
of Ptdins(4)P synthesis by PKC- and PKA-dependent pathways 
will also be evaluated. Finally, the effects of EGF on 
Ptdins 4-kinase activity will be investigated to address 
whether this enzyme may represent a pivotal target for 
cellular regulation initiated by the various signaling 
pathways of the exocrine pancreas. 
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I. Materials 
Materials and Methods 
(r-32P]ATP (6000 Cijmmol) and [32P]P04 were obtained 
from New England Nuclear (Boston, MA). Collagenase (0.48 
unitsjmg) derived from Clostridium histolyticum, leupeptin, 
para-nitrophenylphosphate, and Ptdins(4)P were obtained from 
Boehringer-Mannheim (Indianapolis, IN). Ptdins(4,5)P2 and 
staurosporine were from Calbiochem (San Diego, CA). OAG was 
from Serdary Research Laboratories (London, ONT) . EGF was 
obtained from Upstate Biotechnology Incorporated (Lake 
Placid, NY). Vasoactive Intestinal Peptide was from 
Peninsula Laboratories (Belmont, CA). Purified 
phospholipase c was from American Radiolabeled Chemicals 
(St. Louis, MO). Rabbit anti-cAMP was from Kew Scientific 
(Columbus, OH). All other chemicals were obtained from 
Sigma Chemical Company (St. Louis, MO). 
II. Methods 
A. Preparation of Dispersed Acini 
Male Sprague-Dawley rats, weighing approximately 175 g, 
were fasted 16 hr. prior to sacrifice by decapitation. 
Pancreatic acini were prepared by a modification of the 
method of Halenda and Rubin (1982) utilizing the following 
53 
54 
procedure. After the abdominal cavity was opened, the 
pancreas was removed and placed in 5 ml of a pH 7.4 Krebs­
Henseleit medium containing in millimolar: NaCl, 98.3; KCl, 
4.7; KH2P04, 1.2; CaC12, 0.1; Mgso4, 1.2; NaHC03, 2.5; 
HEPES, 10; and glucose, 11. The media was supplemented with 
soybean trypsin inhibitor (0.1 mgjml), 2% (vjv) essential 
amino acids (SOX), and 0.25% (wjv) BSA and maintained under 
an atmosphere of 95% o2 and 5% co2. The pancreas was dis­
sected free of fat, lymph nodes, and large blood vessels -and 
minced with a surgical scissor. The minces were rinsed 
twice in the above media, resuspended in 10 ml of medium 
containing 80-100 unitsjml collagenase, and incubated for 10 
min at 37°C in an Orbit shaking water bath oscillating at 
150 cyclesjmin under an atmosphere of 95% o2 and 5% co2. 
The media was then replaced with 10 ml of fresh digestion 
media and incubation continued for an additional 5 min. 
Acini were dispersed by vigorous shaking, and the 
suspension filtered through nylon mesh (150 urn). The 
filtrate was layered over 10 ml of Krebs-Henseleit media 
containing amino acids, trypsin inhibitor, 4% (wjv) BSA, and 
1.2 mM cac12 in 15 ml tapered polypropylene centrifuge 
tubes. The tubes were centrifuged for 5 min at room 
temperature at 50 x g in a Sorvall GLC centrifuge. The 
undigested tissue was resuspended in 10 ml of the digestion 
media and shaken vigorously for an additional 3 min. The 
suspension was then filtered and centrifuged as described 
above. The filtration and washing procedures facilitate the 
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removal of cell debris and collagenase from the preparation 
(Amsterdam et al., 1978). Following two additional wash 
steps, the acini were resuspended in the same buffer 
containing 1% BSA. The acini were incubated for 30 min at 
37° C under 95% o2 and 5% co2 to provide a recovery period 
prior to a final resuspension in 10 ml of Krebs-Henseleit 
buffer (KHB) containing 0.1% BSA. A cell density equivalent 
to 0.2- 0.5 mg proteinjml was provided by this procedure. 
KHB was used for all subsequent incubations except when 
prelabeling acini with [3
2
P]P04, in which case the KH2Po4 
concentration was reduced from 1.2 mM to 0.01 mM . 
Viability of the acini, as assessed by the ability to 
exclude trypan blue, was approximately 95%. This 
preparation consists of greater than 90% acini with a small 
number of individual acinar cells. Although intact islets 
of Langerhans, vascular cells, or ductal cells were not 
observed, a small contribution to the observed responses 
cannot be completely ruled out. However, the susceptibility 
of these cell types to collagenase digestion as well as the 
relative dearth of these cells, less than two per 100 
acinar cells (Williams et al., 1978; Schulz, 1987), 
minimizes the probability that these cell types contribute 
to the experimental results presented throughout this study. 
B. Preparation of homogenates and subcellular fractions 
Following incubation of acini with various agonists, 
aliqots of the suspension were removed and placed in ice­
cold 1.8 ml microfuge tubes and immediately microfuged for 5 
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sec at 15,600 x g to pellet the acini. The supernatant was 
discarded and the cell pellet washed with ice-cold Krebs­
Henseleit media containing 0.25% BSA. The suspension was 
microfuged again and the pellet resuspended in ice-cold 
Ptdins kinase reaction buffer (pH 7.0) containing in 
millimolar: HEPES, 30; MgC12, 20; EGTA, 1; plus soybean 
trypsin inhibitor (0.1 mgjml), leupeptin (5 ugjml), 
pepstatin A (1 ugjml), and phenylmethylsulfonylfluoride (300 
uM) . For experiments characterizing the effects of N6-
monobutyryl cAMP on Ptdins Kinase activity, the broad­
spectrum phosphatase inhibitor, para-nitrophenylphosphate, 
was included at a concentration of 10 mM. The rationale for 
the inclusion of this inhibitor was based upon the finding 
that the cAMP-mediated increase in Ptdins kinase activity 
diminished in a time-dependent manner. In the presence of 
the phosphatase inhibitor, the observed stimulation was 
sustained for a greater length of time. 
For experiments in which the pH was varied, the buffer 
system was changed accordingly to allow for buffering over 
the appropriate pH range. The buffer systems were as 
follows: sodium acetate-acetic acid (pH range 4.5 - 5.5); 
MES (pH=6.5); HEPES (pH=7.0); and Tris-HC1 (pH range 7.5-
9.0). For experiments designed to elucidate the subcellular 
distribution of Ptdins kinase activity, a Ptdins kinase 
reaction buffer which more closely mimicked the 
intracellular milieu was utilized (Channen & Leslie, 1990). 
This reaction buffer was identical to the HEPES buffer 
routinely employed; however, KCl (140 mM) and NaCl (lOmM) 
were also included. The pH was adjusted to 7.0 with KOH. 
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Cell suspensions in the various reaction buffers (0.2-
0.5 mgjml) were homogenized on ice for 6 sec using a 
Brinkmann polytron at the maximum setting. Homogenization 
was carried out in a volume of 500 ul. This protocol 
resulted in a homogeneous mixture as determined visually 
under a light microscope and provided consistency among 
various preparations. The homogenate was then centrifuged 
for 10 min at 120 x g in a Jouan CR-412 centrifuge at 4°C. 
The pellet which contained whole cells, intact nuclei, and 
large cell debris, was discarded. Recovery of Ptdins 4-
kinase activity from this first centrifugation averaged 65-
85%. The supernatant (cell-free extract) was centrifuged 
for 60 min at 100,000 x g in a Beckman L5-65B 
ultracentrifuge at 4°C. The resulting supernatant was 
designated s1 and represented soluble material. The pellet 
was resuspended in a small volume (usually 200-300 ul) of 
the homogenization buffer and designated as P1. This 
fraction contained plasma membranes, intracellular organelle 
membranes, as well as intact organelles which may have 
survived the homogenization procedure. 
Purified zymogen granule membranes were prepared as 
described previously (Rubin et al., 1990; 1991) with the 
following modifications. Following isolation from 
pancreatic minces using 50% Percoll, the granules were lysed 
by high pH solution; the lysate was applied to a step 
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gradient containing 10% sucrose plus 600 mM NaCl layered 
over 20% sucrose to separate soluble components from the 
pellet. The purity of the granule membrane fraction was 
verified by the complete absence of mitochondria or plasma 
membranes (as assessed by enyzme markers) and a six-fold 
enrichment of amylase in the washed granule fraction 
relative to the crude homogenate ( M. Withiam-Leitch person­
al communication) . Protein was determined according to the 
method of Bradford (1976) using BSA as a standard. 
C. Measurement of Ptdins kinase Activity 
Ptdins kinase activity was determined using homogenates 
or subcellular fractions derived from acini or minces which 
had been stimulated with various agonists. Enzyme activity 
was measured by quantitating the transfer of the r-phosphate 
from [r-32P]ATP to either endogenous or exogenously added 
Ptdins. Assays were carried out in the homogenization 
buffers described above and contained 15-75 ug protein and 
0.5 mM [r-32P]ATP (1.5-4.5 uCijml) in a total volume of 75-
100 ul unless otherwise noted. Calcium was not included 
because of its well-known ability to retard Ptdins 4-Kinase 
activity in vitro (Husebye and Flatmark, 1988; Asotra et 
a1., 1991; Jenkins et al., 1991). 
Reactions were initiated by the addition of [r-32P]ATP 
to the preparation and terminated by removing aliquots (50-
85 ul) at the appropriate time. Aliquots were placed in 12 
x 75 mm borosilicate tubes containing 575 ul of 
chloroform/methanol (1:2 vjv) plus 0.005 N HCl. The 
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phospholipids were extracted according the method of Bligh 
and Dyer (1959) as modified by Lapetina and Michell (1972). 
Tubes were allowed to stand covered at room temperature for 
30 min, after which time 185 ul chloroform was added. Each 
tube was vortexed for 30 sec and 185 ul of 2 M KCl was 
added. The tube was again vortexed for 30 sec and centri­
fuged for 2 min at 1500 x g to allow phase separation. The 
organic layer was transferred to a tube using a 5 3/4 inch 
Pasteur pipet. The aqueous phase was re-extracted with 300 
ul chloroform and centrifuged a second time. The organic 
phase was removed and combined with that from the first 
extraction. The pooled organic phase was washed with 250 ul 
of methanol/1N HCl (1:1 vjv) by vortexing for 30 sec and 
then centrifuged to separate the phases. The organic phase 
was then transferred to a borosilicate tube (12 x 75 mm) and 
the lipid extract dried under nitrogen and redissolved in 50 
ul of chloroform/methanol (9:1 vjv). 
Ptdlns(4)P and Ptdlns(4,5)P2 were separated from other 
radioactive phospholipids by thin layer chromatography (TLC) 
in one dimension as described by Schacht (1978). The method 
employs 20 x 20 em plates coated with 0.25 mm silica gel G 
(Merck) and a solvent system of chloroformjmethanoljammonium 
hydroxide/water (90:90:7:20 by volume). TLC plates were 
heat activated for 120 min at 100°C to remove moisture prior 
to the application of lipid extracts. The spots described 
by Schacht as being Ptdlns(4)P and Ptdlns(4,5)P2 co-migrated 
with authentic standards. Radioactive phospholipids were 
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visually detected by autoradiography. 
Areas corresponding to Ptdlns(4)P and Ptdlns(4,5)P2 
were scraped into scintillation vials, 5 ml of Beckman Ready 
Value scintillation cocktail added, and radioactivity 
quantified by counting for 5 min in an LKB-1211 liquid­
scintillation counter. The 32p window background 
(approximately 20 cpms) was subtracted from sample 
radioactivity. Enzyme activity was calculated using the 
specific activity of the [r-32P]ATP. Assays were done in 
duplicate or triplicate. Data are expressed as pmols of 
Ptdlns(4)P formed per mg of protein per min or as a 
percentage of control values. 
D. Linearity of Ptdlnsl4lP formation 
To determine the time course over which product 
formation remained linear using homogenates or purified 
zymogen granule membranes, assays were conducted in a total 
volume of 575 ul and contained 50 ug of total protein. The 
phosphorylation of exogenous Ptdlns (50 uM) was monitored by 
removing 50 ul aliqots of the reaction mixture at various 
times and [32P]Ptdlns(4)P extracted and analyzed as 
described above. Assays were done in triplicate and the 
data expressed as a percentage of maximal activity. 
E. Determination of Ptdlnsl4lP Stability 
To establish that [32P]P04 incorporation into 
Ptdlns(4)P was an accurate reflection of synthesis and was 
not significantly affected by breakdown of [32P]Ptdlns(4)P 
by phospholipase C or phosphomonoesterase activities within 
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the kinase assay itself, the homogenate was prelabeled with 
0.5 mM (r-32P]ATP and breakdown monitored over time 
following the addition of a large excess of non-radioactive 
ATP. After a 45 sec prelabeling period, an aliquot was 
removed and (32P]Ptdlns(4)P was extracted and analyzed as 
described above. Unlabeled ATP (50 mM) was added to the 
remaining mixture to prevent additional [32P]Ptdins(4)P 
formation. Aliquots of the quenched reaction mixture were 
taken after an additional 4 min and analyzed for 
(32P]Ptdlns(4)P. These values were compared with the values 
following the 45 sec labeling period to determine whether 
Ptdins(4)P degradation occurred during the assay. 
F. Identification of Phosphoinositides 
To date at least two major classes of Ptdlns kinase 
have been described (Whitman et al., 1987). The type 1 
Ptdlns kinase is responsible for phosphorylation of the D-3 
position of the inositol ring giving rise to the novel 
polyphosphoinositide, Ptdins(3)P. The function of this 
phosphoinositide remains unclear. Type 2 Ptdlns kinase 
phosphorylates the D-4 position of the inositol ring leading 
to the formation of Ptdlns(4)P, the immediate precursor for 
Ptdlns(4,5)P2. Although Ptdlns(3)P has an Rf value slightly 
different from that of Ptdlns(4)P in some thin-layer chro­
matography systems (Whitman et al., 1988), no system has yet 
been developed that reproducibly resolves these two isomers. 
Rigorous proof of the structure of the reaction product is, 
of course, necessary to identify conclusively the kinase 
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which we are studying. This involves the deacylation of the 
phosphoinositide using methylamine reagent and the subse­
quent separation of the glycerophosphoinositol esters by 
anion-exchange chromatography. 
To demonstrate conclusively that the enzyme being 
studied was in fact a type 2 Ptdins kinase, the reaction 
product was analyzed according to the following procedure. 
Ptdins kinase activity was measured essentially as described 
with several modifications. Because Ptdins(3)P comprises 
less than 5% of the total PtdinsP within the cell, it was 
necessary to increase the radioactivity to provide an ade­
quate signal. To accomplish this, the amount of unlabeled 
ATP was reduced from 500 uM to 350 uM and the radioactivity 
was increased by an order of magnitude (45 uCijml). The 
radiolabeled phosphoinositides were then extracted as de­
scribed above. The phospholipids were separated by thin­
layer chromatography using aluminum-backed Whatman silica 
plates (20 x 20 em). The plates were impregnated with 
potassium oxalate by predeveloping them for 1 hr in 1% po­
tassium oxalate, 50% methanol and air-dried overnight. 
Plates were heat-activated at l00°C for 1 hr prior to use 
and developed in a solvent system of chloroformjmethano1/ 
ammonium hydroxidejwater (90:90:7:20 by volume). The region 
of the chromatography plate corresponding to PtdinsP (as 
determined by co-migration with authentic Ptdins(4)P stan­
dard) was excised and deacylated according to the procedure 
of Clark & Dawson (1981) as modified by Auger et al. (1989). 
This method will not yield intact lipids but it avoids the 
tedious process of lipid elution from silica gel. It is 
also particularly useful to study the position of the 
phosphate headgroups on polyphosphoinositides. The lipids 
were washed with 1 ml chloroform and an equal volume of 
methanol/0.1 M EDTA (1:0.9 vjv) and dried under N2. Methy­
lamine reagent ( 3 ml) (42.8% of 25% methylamine in H2o, 
45.7% methanol, and 11.4% n-butanol) was added to the dried 
lipids. 
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Lipids were solubilized in a tightly stoppered tube by 
heating at 53°C for 50 min. The mixture was cooled on ice 
and 1.5 ml of ice-cold n-propanol added to prevent frothing 
during the evaporation step. The mixture was then dried in 
vacuo. H2o ( 1 ml) was added to the residue and the sample 
dried again. The samples were resuspended in 1 ml of H2o 
and extracted twice with an equal volume of n-butanoljlight 
petroleum etherjethyl formate (20:4:1 vjv) to neutralize any 
remaining monomethylamine. After shaking and centrifuga­
tion, the lower aqueous layer containing the water-soluble 
deacylation products was carefully removed and dried in 
� and stored at -70°C until it was used. 
G. HPLC analysis of deacylated reaction products 
Since the headgroups of the polyphosphoinositides are 
much more polar than those of other lipids, the glycer­
ophosphoinositol (GroPins) esters derived from the deacyla­
tion procedure outlined above may be readily separated by 
anion-exchange chromatography (Creba et al., 1983). This 
analysis was done as described by Auger et al. (1989}. 
Glycerophosphoinositols were eluted from a 4.6 mm x 100 mm 
Partisphere SAX column (Whatman) on a gradient of 
(NH4)2HP04. Dual pumps were used to establish a gradient 
from 0 to 1.0 M (NH4)2HP04 over 130 min. Pump A contained 
H2o and pump B contained 1.0 M (NH4)2HP04 which had been 
adjusted to pH 3.8 with phosphoric acid. The. gradient was 
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developed as follows: time 0-10 min, 0% B, followed by a 
gradient to 25% B over 60 min and then to 100% B over 50 min 
at a flow rate of 0.5 mljmin. Eluate from the HPLC column 
flowed into an on-line continuous flow scintillation detec-
tor (Radiomatic Instruments) for isotope detection and data 
were transmitted to a Macintosh SE for further analysis. 
GroP[3H]Ins, GroP[3H]Ins(4)P, and GroP[3H)Ins{4,5)P2 stan­
dards were prepared by deacylation of Ptd[3H]Ins, 
Ptd[3H]Ins(4)P, and Ptd[3H]Ins (4,5)P2, respectively. They 
were run simultaneously with the deacylated [32P)P04-labeled 
product of the Ptdins kinase assay. 
H. Kinetic Analysis of Ptdins 4-kinase Activity 
To determine the kinetic properties of Ptdins 4-kinase 
with respect to the utilization of Ptdins, the endogenous 
stores of Ptdins in acinar homogenates were depleted prior 
to the assay. To accomplish this, control and agonist­
stimulated acini were homogenized as described above. The 
homogenization buffer for this procedure lacked EGTA and 
contained 100 uM calcium to maintain endogenous phospholi-
pase C activity. Purified Ptdins-specific phospholipase c 
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(0. 9 unitsjml) was then added to the homogenate (0.5-1. 5 mg 
proteinjml) and incubation was carried out for 15 min at 
37°C. One unit of phospholipase c is defined as the amount 
of enzyme which hydrolyzes one micromole of Ptdlns per min 
at 37°C. After 15 min, endogenous phospholipase C activity 
was inactivated by chelating the calcium with ice-cold 
homogenization buffer containing 1 mM EGTA. This procedure 
failed to inactivate the exogenously added Ptdlns-specific 
phospholipase C as the purified enzyme lacks an absolute 
calcium requirement. Thus, the amount of exogenous Ptdlns 
subsequently added for the kinetic analysis was corrected 
for the slight breakdown produced by residual phospholipase 
activity based upon optimal conditions. Ptdlns kinase 
activity was determined as described above. In the absence 
of exogenous Ptdlns, basal Ptdlns(4)P formation in phospho­
lipase c-treated homogenates was completely abolished, 
suggesting that the pool of Ptdlns utilized by Ptdlns 4-
kinase was completely depleted by the phospholipase c treat­
ment. Upon administration of exogenous Ptdlns in varying 
concentrations, accurate kinetic parameters were attainable. 
To analyze the utilization of Ptdlns by Ptdlns 4-kinase, 0-
50 uM Ptdlns was added. A near-saturating concentration of 
ATP (300 uM) was also employed for these studies. 
To study the utilization of ATP by the enzyme, 
Ptdlns(4)P formation was measured in the presence of 0-500 
uM ATP using a near-saturating concentration of 50 uM 
Ptdlns. For experiments designed to elucidate the effect of 
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N6-monobutyryl cAMP on the utilization of ATP by Ptdins 
kinase, a slightly different protocol was employed. 
Homogenates derived from control or stimulated acini were 
not depleted of endogenous Ptdins prior to the Ptdins kinase 
assay. As mentioned above, the N6-monobutyryl cAMP-mediated 
increase in Ptdins kinase activity appeared to be more 
labile than that of CCh. Even in the presence of para­
nitrophenylphosphate, the cAMP-mediated effect diminished in 
a time-dependent manner. Therefore, to minimize the time 
interval between the preparation of the homogenate and the 
Ptdins kinase assay, the phospholipase C treatment step was 
omitted. Omission of this step provided consistent results, 
while maintaining the validity of the kinetic parameters 
determined for ATP utilization. 
I. Preparation of Triton X-100/Ptdins Mixed Micelles 
For kinetic experiments, as well as those designed to 
elucidate the subcellular distribution of Ptdins kinase 
activity, exogenous Ptdins was utilized. Ptdins was 
solubilized in reaction buffer containing 1% (vjv) Triton X-
100. This procedure results in the formation of uniform 
Triton X-100/Ptdins mixed micelles (Ganong & Lu, 1989). 
This mixed micelle system is believed to provide an environ­
ment that mimics the physiological surface of the membrane 
(Dennis, 1983; and Hannun et al., 1985). To accomplish 
this, 10 ul of Ptdins (10 mgjml in chloroform) was trans­
ferred to a 1.8 ml microfuge tube and dried under a stream 
of N2. Reaction buffer (100 ul) containing 1% (vjv) Triton 
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X-100 was then added to the dried Ptdins. The solution was 
then vortexed briefly and sonicated for 5 min using a Cole­
Farmer sonication bath. The sample was kept chilled by the 
addition of ice to the bath. After 5 min, 120 ul of buffer 
containing 1% Triton X-100 was added. This mixture was 
diluted ten-fold into the reaction mixture to provide a 
final concentration of 45 ugjml Ptdins (50 uM) in 0.1% 
Triton X-100. The enzyme preparation was then preincubated 
with the Triton X-100/Ptdins mixed micelles for 5 min prior 
to the addition of [r-32P]ATP. This preincubation allows 
the Ptdins kinase to interact with the mixed micelle accord­
ing to the dual phospholipid kinetic model (Buxeda et al., 
1991). 
J. Measurement of Ptdins(4)P 5-kinase Activity 
Following the phosphorylation of Ptdins on the D-4 
position of the inositol ring by Ptdins 4-kinase, a 
subsequent phosphorylation on the D-5 position results in 
the generation of Ptdins(4,5)P2. This second phosphoryla­
tion is catalyzed by Ptdins(4)P 5-kinase. Using a similar 
protocol to that employed for the measurement of Ptdins 4-
kinase, Ptdins(4)P 5-kinase activity could also be deter­
mined. Homogenates derived from acini previously stimulated 
with CCh were used as the source of enzyme. Enzyme activity 
was assessed by quantitating the transfer of the r-phosphate 
from [r-32P]ATP to exogenously added Ptdins(4)P. Ptdins(4)P 
micelles were prepared in the absence of Triton X-100 due to 
the inhibitory effect of the detergent on Ptdins(4)P 5-
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kinase activity. Assays were carried out in standard homog­
enization buffer and contained 200-300 ug protein in a total 
volume of 275 ul. Homogenates were preincubated for 2 min 
with Ptdlns(4)P (100 ugjml) prior to initiation of the 
reaction with (r-32P]ATP. The reactions were terminated by 
removing aliquots (60 ul) at the appropriate times. 
(32P]Ptdlns(4,5)P2 was extracted and analyzed as described 
above. 
K. Polyphosphoinositide Metabolism Studies 
The metabolism of polyphosphoinositides was examined by 
measuring the release of radioactivity from r32P]P04-
prelabeled phospholipids according to the method of Putney 
et al. (1983). Pancreatic acini (50 mg protein/ml) were 
prelabeled with (32P]P04 (25 uCijml) in low-phosphate Krebs­
Henseleit buffer containing 0.1% BSA for 60 min, after which 
time radioactivity associated with Ptdins(4)P or 
Ptdlns(4,5)P2 did not increase further. The prelabeled 
acini were centrifuged for 5 min at 50 x g and resuspended 
at a final concentration of 0.2-0.5 mg proteinjml in media 
containing 0.1% BSA plus (32P]P04 (25 uCijml). Agonists 
were added to the prelabeled acini and aliquots of the 
suspension were removed at various times for analysis. 
Aliquots (200 ul) were removed and placed in 16 x 100 mm 
borosilicate tubes containing 2.25 ml of chloroform/methanol 
(1:2 vjv) plus 0.005 N HCl. The phospholipids were extract­
ed as described above using the appropriate volumes. Since 
there was insufficient Ptdlns(4)P or Ptdlns(4,5)P2 present 
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for chemical determination, the extent of radioactive label­
ing is expressed as a percentage of a control value prior to 
drug addition (time zero). 
L. Measurement of cAMP levels in Pancreatic Acini 
Cyclic AMP levels were determined in pancreatic acini 
by radioimmunoassay according to the method of Brooker et 
al. (1979). Briefly, cells were exposed to agonist prior to 
extraction with 9% trichloroacetic acid (TCA). Following 
the removal of TCA with three ether extractions, cyclic 
nucleotides were acetylated using triethylamine and acetic 
anhydride to improve assay sensitivity and antibody 
selectivity. Acetylated samples (and standards) were 
incubated with rabbit anti-cAMP and succinyl cAMP [l25I] 
tyrosyl methyl ester (10,000 cpms;tube) for 18 hours to 
allow complete equilibration. A charcoal adsorption 
technique was utilized to separate free and bound cAMP. 
Following centrifugation for 10 min at 1500 x g, aliquots of 
the supernatant were removed and counted for 5 min in .a 
Beckman gamma counter (#5500) to quantitate bound 125r­
labeled cAMP. Experimental values were calculated from the 
standard curve. All samples were done in triplicate and the 
data are expressed as pmol of cAMP/mg protein. 
M. Statistical Analysis. 
Differences were determined by one or two way analysis 
of variance using Duncan's multiple comparisons test or by 
paired Student's t-test. Data represent means (±S.E.M.), 
and a level of P<0.05 was required for significance. 
RESULTS 
I. Characterization and Localization of Ptdins kinase. 
To optimize the conditions for the measurement of 
Ptdins 4-kinase activity in pancreatic acini, we 
investigated the kinetics of [32P]Ptdins(4)P formation. 
[32P]Ptdins(4)P formation remained linear for only a brief 
period of time ( 15-75 sec) when the homogenate was used as 
the source of Ptdins 4-kinase activity (Fig. 4 A). After 2-
3 min, the rate of [32P]Ptdins(4)P formation diminished. In 
contrast, the reaction velocity of the enzyme in purified 
zymogen granule membranes remained linear for 5-10 min (Fig. 
4 B) . This was probably a consequence of the removal of 
degradative enzymes. Therefore, reactions were carried out 
at 30°C for either 45 sec or 5 min, depending upon the 
preparation employed. 
Since the homogenates in which Ptdins 4-kinase activity 
was measured may contain phosphomonoesterase andjor 
phospholipase activities, the stability of [32P]Ptdins(4)P 
was determined using a pulse-chase procedure as described in 
Materials and Methods. When excess unlabeled ATP (50 mM) 
was added to the standard reaction mixture, the formation of 
radiolabeled Ptdins(4)P ceased, with little breakdown of 
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Figure 4. Time-course of r32PJPtdinsC4lP formation in 
acinar homogenates and purified zymogen granule 
membranes. 
Homogenates (A} and purified zymogen granule membranes (B) 
were incubated with exogenous Ptdins (50 uM) and 300 uM 
[ �2
32P]ATP at 30° c for the indicated times. 
[ P]Ptdins(4)P was analyzed as described in Materials and 
M��hods. The data are expressed as a percentage of maximal 
[ P]Ptdins(4)P formation which were 1049 (±116) and 4097 
(±1264) pmol Ptdins(4)P formedjmg protein for homogenates 
and granule membranes, respectively. Values represent the 
means (± S.E.M.) from three independent experiments. 
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Figure 5. Effect of excess unlabeled ATP on r32PJPtdins(4)P 
formation. 
Homogenates were incubated with 500 uM [r-32P)ATP for 45 sec 
a% which time an aliquot was removed to quantitate 
[ 2P]Ptdins{4)P formation. The remaining mixture received 
buffer (solid line) or a pulse of excess unlabeled ATP (50 
mM ) (dotted line). [32P]Ptdins(4)P formation was measured 
after an addition�! 4 min. Data are expressed as a percent­
age of maximal [3 P]Ptdins(4)P formation which was 192 (±5) 
pmol Ptdins{4)P formed 1 mg protein. Each value was deter­
mined in triplicate and the results given as the mean of two 
independent experiments. 
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[32P]Ptdlns(4)P occurring under the conditions of our assay 
during the 5 min time period examined (Fig. 5). The 
negligible loss of radiolabeled Ptdlns(4)P indicates that 
[32P]P04 incorporation into Ptdins(4)P is a reliable 
estimate of phosphoinositide synthesis elicited by Ptdins 
4-kinase, thus validating the assay system. 
The incorporation of [32P]P04 into [
32P]Ptdins(4)P by 
Ptdins 4-kinase was linear with respect to protein 
concentration (Fig. 6). Product formation remained linear 
up to a concentration of 2.5 mgjml; therefore, subsequent 
assays were performed with protein concentrations less than 
this value. 
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To further optimize the enzyme assay, the pH optimum 
for Ptdins 4-kinase was determined. The pH profile of 
Ptdins 4-kinase activity of acinar homogenates was very 
broad, with the highest activity in the pH range of 5.5-8.5 
(Fig. 7 A). The pH profile of the zymogen granule membrane 
Ptdins 4-kinase was also very broad, with optimal activity 
in the pH range of 5.5-9.0 (Fig. 7 B). Therefore, reactions 
were conducted at pH 7.0 for all subsequent studies. 
To determine the properties of substrate utilization by 
Ptdins 4-kinase, acinar homogenates were pretreated with 
phospholipase C to deplete the stores of endogenous Ptdins 
prior to the assay (see Materials and Methods). The effect 
of increasing ATP concentrations on Ptdins 4-kinase activity 
is shown in Fig. 8 A. Saturation of enzyme activity was 
observed at concentrations of ATP above 300 uM. Analysis of 
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Figure 6. Protein-Dependence of r32PJPtdins(4)P formation. 
Ptdins kinase activity was measured using acinar homogenates 
as the source of enzyme. Increasing amounts of protein were 
added to the standard assay which was carried out at 30° c 
for 45 sec. Values represent the means ( ±S.E.M.) from 
three separate experiments. 
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Figure 7. The pH dependence of Ptdins 4-kinase activity in 
homogenates and purified zymogen granule 
membranes. 
Ptdins kinase activity was determined in acinar homogenates 
(A) and purified granule membranes (B) using the following 
buffer systems; Sodium acetate-acetic acid (pH 4.5-5.5), 
MES (pH 6.5), HEPES (pH 7.0), and Tris-HCl (pH 7.5-9.0). 
Data are expressed as a percentage of maximal activity which 
averaged 79 (±16) and 280 (+67) pmol [32P]Ptdins(4)Pjmg 
protein per min for homogenates and granule membranes, 
respectively. Values are the means (± S.E.M.) for three 
independent experiments. 
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Figure 8. Ptdins and ATP dependence of Ptdins 4-kinase 
activity. 
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Assays were performed using homogenates which were depleted 
of endogenous Ptdins by treating with phospholipase C as 
described in Materials and Methods. Standard reactions were 
carried out in duplicate for 45 sec at 30° c (pH 7.0). (A) 
Dependence of Ptdins 4-kinase activity on increasing ATP 
concentrations was determined at a fixed concentration of 
Ptdins (50 uM). (B) Dependence of increasing Ptdins con­
centration using the same protocol, except that a fixed 
concentration of ATP (300 uM) was employed. Results shown 
are representative of six experiments. 
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the data according to Michaelis-Menten saturation kinetics 
revealed an average apparent � value of 63 (±5) uM and a 
Vmax of 123 (±16) pmoljmgjmin derived from six experiments. 
The effect of Ptdins concentration on Ptdins 4-kinase 
is shown in Fig. 8 B. Optimal activity was observed at a 
concentration of Ptdins greater than 30 uM .  Analysis of 
data from six experiments revealed an average apparent Km 
value of 5 (± 1) uM (assuming a molecular weight of 905 
gjmole for Ptdins) and a Vmax of 343 (± 47) pmoljmgjmin. 
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The different vmax values may be explained by the differing 
degree of saturation by the co-substrates (Segel, 1976). 
This curve was also used to approximate the concentration of 
endogenous Ptdins present in the homogenate. Using a non­
linear regression analysis, the concentration of Ptdins was 
determined to be 3-4 uM, a value similar to that observed in 
the pancreas as well as other systems (Farese et al., 1981; 
Walker and Pike, 1987). 
Subcellular fractionation of acini revealed that 97% of 
the Ptdins 4-kinase activity obtained from the acinar cell 
extract was associated with the 100,000 x g pellet (P1), 
thus indicating that the enzyme is predominantly membrane­
associated. The relative specific activity of the P1 
fraction was 1.6-fold greater than that of the homogenate, 
indicating an enrichment of Ptdins 4-kinase activity in the 
membrane fraction (Table 1) . The small amount of total 
activity present in the soluble fraction (S1) (19 pmoljmin) 
probably does not constitute a major source of enzyme 
Table 1. Subcellular distribution of Ptdins 4-kinase in 
pancreatic acini. 
Subcellular fractions were prepared and assayed for Ptdins 
4-kinase activity as described in Materials and Methods. 
Values are the means ± S.E.M. from three to six independent 
experiments. 
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Subcellular Relative Specific Activity Total Activity 
fraction pmoljmgjmin pmoljmin 
Homogenate (acini) 292 
± 
21 1352 
± 
256 
sl 15 ± 3 19 ± 4 
p1 557 ± 74 590 ± 187 
Homogenate (fragments) 244 
± 
5 3931 
± 
490 
Zymogen granule membranes 1466 
± 
405 107 
± 
34 
activity, since its relative specific activity was very low 
compared to the membrane-associated enzyme ( 15 versus 
557 pmoljmgjmin) (Table 1). 
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The zymogen granule membrane fraction derived from 
pancreatic minces also possessed Ptdins 4-kinase activity. 
Although this fraction contained only 3% of the total enzyme 
activity, the relative specific activity was six-fold higher 
than that of the homogenate (1466 versus 244 pmoljmgjmin) 
(Table 1). In all subsequent studies, crude acinar homage­
nates or purified zymogen granule membranes isolated from 
pancreatic minces were used. 
II. Regulation of Phosphoinositide metabolism by 
Muscarinic Agents. 
A. Carbachol-mediated r32PJPtdinsl4.5lP2 hydrolysis. 
Since the extent of Ptdins(4)P synthesis in the intact 
cell may reflect the relative contributions of phospholipase 
C as well as Ptdins kinase activities, the effect of CCh on 
[32P]Ptdins(4,5)P2 hydrolysis was examined in [
32P]P04-
prelabeled pancreatic acini. Stimulation of acini with CCh 
(50 uM) caused a rapid and pronounced decrease in 
[32P]Ptdins(4,5)P2 levels which became significant after 1 
min (Fig. 9). Furthermore, the CCh-mediated hydrolysis of 
[32P]Ptdins(4,5)P2 was concentration-dependent and maximal 
following stimulation with 50 uM CCh (Fig. 10). These 
results confirm the ability of CCh to catalyze the phospho­
lipase c-mediated hydrolysis of Ptdins(4,5)P2 (Putney et 
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Figure 9. Effect of CCh on r32PJPtdins(4,5lP2 levels. 
Acini were prelabeled for 60 min with [32P]P04 and then 
incubated in the absence (filled circles) or presence 
(filled triangles) of 50 uM CCh. Aliquots were removed and 
processed at the indicated times. Data are expressed as the 
percentage of basal values at time zero for control and CCh, 
which averaged 1469 (± 133) and 1872 (± 288) cpm, 
respectively. Values represent means (±S.E.M.) from three 
to six experiments. *significantly different from basal 
values at corresponding time points which did not change 
over time using a paired Student's t-test (P<0.05). 
0 .., 
0 0 "' 
• 
0 
.... 
(OJ9Z 9W!� JO %) 
� dS'tr-SUJP�d(dn) 
--1 10 
.., 
('I 
0 
0 
10 
86 
c 
:§ 
Q) 
E += 
87 
Figure 10. 
�oncentration-dependent effect of CCh on 
r 2PJ Ptdins(4.5lP2 levels. 
[32P]P04-prelabeled acini were incubated in the presence of 
varying concentrations of CCh for 1 min, at which time 
aliquots were removed and processed. Data are expressed as 
a percentage of the basal value at time zero which averaged 
1465 (±179) cpm and did not change over time. Values 
represent the means (±S.E.M.) from five experiments. *significantly different from control as determined by one­
way analysis of variance (P<0.05). 
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al.,l983; orchard et al., 1984). 
B. Mediation of Ptdlns(4lP synthesis by Muscarinic Agents 
To determine whether the stimulation of Ptdlns(4,5)P2 
hydrolysis was accompanied by an increase in polyphospho­
inositide synthesis, we examined the effect of CCh on Ptdlns 
4-kinase activity. In homogenates obtained from cells 
exposed to 50 uM CCh for various times, Ptdlns 4-
kinase activity was increased in a time-dependent manner, 
with maximal stimulation occurring after a 5 min stimulation 
(Fig. 11). Thus, in all subsequent experiments utilizing 
acini, Ptdlns 4-kinase activity was measured after a 5 min 
exposure to CCh. 
The addition of CCh (1-50 uM) to intact acini caused a 
concentration-dependent increase in Ptdlns 4-kinase activity 
in the corresponding homogenates (Fig. 12). A discernible 
but non-significant increase was detected with 1 uM CCh. 
The response was significantly increased with 10 and 50 uM 
CCh and then declined with higher CCh concentrations. 
The ability of CCh to stimulate Ptdlns 4-kinase 
activity localized to the zymogen granule membrane was also 
assessed. When pancreatic minces were exposed to 10 uM CCh 
and the zymogen granule membrane fraction subsequently 
isolated, Ptdlns 4-kinase activity was maximally and 
significantly increased after a 10 min exposure to CCh by an 
average of 164 (±26) percent of control (P<0.05) (n=4). 
Thus, there appears to be an enduring activation of Ptdlns 
4-kinase, which retains the state of CCh stimulation 
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Figure 11. Time-dependent effect of CCh on Ptdins 4-kinase 
activity measured in acinar homogenates. 
Intact acini were incubated with CCh (50 uM) for the times 
indicated prior to homogenization and assay of Ptdins kinase 
activity. Ptdins(4)P formation is expressed as a percentage 
of paired control values which averaged 162 (±15) pmol 
[32P]Ptdins(4)P formedjmg protein and did not change over 
time. Values are the means (±S.E.M.) of five independent 
experiments. *significantly different from control values 
as determined by one-way analysis of variance (P<0.05). 
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Figure 12. Concentration-dependent effect of CCh on Ptdins 
4-kinase activity. 
Intact pancreatic acini were incubated for 5 min in the 
absence or presence of varying concentrations of CCh. Acini 
were homogenized and assayed for Ptdins kinase activity. 
Data are the means (±S.E.M.) from three to five experiments. *significantly different from control as determined by one­
way analysis of variance. 
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Figure 13. Concentration-dependent effect of muscarine on 
Ptdins 4-kinase activity. 
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Intact acini were incubated for 5 min with increasing con­
centrations of muscarine prior to enzyme assay. Data are 
ex�ressed as a percentage of control values (181 ± 22 pmol 
[3 P)Ptdins(4)Pjmg protein). Values are the means (±S.E.M.) 
from five independent experiments. *significantly different 
from control values as assessed by one-way analysis of 
variance (P<0.05). 
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achieved in pancreatic minces. 
To further verify that the stimulation was mediated via 
muscarinic receptors, the muscarinic agonist, muscarine, as 
well as the antagonist N-methylscopolamine were employed. A 
5 min stimulation of intact acini with muscarine produced a 
concentration-dependent increase in Ptdlns 4-kinase activity 
in the corresponding homogenates (Fig. 13). The stimulation 
of enzyme activity induced by muscarine was observed over a 
range of concentrations (5-25 uM) which reflects its greater 
potency as a muscarinic receptor agonist (Dehaye et al., 
1984). Furthermore, the stimulatory effect of 10 uM CCh 
was blocked by the potent muscarinic antagonist, N­
methylscopolamine (Fig. 14). Thus, a 20 min pretreatment 
of intact acini with 1 nM N-methylscopolamine reduced CCh­
stimulated Ptdlns 4-kinase activity by 79 % (P<0.05) (n=3). 
To demonstrate conclusively that the species of PtdinsP 
produced in the assay system was Ptdlns(4)P rather than 
Ptdlns(3)P, the product was deacylated and analyzed by HPLC 
as described under Materials and Methods. Analysis of the 
deacylated product revealed that the PtdinsP produced co­
eluted with the 3H-GroPins(4)P standard (Fig. 15A). Gro­
Pins(3)P, which elutes approximately 2 min prior to the 
GroPins(4)P, was not detectable, suggesting that unstimulat­
ed pancreatic acinar cells lack significant type 1 Ptdlns 
kinase activity. Furthermore, the product of the CCh-regu­
lated enzyme was confirmed to be Ptdlns(4)P (Fig. 15B), thus 
97 
Figure 14. Blockade of the CCh-mediated increase in Ptdins 
4-kinase activity by the muscarinic receptor 
antagonist. N-methyl-scopolamine. 
Intact acini were pretreated with vehicle or 1 nM 
N-methylscopolamine (NMS) for 20 min prior to a 5 min 
incubation with 10 uM CCh. Homogenates were prepared and 
assayed for enzyme activity. Data are expressed as a 
percentage of control values (154 ± 10 pmol 
[32P]Ptdins(4)P/mg protein). Values are the means (±S.E.M.) 
from four independent experiments. *significantly different 
from the CCh-treated sample as assessed by paired Student's 
t-test (P<0.05). 
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Figure 15. HPLC analysis of the deacylated product of CCh­
regulated Ptdins kinase. 
Intact acini were incubated with buffer or CCh (�� uM) for 5 
min prior to homogenization and measurement of [ P]PtdinsP 
formation. The product was deacylated and separated by HPLC 
on a Partisphere SAX anion-exchange column using a gradient 
of (NH4)2HPo4 as described in Materials and Methods. Position of (A) the deacylated product of the unstimulated 
Ptdins kinase; (B) the deacylated product of the CCh­
regulated Ptdins kinase; (C) and (D) the [3H]GroPins(4)P 
internal standard. 
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indicating that the Ptdlns kinase is a type 2 kinase 
phosphorylating the D-4 position of the inositol ring. 
To determine whether the CCh-mediated stimulation of 
Ptdlns 4-kinase was limited by the concentration of 
endogenous Ptdlns, enzyme activity in homogenates prepared 
from control and CCh-stimulated acini was determined in the 
absence or presence of exogenously added Ptdlns. The addi­
tion of exogenous Ptdlns (50 uM) had no significant 
effect on the degree of stimulation elicited by CCh (Table 
2). Therefore, the observed response to CCh is not limited 
by the endogenous pool of Ptdlns. 
c. Kinetic Properties of CCh-stimulated Ptdlns 4-kinase 
A kinetic analysis of CCh stimulation was performed to 
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determine if Ptdlns kinase activation was modulated through 
changes in the apparent Vmax andjor the apparent Km for 
either Ptdlns or ATP. To determine the kinetic properties 
for Ptdlns utilization by Ptdlns 4-kinase, acinar homage­
nates were pretreated with phospholipase c to deplete the 
stores of endogenous Ptdlns prior to the assay (see Materi­
als and Methods section). Results of a representative ex­
periment are presented in Fig. 16A as a double reciprocal 
(Lineweaver-Burk) plot of initial velocity versus Ptdlns 
concentration. The apparent Rro was unchanged after a 5 min 
exposure of intact acini to 10 uM CCh; however, the apparent 
Vmax for the reaction was increased significantly by CCh. 
The average Vmax values from four experiments were 294 (±26) 
and 375 (±39) pmols of [32P)Ptdlns(4)P formedjmg protein/min 
Table 2. The effect of exogenous Ptdins on CCh-stimulated 
r32PJPtdins(4)P formation. 
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Intact acini were incubated for 5 min with various conc­
entrations of CCh. Acinar homogenates were pretreated for 2 
min with or without exogenous Ptdins (50 uM) in 0.1% of 
Triton X-100 and assayed for Ptdins 4-kinase activity. Data 
are expressed as a percentage of control values, which 
averaged 154 (±31) and 127 (±26) pmol c
3 2P]Ptdins(4)P 
formedjmg protein in the presence (+) or absence (-) of 
exogenous Ptdins respectively. Values are the mean 
(±S.E.M.) of four experiments. 
[32P]Ptdins(4)P formation 
CCh (uM) (% of control) 
- Ptdins + Ptdins 
1 106 ± 13 112 ± 9 
10 127 ± 16 125 ± 5 
50 121 ± 15 118 
± 
8 
Figure 16. Effect of CCh on the kinetic properties of 
Ptdins 4-kinase. 
103 
Intact acini were incubated with (filled circles) or without 
(open circles) CCh (10 uM) for 5 min, and homogenates 
assayed in triplicate for Ptdins kinase activity. The data 
are plotted as 1/V versus the reciprocal of (A) Ptdins or 
(B) ATP concentrations. Vmax and apparent � values for 
this representative experiment are provided ln the inset. 
(See text for mean values). 
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in the absence and presence of 10 uM CCh, respectively 
(p<0.05). 
The kinetic properties for ATP utilization are 
presented in Fig. 16B. The apparent � for ATP was 60 uM, 
both in the presence and absence of 10 uM CCh. However, in 
homogenates derived from acini exposed to CCh, the Vmax for 
ATP utilization was significantly increased. The average 
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Vmax values from four experiments were 109 (±3) and 136 (±1) 
pmols of c32P]Ptdins(4)P formedjmg protein/min in 
the absence and presence of 10 uM CCh, respectively 
(p<0.05). These experiments demonstrate that the CCh­
stimulated Ptdins Kinase activity is mediated by changes in 
the apparent Vmax but not the � for either substrate. 
D. Modulation of Ptdins(4.5lP2 Synthesis by Carbachol 
To determine whether the increase in Ptdins 4-kinase 
activity elicited by muscarinic agents was accompanied by an 
alteration in Ptdins(4)P 5-kinase activity, we investigated 
the kinetics of Ptdins(4,5)P2 formation as well as the 
ability of CCh to modulate the enzyme activity. 
c32P]Ptdins(4,5)P2 formation remained linear for only 1 min, 
after which time the rate of product formation diminished 
(Fig. 17). Therefore reactions were conducted for 1 min. 
The lack of linearity at longer incubation times is presum-
ably due to the presence of degradative enzymes including 
phospholipase C (see Discussion) . 
Since Triton X-100 is routinely employed to assess 
Ptdins(4)P 5-kinase activity, we examined the detergent 
Figure 17. Time-course of r32PJPtdlnsl4.5lP2 formation in 
acinar homogenates and inhibitory effect of 
Triton X-100. 
Homogenates were incubated with varying concentrations of 
Triton X-100 and exogenous Ptdlns(4)P (100 ug�ml) at 30°C 
for 2 min prior to the addition of 500 uM (r- 2P)ATP. At 
the indicated times, aliquots were removed and 
r 32P ) Ptdlns(4,5)P 2 analyzed as described in Materials and 
Methods. Each value was determined in duplicate and the 
results given as the mean of two independent experiments. 
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requirements for the enzyme (Fig. 17). Triton X-100 at 
concentrations as low as 0.01% (vjv) produced a marked 
inhibition of Ptdlns(4)P 5-kinase activity, therefore Triton 
X-100 was excluded from the reaction mixture. 
To determine whether muscarinic agonists such as 
carbachol were also capable of modulating Ptdlns(4)P 5-
kinase activity, intact acini were stimulated for various 
times with CCh and Ptdlns(4)P 5-kinase activity measured in 
homogenates. Stimulation of acini with CCh (50 uM) for 30 
sec produced a significant decrease in [32P]Ptdlns(4,5)P2 
formation in homogenates (Fig. 18). A similar effect was 
observed following a 1 or 5 min exposure to CCh. These re­
sults may indicate a CCh-mediated inhibition of Ptdlns(4)P 
5-kinase activity or an activation of one or more enzymes 
responsible for Ptdlns(4,5)P2 degradation including phospho­
lipase C (see Discussion). 
E. Role of Protein Kinase c in Ptdlns 4-kinase Regulation 
Muscarinic-receptor agonists are known to activate PKC 
in rat pancreatic acinar cells (Ishizuka et al., 1987). We 
therefore hypothesized that Ptdlns 4-kinase activity may be 
modulated by a PKC-dependent pathway. A 20 min exposure of 
intact acini to the cell permeable PKC activators 
dioctanoylglycerol (DiC8) or oleoyl acetylglycerol (OAG) 
produced a concentration-dependent increase in Ptdlns 4-
kinase activity (Fig. 19). This effect appeared to be 
mediated by PKC, as a 3 min pretreatment with the PKC in­
hibitor staurosporine (10 nM) significantly reduced the 
Figure 18. Time-dependent effect of CCh on Ptdins(4lP 
5-kinase activity. 
Intact acini were incubated with buffer (solid line) or 50 
uM CCh (dotted line) for the indicated times prior to 
homogenization and measurement of Ptdins(4)P 5-kinase 
activity. Values are the means {S.E.M.) from three 
independent experiments. *Significantly different from 
control values as assessed by two-way analysis of variance 
{P<0.05). 
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Figure 19. Concentration-dependent effects of cell 
permeable diglyceride analogues on Ptdlns 4-
kinase activity. 
Intact acini were incubated for 20 min with increasing 
concentrations of DiC8 or OAG and homogenates assayed for 
enzyme activity. Values are t�� percentage of controls 
which averaged 87 (±14) pmol [ P)Ptdlns(4)Pjmg protein). 
Values are the mean (±S.E.M.) of eight independent 
experiments. *significantly different from control as 
assessed by one-way analysis of variance. 
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Figure 20. Blockade of the Dies-mediated increase in Ptdins 
kinase activity by pretreatment with 
staurosporine. 
Intact acini were incubated with vehicle or 10 nM 
staurosporine (St) for 3 min prior to a 20 min stimulation 
with 200 uM Dies. Ptdins kinase activity was measured in 
homogenates. Data are expressed as a percentage of control 
values (150 ± 31 pmol [32P]Ptdins(4)P/mg protein). Values 
are the mean (±S.E.M.) from three experiments. *significantly different from the Dies-treated samples as 
assessed by paired student's t-test (P<0.05). 
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stimulatory effect of 200 uM DiC8 by 74 (±7) % (Fig. 20). 
Attempts were also made to examine whether direct addition 
of partially purified protein kinase C (type III) to the 
homogenate was capable of regulating Ptdins 4-kinase 
activity. However, stimulation was inconsistent and highly 
variable from day to day. 
III. Role of cAMP-dependent Protein Kinase in 
Ptdins 4-kinase Regulation. 
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Secretagogues such as VIP and secretin markedly poten­
tiate CCh-stimulated amylase secretion, while having only a 
marginal effect on secretion when administered alone (Singh, 
1982). Furthermore, these agonists elevate cAMP levels in 
rat pancreatic acinar cells (Collen et al., 1982). There­
fore, we examined whether Ptdins 4-kinase activity may be 
regulated by cAMP or PKA. Intact acini were exposed to the 
cell permeable cAMP analogue, monobutyryl cAMP (1 rnM) for 
various times and Ptdins kinase activity measured in corre­
sponding homogenates. Ptdins kinase activity was increased 
maximally and significantly after a 20 min exposure to 
monobutyryl cAMP by an average of 157 ± 17 percent of con­
trol (P<0.05) (n=3). To determine the concentration-re­
sponse relationship, intact acini were exposed to 0.1 and 1 
rnM monobutyryl cAMP for 20 min and homogenates prepared and 
assayed for Ptdins kinase activity. The effect of monobu­
tyryl cAMP was concentration-dependent and mimicked by a­
bromo-cAMP (Table 3). Furthermore, the effect was specific 
for cAMP analogues, as 0.1 rnM 8-bromo-cGMP had no effect. 
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Table 3. Effect of cAMP analogues and PKA catalytic subunit 
on Ptdins 4-kinase activity. 
Intact acini were incubated for 20 min with cell permeable 
cyclic nucleotides and homogenates prepared and assayed for 
Ptdins 4-kinase activity. Homogenates derived from 
pancreatic acini were incubated with catalytic subunit of 
PKA for 20 min prior to the assay. Values shown are the 
means (±S.E.M.) of three to six separate experiments. 
*Significantly different from basal values as assessed by 
analysis of variance (P<0.05). 
Addition ( 32P] Ptdins ( 4) P formation 
(pmoljmg protein) 
None 127 
± 
26 
mbcAMP (0.1 mM) 178 ± 22
* 
mbcAMP (1 mM) 202 ± 21
* 
8-bromo-cAMP (1 mM) 181 ± 22
* 
8-bromo-cGMP (0.1 mM) 119 ± 9 
None 122 ± 20 
PKA catalytic 
subunit (2.5 ugjml) 151 ± 20 
PKA catalytic 
subunit (25 ugjml) 208 ± 19
* 
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To examine directly whether cAMP-dependent protein 
kinase regulates Ptdlns kinase activity, control acinar 
homogenates were treated with the catalytic subunit of PKA 
for 20 min and Ptdins kinase activity measured. Graded 
concentrations of the catalytic subunit of cAMP-dependent 
protein kinase produced a concentration-dependent 
enhancement of Ptdins 4-kinase activity (Table 3 ). The 
effects elicited by the catalytic subunit were comparable in 
magnitude to those elicited by CCh (compare Table 3 with 
Fig. 12). To ensure that this effect was not due to an 
impurity in the preparation of PKA, phosphorylation of 
exogenous Ptdlns was measured in the absence of homogenate. 
The catalytic subunit of PKA was completely devoid of Ptdins 
4-kinase activity. These findings taken together suggest 
that Ptdins 4-kinase activity is regulated by cAMP, presum­
ably through PKA. 
A. Kinetic analysis of the cAMP-mediated stimulation of 
Ptdlns 4-kinase activity 
To delineate further the mechanism by which cAMP 
stimulates Ptdlns kinase activity, the kinetic parameters 
with respect to ATP utilization were investigated. Results 
of a representative experiment are presented .in Fig. 21(A) 
as a double-reciprocal plot of the initial velocity versus 
the ATP concentration. The apparent Vmax was unchanged 
following a 20 min exposure of intact acini to 1 mM monobu­
tyryl cAMP; however, the apparent Km for ATP was signifi­
cantly decreased by the cAMP analogue. The average � 
Figure 21. The effect of monobutyry1 cAMP on the kinetic 
properties of Ptdins 4-kinase. 
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Intact acini were incubated with (filled circles) or without 
(open circles) 1 mM monobutyryl cAMP for 20 min, and 
homogenates assayed in triplicate for Ptdins kinase 
activity. The data are plotted as 1/V versus the reciprocal 
of the concentrations of (A) ATP or (B) Ptdlns. Vmax and 
apparent Km values for this representative experiment are 
provided in the inset. (See text for mean values). 
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values from three experiments were 82 (±9) and 52 (±5) uM in 
the absence and presence of 1 mM monobutyryl cAMP respec­
tively (p<0.025). There was no effect on the reaction 
velocity or the Km for Ptdins utilization 
(Fig. 21B). 
IV. Regulation of polyphosphoinositide synthesis by 
Epidermal Growth Factor 
Short-term exposure to epidermal growth factor (EGF) 
fails to enhance basal or CCh-stimulated amylase secretion 
from pancreatic acini (Korc et al., 1983); however, a com­
plex interaction between ca2+-mobilizing agonists and EGF 
has been suggested (Korc et al., 1984; Morisset et al., 
1989). Since Ptdins 4-kinase has been shown to be regulated 
by EGF in A431 cells Walker and Pike, 1987), this enzyme 
may represent a common locus of action between EGF and CCh 
in pancreatic acini. As shown in Fig. 22, the addition of 
EGF (5-40 nM) to intact acini for 5 min caused a concentra­
tion-dependent increase in [32P)Ptdins(4)P formation meas­
ured in acinar homogenates. The effect was significant 
using 25 nM and 40 nM EGF. The product of the EGF-regulated 
Ptdins kinase was confirmed to be Ptdins(4)P by HPLC analy­
sis (Fig. 23), thus demonstrating that the enzyme is in fact 
a type 2 Ptdins kinase. 
In order to determine whether EGF and CCh are 
modulating Ptdins kinase activity via similar mechanisms, 
enzyme activity was measured in homogenates prepared from 
acini stimulated with EGF and CCh alone or in combination. 
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Figure 22. Concentration-dependent effect of EGF on Ptdins 
4-kinase activity. 
Intact acini were incubated for 5 min with increasing 
concentrations of EGF. Homogenates were prepared and 
assayed for Ptdins kinase activity. Data are expressed as a 
percen��ge of the control value which averaged 156 (±31) 
pmol [ P]Ptdins(4)P formedjmg protein. Values are the 
means (±S.E.M.) from seven experiments. *significantly 
different from control as determined by one-way analysis of 
variance. 
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Figure 23. HPLC profile of the deacylated product of EGF­
regulated Ptdins kinase. 
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Intact acini were incubated with 40 nM EGF for 5 min prior 
to homogenization and measurement of Ptdlns kinase activity. 
The phospholipid product was deacylated and separated by 
HPLC as described in Materials and Methods. Position of (A) 
the deacy�ated product of EGF-regulated Ptdlns kinase and 
(B) the [ H)GroPins(4)P internal standard. 
100 �������������������, 
A 
(/) 
EGF 
40nM 
GroPins(4)P 
""' 
�
 o�������������������� 0 100 B 
1-
w 
z 
3H-GroPins(4)P std. 
� 
0 5 10 15 20 25 30 35 40 45 50 55 
Time (min) 
124 
Table 4. The effects of CCh and EGF alone and in 
combination on r32PJPtdins(4)P formation. 
Results were obtained following a 5 min exposure of intact 
acini to each agent alone or in combination. Data are 
represented as a percent��e of control values, which 
averaged 181 ± 30 pmol [ P]Ptdins(4)P formedjmg protein. 
Numbers in parenthesis denote number of experiments 
performed for each treatment. 
[32P]Ptdins(4)P Formation 
Treatment (% of control) 
EGF 5 nM 104 ± 5 (5) 
CCh 1 uM 117 ± 5 (9) 
CCh 1 uM + EGF 5 nM 123 ± 7 (6) 
EGF 25 nM 121 ± 8 (8) 
CCh 1 uM + EGF 25 nM 119 ± 4 (8) 
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[32P]Ptdlns(4) P formation in response to either EGF or CCh 
was comparable to that detected when both agonists were 
employed in combination (Table 4) . Thus, a threshold (5 nM) 
and a submaximal (25 nM) concentration of EGF failed to 
significantly enhance the elevation in [32P]Ptdlns(4) P 
accumulation induced by a submaximal CCh concentration. 
To determine whether EGF may be modulating Ptdlns 4-
kinase activity via the generation of DAG and the subsequent 
activation of PKC, acini were prelabeled with (32P]P04 and 
[32P]Ptdlns(4,5) P2 hydrolysis measured in response to EGF. 
In contrast to 100 uM CCh, 40 nM EGF, which elicited a 
significant increase in Ptdlns kinase activity, failed to 
cause [32P]Ptdlns(4,5) P2 hydrolysis during the 5 min time 
course (Fig. 24) . These data suggest that EGF and CCh 
modulate Ptdlns 4-kinase activity via distinct pathways and 
that the EGF response does not involve the PLC-mediated 
hydrolysis of Ptdlns(4,5) P2. 
The findings that EGF increases cAMP levels in several 
systems (!washita et al., 1990; Nakagawa et al., 1991) taken 
together with the observation that cAMP increases Ptdlns 4-
kinase activity (cf. Table 3) suggested the possibility that 
EGF was regulating enzyme activity by increasing cAMP levels 
in pancreatic acini. However, treatment of acini with 40 nM 
EGF for either 5 or 30 min failed to alter cAMP levels 
(Table 5) . 
Figure 24. Effects of EGF and CCh on r32PJPtdlns(4,5lP2 
levels. 
127 
Acini were prelabeled for 60 min with [32P)P04 and then 
incubated in the absence (solid line) or presence of either 
EGF (40 nM) (dotted line) or CCh (100 uM) (dashed line). 
Aliquots were removed and processed at the indicated times. 
Data are expressed as a percentage of basal values at time 
zero for control, EGF, and CCh-stimulated acini, which 
averaged 1469 (±133), 1694 (±126) and 1902 (±369) cpm, 
respectively and did not change over time. Values are the 
mean (±S.E.M.) from three to six experiments. *significantly different from basal values at corresponding 
time points as assessed by paired student's t-test (P<0.05). 
128 
• ,----� II) 
. i . 
\ 
. . 
\ "' \ 
. 
\ 
. . . 
\ . .., c . \ :g . . \ . i . . 
\ 
4) 
E 
• J-i � :;:: 
I 
• 
�� i 
�-----� .. • i 
. ... ..... 
.S--1 
·. .,., . 
. ......... . 0 
0 0 0 0 0 0 "' � 0 CD Ul "' 
(OJez eW!l JO %) 
a dS't-SUJPld[d11] 
Table 5. Inability of EGF to elevate cAMP levels in rat 
pancreatic acini. 
Pancreatic acini were incubated with the indicated agents 
for either 5 or 30 min at 37°C. Cyclic AMP levels were 
measured as described in Materials and Methods. Each value 
was determined in triplicate and results given as the means 
± S.E.M. of three independent experiments. The adenylate 
cyclase activator forskolin was employed as a positive 
control. 
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pmol cyclic AMP/mg protein 
Treatment 5 min 30 min 
Control 1.9 ± 0.2 1.9 ± 0.7 
EGF 40 nM 1.8 ± 0.5 1.9 ± 0.5 
Forskolin 10 uM 18.7 ± 5.4 16.3 ± 3.2 
DISCUSSION 
I. General Properties of Acinar Ptdins 4-kinase 
In this study we have described an agonist-sensitive 
Ptdins 4-kinase in homogenates derived from pancreatic 
acini. The majority of enzyme activity was recovered in the 
particulate fraction, indicating that Ptdins kinase is 
predominantly membrane-associated with little activity 
residing in the soluble fraction. Furthermore, the 
relative specific activity of the particulate fraction is 
approximately twice that of the homogenate, a finding 
consistent with the two-fold enrichment of Ptdins kinase 
observed in rat brain microsomes (Kai et al., 1966). The 
present findings are in agreement with several published 
reports demonstrating that Ptdins kinase is associated 
almost exclusively with the particulate fraction (Cockcroft 
et al., 1985a; Payrastre et al., 1990; Wetzger et al., 
1991). Ptdins kinase activity has also been described on 
the Golgi apparatus (Jergil & Sundler, 1983); endoplasmic 
reticulum (Lundberg & Jergil, 1988), mitochondria (Stubbs et 
al., 1988), and nucleus (Smith & Wells, 1983). 
In addition to the demonstration of Ptdins kinase 
activity in crude acinar homogenates, enzyme activity was 
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also localized to purified zymogen granule membranes 
isolated from pancreatic minces. Our finding that the 
relative specific activity of Ptdins 4-kinase activity 
associated with granule membranes is approximately six-times 
that detected in tissue homogenates affirms that this frac­
tion represents a highly active source of the enzyme. 
Furthermore, this finding is consistent with the observation 
of Trifaro & Dworkind (1971) who first reported the presence 
of Ptdins kinase on chromaffin granules isolated from the 
adrenal medulla. In this system, the highest specific 
activity of Ptdins 4-kinase was likewise observed in the 
granule fraction (Lefebvre et al., 1976). Although Ptdins 
kinase has been described on granule membrane preparations 
isolated from several tissues including mast cells (Kurosawa 
& Parker, 1986), insulinoma cells (Tooke et al., 1984), and 
the rat parotid gland (Oron et al., 1978), the enzyme pres­
ent on the chromaffin granule membrane remains the most 
extensively characterized. 
The Ptdins kinase activities associated with acinar 
homogenates and zymogen granule membranes exhibit a broad pH 
profile with only minor variations in activity in the pH 
range of 6-8. This pH dependence curve is similar to that 
observed for the chromaffin granule membrane-associated 
Ptdins kinase (Trifaro & Dworkind, 1975) and that of a 
purified enzyme from bovine uterus (Porter et al., 1988). 
When acinar homogenates were utilized as the source of 
Ptdins kinase, (32P]Ptdins(4)P formation remained linear for 
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only 75 sec. The reason for this deviation from linearity 
has not been adequately defined; however, it is unlikely 
that depletion of endogenous Ptdlns is a contributing factor 
since the size of the specific pool of Ptdlns recognized by 
the enzyme is approximately 5 .0 nmol of Ptdlnsjmg protein 
and only 0.2 nmol or 4 % of Ptdlns would be utilized after 
maximal synthesis has been achieved. Likewise, the 
inclusion of a large excess of ATP in the reaction suggests 
that this substrate is not limiting; however, due to the 
possibility of contaminating ATP-consuming enzymes, this 
possibility cannot be completely ruled-out. Degradative 
enzymes may also contribute to the loss of linearity over 
time. 
Lefebvre et al. (1976) reported that product formation 
remained linear for at least 5 min using purified chromaf­
fin granule membranes as the source of Ptdlns kinase. The 
extended linearity was attributed to the absence of phospho­
monoesterase and phosphodiesterase activities on the granule 
membranes. Similarly, Ptdlns(4)P formation remains linear 
for at least 5 min when purified zymogen granule membranes 
are utilized as the source of Ptdlns kinase. This observa­
tion suggests that degradative enzymes may contribute to the 
loss of linearity observed in acinar homogenates; however, 
direct evaluation of Ptdlns(4)P stability after quenching 
the reaction with a large excess of unlabeled ATP revealed 
that degradation was negligible in our assay system. Fur­
thermore, Ptdlns(4)P phosphomonoesterase activity appears to 
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be ca2+-dependent (Tooke et al., 1984); therefore, under our 
ca2+_free assay conditions the contribution of this enzyme 
to Ptdlns(4)P degradation would appear to be minimal. 
Despite our efforts, the question as to whether degradative 
enzymes contribute at least in part to the time-dependent 
loss of linearity remains unanswered. Finally, end-product 
inhibition of Ptdlns kinase may be a plausible explanation 
for the deviation from linearity, as this phenomenon has 
been reported in several systems (Van Rooijen et al., 1985; 
O'Shea et al., 1986; Stubbs et al., 1988); however, addi­
tional studies are necessary to elucidate whether this 
occurs in the presence of physiological levels of poly­
phosphoinositides. 
our kinetic studies utilizing acinar homogenates have 
demonstrated that Ptdlns kinase activity follows Michaelis­
Menten saturation kinetics with regard to ATP and Ptdlns 
utilization. The apparent � value of 60 uM for ATP is 
similar to that of previously described Ptdlns 4-kinases, 
including a membrane-associated Ptdlns 4-kinase purified to 
apparent homogeneity (Endemann et al., 1987; Walker & Pike, 
1987; Jenkins et al., 1991). The somewhat lower� value 
for Ptdlns (5 uM) than corresponding kinetic constants 
obtained in these same systems may be ascribed to our novel 
experimental protocol, which included the elimination of 
endogenous Ptdlns prior to kinetic analysis (see also Khalaf 
& Laychock, 1992). 
The enzyme in acinar homogenates has been identified as 
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a Ptdins 4-kinase by HPLC analysis of the deacylated 
reaction product according to the procedure of Auger et alo 
(1989) o In contrast to the Ptdins 3-kinase described by 
Whitman et alo (1987), Ptdins 4-kinase is activated by 
Triton X-100 and phosphorylates only the D-4 position of the 
inositol ring of Ptdinso 
Recent investigations in mammalian systems have de­
scribed a family of Ptdins 4-kinases comprised of at least 
three distinct isozymes (Endemann et alo, 1987; Saltiel et 
alo, 1987) o These isozymes can be differentiated on the 
basis of their kinetic properties and sensitivities to 
adenosine and non-ionic detergents (Carpenter & Cantley, 
1990) o The type 2 isozyme has a Km for ATP utilization 
ranging from 30-70 uM, approximately one order of magnitude 
lower than that observed for the other isozymes (Porter et 
alo, 1988; Walker et alo, 1988; Yamakawa & Takenawa, 1988) o 
In addition, only this isozyme appears to be sensitive to 
inhibition by adenosine (Endemann et alo, 1987; Cochet et 
alo, 1991) o Positive identification of the reaction product 
as Ptdins(4)P demonstrates that the Ptdins kinase present in 
pancreatic acini is, in fact, a Ptdins 4-kinaseo As de­
scribed above, the Ptdins 4-kinase has an apparent � of 
approximately 60 uM for ATP, which suggests that this enzyme 
is in fact a type 2 Ptdins 4-kinaseo Collectively, these 
observations indicate that the species of enzyme present in 
pancreatic acini can tentatively be identified as a type 2 
Ptdins 4-kinaseo 
II. Regulation of Ptdins 4-kinase Activity 
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Our data demonstrate that Ptdins kinase activity is 
regulated by CCh. The CCh-mediated increase in Ptdins 4-
kinase activity is mediated via muscarinic receptors since 
this effect is sensitive to inhibition by the potent muscar­
inic receptor antagonist N-methylscopolamine and mimicked by 
the agonist muscarine. Although the increases in Ptdins 
kinase activity were of a similar magnitude regardless of 
which muscarinic receptor agonist was employed, the concen­
tration-response curve for muscarine was shifted slightly to 
the left. This observation is likely to be a reflection of 
the greater potency of muscarine as a pancreatic secreta-
gogue (Dehaye et al., 1984). 
To gain further insight into the physiological rele­
vance of these findings, we examined the temporal relation­
ship between the CCh-mediated increase in polyphosphoinosi­
tide synthesis and CCh-mediated (32P]Ptdins(4,5)P2 hydroly­
sis. Analysis of the time course for Ptdins kinase activa­
tion revealed a maximal stimulatory response following a 5 
min exposure to CCh, a time coincident with the return of 
[32P]Ptdins(4,5)P2 levels towards control values in 
[32P]P04-prelabeled acinar cells (see also Orchard et al., 
1984). In addition, the CCh-mediated increase in Ptdins 4-
kinase activity occurs over the same range of concentrations 
that promote [32P]Ptdins(4,5)P2 hydrolysis in pancreatic 
acini (Fig. 10). These results suggest that CCh, in addi­
tion to catalyzing the PLC-mediated hydrolysis of 
Ptdins(4,5)P2, also increases the synthesis of Ptdins(4)P, 
the immediate precursor for Ptdins(4,5)P2. Finally, the 
CCh-induced increase in Ptdins 4-kinase activity paralleled 
the time course and concentration-dependence for activation 
of amylase secretion (Halenda & Rubin, 1982; Merritt & 
Rubin, 1985), thus substantiating the physiological rele­
vance of these findings. 
The stimulation of Ptdins 4-kinase activity following 
CCh exposure cannot be attributed simply to an increase in 
the substrate since the enhanced enzyme activity is not 
attenuated in the presence of Triton X-100/Ptdins mixed 
micelles. Although, the interpretation of studies 
utilizing hydrophobic substrates in detergent micelles is 
complicated by the existence of two phases; one which is 
dependent upon the bulk concentration of Ptdins and one 
which is dependent upon the ratio of Ptdins to detergent on 
the micelle surface, these results appear valid based upon 
several lines of evidence. 
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Ganong (1990) and Buxeda et al. (1991) have demonstrat­
ed that Ptdins kinase activity follows saturation kinetics 
with respect to the bulk concentration of Ptdins at concen­
trations below 100 uM. At Ptdins concentrations greater 
than 100 uM, Ptdins 4-kinase activity becomes dependent upon 
the ratio of Ptdins and detergent present on the micellar 
surface. During this investigation, the concentration of 
exogenously added Ptdins was never in excess of 50 uM; thus, 
reliable measurements of Ptdins kinase activity could be 
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obtained using a fixed concentration of Triton X-100. 
Furthermore, in a comparative study of non-ionic detergents, 
Ganong & Lu (1989) demonstrated that Triton X-100 is best 
suited for studies of Ptdins kinase activity due to its 
ability to form uniform micelles, thus creating a homogene­
ous dispersion of substrate, enzyme, and membrane lipids. 
Therefore, Triton X-100/Ptdins mixed micelles provide a 
valid model system to study the dependence of Ptdins kinase 
activity on exogenous Ptdins, and our results suggest that 
CCh is not eliciting its effect by altering the level of the 
Ptdins substrate. Furthermore, Ptdins has been shown to 
decrease, rather than increase, after CCh stimulation of 
pancreatic acini (Abdel-Latif, 1986), making it unlikely 
that increased Ptdins mass contributes to increased 
Ptdins(4)P formation. Further substantiation that CCh is 
not altering Ptdins levels was provided by the kinetic 
experiments in which a novel approach for completely deplet­
ing endogenous Ptdins in homogenates using Ptdins-specific 
phospholipase C was utilized. This procedure allows for the 
control of substrate levels simply by adding known amounts 
of exogenous Ptdins. Thus, any change in Ptdins levels in 
response to CCh would have been eliminated. 
Kinetic analysis demonstrated that CCh stimulates 
Ptdins kinase activity by increasing the Vmax of the 
reaction. No change in the affinity of the enzyme for 
either Ptdins or ATP was observed. These results are 
similar to those of Payrastre et al. (1991) who observed a 
similar increase in the velocity of the reaction for Ptdins 
kinase following stimulation of A431 cells with EGF. One 
possible explanation for the observed increase in the Vmax 
involves the synthesis of new enzyme; however, the brief 
time interval (5 min) over which this effect occurs would 
suggest that an alternative mechanism is involved. 
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one such mechanism underlying the CCh-mediated increase 
in Vmax may involve a phosphorylation-dependent process. 
Indeed, covalent modification of enzymes by phosphorylation­
dephosphorylation reactions is a pivotal mechanism of 
cellular regulation in many systems (Walaas & Greengard, 
1991) . For example, phosphorylation-mediated changes in 
Vmax and Km values appear to regulate tyrosine hydroxylase, 
the rate-limiting enzyme for the biosynthesis of 
catecholamines. In this system, ca2+-dependent activation 
of tyrosine hydroxylase appears to involve a 
phosphorylation-induced increase in the Vmax of the 
reaction; whereas PKA-dependent phosphorylation results in a 
decrease in the apparent � (El Mestikawy et al., 1983; 
Yanagihara et al. , 1984). A similar pattern exists for the 
regulation of Ptdins kinase activity in the exocrine 
pancreas by CCh and cAMP, respectively. Dual regulatory 
pathways; one involving a PKC-mediated phosphorylation­
induced alteration in Vmax and another involving a cAMP­
mediated phosphorylation-induced change in affinity for 
substrate, appear to be operating to modulate these enzyme 
activities. 
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The basis for the regulation of Ptdins 4-kinase by CCh 
seemingly stems from the ability of CCh to activate protein 
kinase c through the generation of diacylglycerol from 
Ptdins(4,5)P2 and phosphatidylcholine hydrolysis (Matozaki & 
Williams, 1989; and Rubin et al., 1992). The time-course 
for Ptdins kinase activation by CCh is consistent with that 
for diacylglycerol production (Komabayashi et al., 1990), as 
well as activation of PKC in pancreatic acinar cells 
(Ishizuka et al., 1987). Our finding that treatment of 
acini with cell-permeable diglycerides elicits a similar 
effect on Ptdins 4-kinase activity which was blocked by the 
putative PKC inhibitor staurosporine further supports a 
possible role for protein kinase C in the regulation of this 
enzyme. 
Investigations from several laboratories have provided 
data suggesting that PKC may serve as a modulator of poly­
phosphoinositide synthesis (Taylor et al., 1984; Boon et 
al., 1985; Cockcroft et al., 1985 b). Giraud et al. (1988) 
demonstrated that exposure of erythrocytes to phorbol esters 
caused enhanced [32P]Ptdins(4)P labeling which could be 
blocked by pretreatment with PKC inhibitors. Furthermore, 
these authors reported a concomitant increase in the 
phosphorylation of several proteins, one of which was hy­
pothesized to be Ptdins 4-kinase. In addition, de Chaffoy 
de Courcelles et al. (1984) employed cell-permeable diacyl­
glycerol analogues to demonstrate enhanced [32P]Ptdins(4)P 
labeling in human platelets. Collectively, these data 
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suggest that Ptdlns kinase activity may be regulated by a 
PKC-dependent pathway. Furthermore, the CCh-mediated in­
crease in Ptdlns 4-kinase activity may be a consequence of 
PKC activation in response to the agonist, thus creating a 
positive feedback loop for the regulation of polyphosphoino­
sitide synthesis. 
A second possible explanation to account for the 
observed increase in vmax induced by CCh may reside in the 
ability of agonists to recruit Ptdlns kinase. For example, 
the EGF-mediated increase in Vmax observed in A431 cells has 
been attributed to an increase in the association of the 
kinase with the cytoskeleton (van Bergen en Henegouwen et 
al., 1989; Payrastre et al., 1991). Our demonstration that 
zymogen granule membranes possess Ptdlns kinase activity 
raises the possibility that this subcellular component may 
provide a reservoir of Ptdlns kinase which becomes accessi­
ble or catalytically active in response to a stimulatory 
signal. Indeed, Ptdlns kinase has been identified on the 
cytosolic surface of the chromaffin granule membrane (Phil­
lips, 1973). 
More recently, Ptdlns kinase activity has been observed 
on the cytosolic face of coated vesicles isolated from 
bovine brain, rat liver, and chick embryo skeletal muscle 
(Campbell et al., 1985). These authors speculate that 
coated vesicles may represent a transporter serving to 
shuttle Ptdlns kinase to and from the plasma membrane; 
thereby regulating Ptdlns(4)P levels. More recently, Ptdlns 
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kinase activity has been localized on a purified membrane 
fraction suggested to be a component of the vesicular 
trafficking system between the trans-Golgi and plasma 
membrane (Olsson et al., 1991). Likewise, these authors 
suggest that transfer of Ptdins kinase to the plasma 
membrane may represent one mechanism by which 
polyphosphoinositide synthesis is regulated. Moreover, such 
a transport mechanism may partially explain the ubiquitous 
distribution of Ptdins kinase within the cell. 
Indeed, a number of studies have demonstrated the 
occurrence of membrane shuttling between the cell surface 
and various intracellular compartments (Schneider et al., 
1979; Muller et al., 1980; Steinman et al., 1983). Further­
more, shortly after stimulation, there is an enlargement of 
the acinar lumen due to the addition of membrane (Beaudoin & 
Grondin, 1992). This is followed by the process of membrane 
retrieval via endocytosis. Therefore, it appears that an 
equilibrium exists between the addition of membrane and its 
subsequent retrieval. The extent to which recycling occurs 
and the identity of constituents temporarily remaining in 
the plasma membrane have yet to be elucidated. Thus, it is 
possible that the cell, by recruiting Ptdins kinase to the 
plasma membrane, has the ability to replete the pools of 
Ptdins(4)P and Ptdins(4,5)P2 following stimulation. Further 
investigation will be required to support this intriguing 
possibility. Due to the widespread distribution of Ptdins 
kinase among various intracellular membranes, positive 
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identification of a particular pool which may be involved in 
the recruitment process remains a formidable challenge for 
future research. 
Ptdlns kinase activity associated with the zymogen 
granule membrane, as well as the chromaffin granule membrane 
appears to be sensitive to muscarinic stimulation. Trifaro 
& Dworkind (1975) demonstrated that cholinergic stimulation 
of bovine adrenal medulla in situ caused an increase in 
chromaffin granule membrane Ptdlns kinase activity. This is 
similar to our observation that CCh stimulation of 
pancreatic minces in vitro results in an increase in Ptdlns 
kinase activity measured in zymogen granule membranes 
isolated from those minces. 
Although no attempt has been made to define the mechan­
ism(s) underlying the observed CCh-mediated increase in 
Ptdlns kinase activity on the granule membrane, involvement 
of one or more second-messengers appears necessary to ex­
press the effects of muscarinic receptor activation at the 
cell surface. One candidate likely to be involved in the 
regulation of granule membrane-associated Ptdlns kinase 
activity is PKC. Several laboratories have localized this 
enzyme to a purified granule membrane fraction isolated from 
pancreatic acini (Wrenn, 1984; Burnham et al., 1985). 
According to this scheme, DAG generated in response to CCh 
would lead to the activation of PKC in the cytoplasm or the 
granule membrane (Burnham et al., 1985). Once activated, 
PKC catalyzes the phosphorylation of several unidentified 
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proteins also residing on the membrane fraction. The locali­
zation of PKC to the zymogen granule membrane, taken togeth­
er with our finding that PKC regulates Ptdins kinase activi­
ty in acinar homogenates, suggests that Ptdins kinase on the 
granule membrane may also be subject to regulation by PKC; 
however, further studies are required to support or refute 
this hypothesis. Furthermore, the demonstration of an 
agonist-sensitive Ptdins kinase localized to the granule 
membrane raises the possibility that this enzyme may con­
tribute to the processes governing the fusion of the granule 
to the plasma membrane; however, further studies are neces­
sary to establish whether such a relationship exists. 
In the present investigation we also demonstrated the exist­
ence of Ptdins(4)P 5-kinase in acinar homogenates. This 
enzyme catalyzes the phosphorylation of Ptdins(4)P on the D-
5 position of the inositol ring, leading to the production 
of Ptdins(4,5)P2, the substrate for the CCh-sensitive PLC in 
the exocrine pancreas (Putney et al., 1983; Orchard et al., 
1984). Interestingly, this enzyme appears to be highly 
sensitive to inhibition by Triton X-100. This observation 
is not consistent with the findings of other laboratories 
which routinely employ concentrations of Triton X-100 in 
excess of 0.2% in the enzyme reaction mixture (Kato et al., 
1989; Smith & Chang, 1989). In fact, using human placenta, 
Uromow & Wieland (1986) demonstrated that concentrations of 
Triton X-100 less than 0.14 % caused a marked increase in 
Ptdins(4)P 5-kinase activity. 
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One possible explanation for this apparent discrepancy 
may be that Triton X-100 does not inhibit Ptdlns(4)P 5-
kinase activity, but instead activates endogenous PLC in the 
crude acinar homogenate. The result would be enhanced 
breakdown, rather than impaired synthesis, of 
[32P]Ptdins(4,5)P2. Attempts to block this effect using 
neomycin, a non-specific PLC inhibitor, were hampered by the 
ability of this hexavalent cation to avidly bind exogenously 
added Ptdins(4)P substrate (Polascik et al., 1987; Missiaen 
et al., 1989). Therefore, Triton X-100 was omitted from the 
experiments designed to examine whether CCh modulates Ptd­
Ins(4)P 5-kinase activity. 
Unfortunately, omission of Triton X-100 from the 
reaction mixture introduces several variables which preclude 
unambiguous interpretation of the data. For example, in the 
absence of Triton X-100, utilization of exogenous Ptdins(4)P 
by the enzyme may be less than optimal. Since the 
concentration of endogenous Ptdlns(4)P in the membrane is 
very low, the presence of exogenous Ptdins(4)P is essential 
to ensure that the reaction is not limited by substrate. 
Furthermore, in the absence of a large excess of unlabeled 
Ptdlns(4)P, the [32P]Ptdlns(4)P formed by Ptdlns 4-kinase 
during the reaction may contribute significantly to the 
radioactivity recovered in [32P]Ptdlns(4,5)P2, in that both 
the D-4 and D-5 positions may become labeled. In other 
words, complications associated with the omission of Triton 
x-100, including those pertaining to exogenous substrate 
utilization, prevent specific measurement of Ptdins(4)P 5-
kinase activity in this assay system. 
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Keeping in mind these limitations, we attempted to 
examine whether CCh is capable of modulating the activity of 
Ptdins(4)P 5-kinase. Treatment of intact acini with CCh 
resulted in a marked diminution of (32P]Ptdins(4,5)P2 
formation in the above assay system. This observation has 
several possible interpretations, including an inhibitory 
effect of CCh on Ptdins(4)P 5-kinase. However, due to the 
suboptimal conditions employed in this assay, definitive 
proof that this represents a true biological effect awaits 
further investigation. 
An alternative explanation for these results is that 
the [32P]Ptdins(4,5)P2 formed during the assay is subjected 
to hydrolysis catalyzed by residual CCh-sensitive PLC activ­
ity in the crude homogenate. Although the stability of 
Ptdins(4)P has been validated in our assay system, we have 
noted a profound loss of (32P]Ptdins(4,5)P2 in the assay 
mixture even under basal conditions. Moreover, Putney et 
al. (1983) and Orchard et al. (1984) have demonstrated that 
pancreatic acini possess a CCh-sensitive PLC which preferen­
tially hydrolyzes Ptdins(4,5)P2. These findings suggest 
that the observed effect of CCh are most likely due to the 
activation of PLC in the homogenate; however, the possibili­
ty that CCh specifically regulates Ptdins(4)P 5-kinase 
activity in pancreatic acini cannot be excluded. 
III. cAMP-dependent modulation of Ptdins 4-kinase Activity 
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Although CCh does not directly alter cAMP levels in 
pancreatic acini (Collen et al., 1982), other stimuli such 
as VIP and secretin generate cAMP , activate PKA, and 
potentiate CCh-stimulated amylase secretion (Gardner & 
Jensen, 1986; Burnham et al., 1988). The demonstration that 
cell permeable cAMP analogues modulate Ptdins 4-kinase 
activity when added to intact pancreatic acini suggests that 
cAMP also regulates Ptdins 4-kinase. Our finding that 8-
bromo-cGMP failed to produce a similar increase in Ptdins 
kinase activity suggests that this effect is specific for 
cAMP. 
These findings are consistent with those of Giraud et 
al. (1988) who observed enhanced Ptdins kinase activity 
following treatment of intact erythrocytes with comparable 
concentrations of cell permeable cAMP analogues. Further­
more, treatment of acinar homogenates with the catalytic 
subunit of protein kinase A enhances Ptdins 4-kinase activ­
ity. Control experiments indicated that this stimulatory 
effect cannot be attributed to the presence of residual 
Ptdins kinase activity in the commercial PKA preparation- a 
finding similar to that of Sugimoto et a1. (1984). In 
addition, our findings are consistent with a preliminary 
report demonstrating a PKA-mediated phosphorylation of 
purified Ptdins kinase which is accompanied by an increase 
in enzymatic activity (Yamakawa et al., 1991). These re­
sults suggest that a PKA-dependent pathway is capable of 
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regulating Ptdins kinase in the exocrine pancreas. 
In contrast to the stimulatory effect observed in our 
system, several laboratories have reported a cAMP-mediated 
inhibition of Ptdins kinase activity (Kurosawa & Parker, 
1986; O'Shea et al., 1987; Holland et al., 1988). This 
inhibitory effect may involve a direct-interaction between 
Ptdins kinase and the cyclic nucleotide or its adenine 
derivatives (O'Shea et al. 1987). These findings indicate 
that this second-messenger does not augment Ptdins kinase in 
a universal fashion. 
The data presented thus far suggest that Ptdins kinase 
is regulated by dual pathways; one involving PKC and the 
other involving PKA. It has been suggested that an altera­
tion in cAMP levels can modify InsP3 and diacylglycerol 
production (Taylor et al., 1984). However, Trimble et al. 
(1987) have shown that cAMP production following VIP stimu­
lation of pancreatic acinar cells is not associated with an 
increase in InsP3 levels. Similarly, cAMP accumulation in 
response to various agonists failed to alter diacylglycerol 
levels in pancreatic acini (Matozaki & Williams, 1989), thus 
making it unlikely that cAMP is modulating Ptdins kinase 
activity through the generation of diacylglycerol or the 
activation of PKC. Our finding that cAMP modifies Ptdins 4-
kinase activity by lowering the � for ATP utilization, 
whereas CCh increases the Vmax of the reaction further 
demonstrates that different mechanisms of activation are 
involved. 
IV. Regulation of Ptdins 4-kinase Activity by Epidermal 
Growth Factor 
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The present study has also shown that EGF promotes the 
synthesis of Ptdins(4)P. An EGF-mediated increase in Ptdins 
4-kinase activity has been observed in several other systems 
(Pike & Eakes, 1987; Payrastre et al., 1990; Cachet et al., 
1991) 0 
To discern whether similar pathways are involved in the 
EGF- and CCh-mediated increase in Ptdins kinase activity, we 
examined the effect of these agonists on polyphospho­
inositide synthesis alone and in combination. The lack of 
either a synergistic or additive effect supports the concept 
that a complex interaction exists between the pathways 
utilized by EGF and CCh. Furthermore, the concentrations of 
EGF which augmented Ptdins kinase activity failed to promote 
a net loss of [32P)Ptdins(4,5}P2. Although a modest activa­
tion of PLC which is, in turn, compensated for by increased 
Ptdins(4)P synthesis cannot be excluded based upon this type 
of experiment, several lines of evidence suggest that this 
is not the case. For example, EGF, unlike CCh, does not 
elicit a robust increase in intracellular ca2+ levels in 
fura-2 loaded acinar cells (Chandrasekar & Korc, 1991; 
Profrock et al., 199lb}. In addition, the recent report by 
Profrock et al. (199lb} demonstrating that EGF fails to 
stimulate InsP3 formation in pancreatic acinar cells con­
firms that activation of PLC does not occur in response to 
this agonist. These results are consistent with the inabil-
ity of EGF to elicit an acute secretory response (Logsdon & 
Williams, 1983b) and further suggest that EGF does not 
modulate Ptdlns kinase via a PLC-dependent pathway. 
149 
The findings obtained using EGF also demonstrate that 
the synthesis and breakdown of polyphosphoinositides can be 
dissociated from one another in the pancreatic acinar cell. 
One possible explanation for this dissociation is the exist­
ence of an agonist-insensitive polyphosphoinositide pool. 
Alternatively, Ptdlns{4)P may have functions within the cell 
apart from the synthesis of Ptdlns(4,5)P2 and the subsequent 
generation of second-messengers. For example, recent re­
ports indicate that polyphosphoinositides bind to cytoplas­
mic actin binding proteins such as profilin (Goldschmidt­
Clermont et al., 1990; Machesky et al. , 1990), inhibiting 
the interaction between these proteins and actin (Lassing & 
Lindberg, 1988). 
A mechanism whereby EGF causes the release of profilin 
from polyphosphoinositides has been described {Goldschmidt­
Clermont et al., 1991). Once dissociated from Ptdlns(4)P or 
Ptdlns(4, 5)P2 profilin interacts with actin, thereby in­
fluencing polymerization of the cytoskeletal filaments. 
This mechanism has been postulated to account for the EGF­
mediated changes in cell morphology and motility (Gold­
schmidt-Clermont et al., 1991). Therefore, it seems reason­
able to hypothesize that the increase in Ptdlns(4)P synthe­
sis observed following EGF exposure relates to changes in 
cytoskeletal structure rather than generation of signaling 
molecules. However, further investigation is necessary to 
define the molecular basis for the EGF-mediated increase in 
polyphosphoinositide synthesis. 
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EGF interacts with several G proteins localized to the 
plasma membrane of pancreatic acinar cells, including Gs 
which couples to adenylate cyclase (Profrock et al., 1991 
a). This finding, taken together with the observation that 
EGF increases cAMP levels in several systems (!washita et 
al., 1990; Nakagawa et al., 1991), raises the possibility 
that EGF is regulating Ptdins kinase activity by increasing 
cAMP levels in pancreatic acini. However, exposure to 
concentrations of EGF which increase Ptdins kinase activity 
failed to elevate cAMP levels over the time course examined. 
This observation was subsequently confirmed by Profrock et 
al. (1991b). Although these data suggest that EGF does not 
modulate Ptdlns kinase activity by elevating cAMP levels, 
the possibility that EGF directly modulates PKA activity 
cannot be excluded. 
The mechanism by which EGF increases Ptdins 4-kinase 
activity is unknown, although several lines of evidence 
suggest the involvement of a phosphorylation event possibly 
mediated by one of several serine/threonine kinases. For 
example, the EGF-mediated increase in Ptdins kinase activity 
may involve the generation of DAG (Macara, 1986) and 
subsequent activation of PKC (Susa et al., 1989). Although 
treatment of pancreatic acinar cells with EGF did not 
promote the hydrolysis of [32P]Ptdins(4,5)P2, generation of 
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DAG from other phospholipids such as phosphatidylcholine may 
occur. The possible involvement of PKC in the EGF-induced 
stimulation of Ptdins kinase activity is supported by the 
observation that EGF is capable of directly modulating PKC 
activity in several cell types (Sahai et al., 1982; Kasai et 
al., 1989; Susa et al., 1989); however, definitive evidence 
for this hypothesis is lacking. In addition to modulating 
PKC activity, EGF has been shown to stimulate at least seven 
other serine/threonine kinases in fibroblasts (Ahn et al:, 
1990). 
Another possible explanation for the EGF-mediated 
increase in Ptdins 4-kinase activity may involve a tyrosine 
phosphorylation event catalyzed directly by the EGF receptor 
tyrosine kinase. Payrastre et al. (1990) demonstrated an 
EGF-dependent regulation of Ptdins 4-kinase activity by a 
mechanism involving a tyrosine phosphorylation process. 
Furthermore, immunoprecipitation studies demonstrated the 
physical association of Ptdins kinase activity with the EGF 
receptor (Cochet et al., 1991). Using cross-linking 
techniques, this laboratory also showed the existence of 
four phosphotyrosine-containing proteins associated with the 
EGF receptor. These proteins were not specifically 
identified; however, the molecular weight of the most 
prominent band was 55 kDa which corresponds to that of 
Ptdins 4-kinase purified from several cell types (Endemann 
et al., 1987; Whitman et al., 1987; Walker et al., 1988). 
These results suggest, but do not prove, that Ptdins 4-
kinase is associated with, and tyrosine phosphorylated by, 
activated EGF receptors. 
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Therefore, it appears likely that the EGF-induced 
increase in Ptdins 4-kinase activity involves a 
phosphorylation event catalyzed by one of several 
serine/threonine kinases or the EGF receptor tyrosine kinase 
itself. Future investigations aimed towards the 
identification of specific residues phosphorylated following 
EGF stimulation may provide useful information regarding the 
identification of putative protein kinases involved in the 
activation process. 
Several studies in pancreatic acini have suggested the 
possible importance of phosphorylation/dephosphorylation 
reactions in the regulation of cellular function. For 
example, CCh has been demonstrated to alter the 
phosphorylation state of several specific proteins (Burnham 
& Williams, 1982). In addition to the observed increase in 
phosphorylation, the dephosphorylation of at least two 
proteins have been closely correlated with CCh-stimulated 
amylase secretion (Burnham & Williams, 1982). The ability 
of TPA, a potent activator of PKC, to mimic the pattern of 
CCh-induced alterations in protein phosphorylation suggests 
that CCh elicits these changes via the activation of PKC 
(Burnham et al., 1986). It was subsequently demonstrated 
that, in addition to having effects on their own, VIP and 8-
bromo-cAMP considerably enhanced the CCh-mediated phosphory­
lation/dephosphorylation of several of the aforementioned 
proteins (Burnham et al., 1988). These authors also sug­
gested that the enhanced changes in phosphorylation of one 
or more of these proteins may underlie the synergistic 
stimulation of secretion elicited by these two classes of 
secretagogues. 
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In conclusion, the augmentation of Ptdins 4-kinase 
activity under conditions that favor protein phosphorylation 
supports the contention that phosphorylation-mediated events 
are involved in its mode of regulation. Indeed, the ability 
of cell permeable diglyceride analogues and monobutyryl cAMP 
to increase activity when added to intact acini supports the 
contention that activation of Ptdins 4-kinase is associated 
with phosphorylation events, presumably involving protein 
kinase c and cAMP-dependent protein kinase (Fig. 25). The 
fact that stimulation of Ptdins 4-kinase activity attained 
in intact acini or minces was retained in homogenates and in 
a purified zymogen granule membrane fraction that was 
isolated by a procedure taking several hours suggests that 
CCh stimulation produces a stable covalent modification of 
the enzyme. Agonist stimulation of lipid kinase activity 
which persists after isolation of broken cell preparations 
has also been reported in other test systems (Walker & Pike, 
1987; Pike et al., 1990). This regulation may involve the 
direct phosphorylation of distinct sites on the enzyme or a 
dephosphorylation subsequent to the PKC- or PKA-mediated 
alteration in one or more modulatory proteins. Conclusive 
evidence for the covalent modification of Ptdins 4-kinase 
Figure 25. Proposed model for the regulation of Ptdins 
4-kinase activity in the exocrine pancreas. 
a.c.= adenylate cyclase. 
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awaits its purification and the demonstration of altered 
[32P)P04 incorporation into this enzyme subsequent to stimu­
lation. 
The demonstrated abilities of CCh, cAMP and EGF to 
activate Ptdlns 4-kinase as shown in this study imply that 
phosphoinositide synthesis, like hydrolysis, is under 
stringent and complex control which can be regulated by 
physiological stimulation of the acinar cell. In addition to 
providing important.insight into the mechanisms regulating 
phosphoinositide synthesis in the exocrine pancreas, these 
studies also portray yet another pivotal site for cross-talk 
among the intracellular signaling systems which utilize the 
phosphoinositide- and cAMP-mediated pathways. Further 
characterization of the CCh-, cAMP-, and EGF-stimulated 
Ptdlns 4-kinase will be required to comprehend more fully 
the role of these receptor systems in the activation of 
signal transduction pathways in the exocrine pancreas. 
REFERENCES 
157 
REFERENCES 
Abdel-Latif, A.A., Akhtar, R.A. & Hawthorne, J.N. (1977) 
Acetylcholine increases the breakdown of 
trisph�sphoinositide in rabbit iris muscle prelabelled 
with ( 2P]phosphate. Biochem. J. 162: 61-73. 
Abdel-Latif, A.A. (1986) Calcium-mobilizing receptors, 
polyphosphoinositides, and the generation of second 
messengers. Pharmacal. Rev. �: 227-272. 
Agranoff, B.W., Bradley, R.M. & Brady, R.O. (1958) The 
enzymatic synthesis of inositol phosphatide. J. Biol. 
Chern. £2J: 1077-1083. 
Ahn, N.G., Weiel, J.E., Chan, C.P. & Krebs, E.G. (1990) 
Identification of multiple epidermal growth factor­
stimulated protein serine/threonine kinases from Swiss 
3T3 cells. J. Biol. Chern. 265: 11487-11494. 
Akhtar, R.A. & Abdel-Latif, A.A. (1978) Studies on the 
properties of triphosphoinositide phosphomonoesterase 
and phosphodiesterase of rabbit iris smooth muscle. 
Biochim. Biophys. Acta 527: 159-170. 
158 
Akhtar, R.A. & Abdel-Latif, A.A. (1980) Requirement for 
calcium ions in acetylcholine-stimulated 
phosphodiesteratic cleavage of phosphatidyl-myo­
inositol 4,5-bisphosphate in rabbit iris smooth muscle. 
Biochem. J. 142: 599-604. 
Akita, Y., Ohno, S., Konno, Y., Yano, A. & Suzuki, K. (1990) 
Expression and properties of two distinct classes of 
the phorbol ester receptor family, four conventional 
protein kinase C types, and a novel protein kinase c. 
J. Biol. Chern. 265: 354-362. 
Amsterdam, A., Soloman, T.E. & Jamieson, J.D. (1978) 
Sequential dissociation of the exocrine pancreas into 
lobules, acini, and individual acinar cells; In: 
Methods in Cell Biology (Prescott, D.M. ed.) vol. 20, 
pp. 361-378, Academic Press, New York. 
Ashkenazi, A., Ramachandran, J. & Capon, D.J. (1989) 
Acetylcholine analogue stimulates DNA synthesis in 
brain-derived cells via specific muscarinic receptor 
subtypes. Nature (London) 340: 146-150. 
Asotra, K., Lagos, N., & Vergara, J. (1991) Synthesis of 
polyphosphoinositides in transverse tubule and 
sarcoplasmic reticulum membranes of frog skeletal 
muscle. Biochim. Biophys. Acta 1081: 229-237. 
159 
Appert, H.E., Chiu, T.H., 
Howard, J. M. ( 1981) 
dispersed pancreatic 
684. 
�udd, G.C., Leonardi, A.J. & 
H-methylscopolamine binding to 
acini. Cell Tissue Res. 220: 673-
Auger, K.R., Serunian, L.A., Soltoff, S.P., Libby, P. & 
Cantley, L. (1989) PDGF-dependent tyrosine 
phosphorylation stimulates production of novel 
polyphosphoinositides in intact cells. Cell 57: 167-
175. 
Beaudoin, A.R. & Grondin, G. (1992) Zymogen granules of the 
pancreas and the parotid gland and their role in cell 
secretion. Int. Rev. Cytol. 132: 177-222. 
Belunis, C.J., Bae-Lee, M., Kelley, M.J. & Carman, G.M. 
(1988) Purification and characterization of 
phosphatidylinositol kinase from Saccharomyces 
cerevisiae. J. Biol. Chern. �: 18897-18903. 
Bendayan, M. & Ito, S. (1979) Immunohistochemical 
localization of exocrine enzymes in normal rat 
pancreas. J. Histochem. Cytochem. 27: 1029-1034. 
Benistant, c. , Thomas, A.P. & Rubin, R. (1990) Effect of 
guanine nucleotides on polyphosphoinositide synthesis 
in rat liver plasma membranes. Biochem. J. 271: 591-
597. 
Bennett, C.F. & Crooke, S.T. (1987) Purification and 
characterization of a phosphoinositide-specific 
phospholipase C from guinea pig uterus: phosphorylation 
by protein kinase C in vivo. J. Biol. Chern. 262: 
13789-13797. 
Berridge, M.J. (1983) Rapid accumulation of inositol 
trisphosphate reveals that agonists hydrolyse 
polyphosphoinositides instead of phosphatidylinositol. 
Biochem. J. �: 849-858. 
Berridge, M.J. & Irvine, R.F. (1984) Inositol 
trisphosphate, a novel second messenger in cellular 
signal transduction. Nature (London) �: 315-321. 
Bissonnette, B.M., Collen, M.J., Adachi, H. Jensen, R.T. & 
Gardner, J.D. (1984) Receptors for vasoactive 
intestinal peptide and secretin on rat pancreatic 
acini. Am. J. Physiol. 246: G710-G717. 
160 
Bligh, E. G., and Dyer, W.J. (1959) A rapid method of total 
lipid extraction and purification. Canadian J. 
Biochem. Physiol. }2: 911-917. 
Bolender, R.P (1974) Stereological analysis of the guinea­
pig pancreas. I. Analytical model and quantitative 
description of nonstimulated pancreatic exocrine cells. 
J. Cell Biol. 61: 269-287. 
Boon, A.M., Beresford, B.J. & Mellors, A. (1985) A tumor 
promoter enhances the phosphorylation of polyphospho­
inositides while decreasing phosphatidylinositol 
labeling in lymphocytes. Biochem. Biophys. Res. 
Commun. 129: 431-438. 
Bradford, M.M. (1976) A rapid and sensitive method for the 
quantitation of microgram quantitiies of protein 
utilizing the principle of protein-dye binding. Anal. 
Biochem. 2£: 248-254. 
Brockerhoff, H. & Ballou, C.E. (1962) Phosphate 
incorporation in brain phosphoinositides. J. Biol. 
Chern. £d2: 1764-1766. 
Brockman, D.E. (1978) Anastomosing tubular arrangement of 
dog exocrine pancreas. Cell Tissue Res. 189: 497-500. 
Brooker, G., Harper, J.F., Terasaki, W.L. & Moylan, R.D. 
(1979) Radioimmunoassay of cyclic AMP and cyclic GMP. 
Adv. Cyc. Nuc. Res. 10: 1-33. 
Burnham, D.B., Munowitz, P., Hootman, S.R. & Williams, J.A. 
(1986) Regulation of protein phosphorylation in 
pancreatic acini: distinct effects of ca2+ ionophore 
A23187 and 12-0-tetradecanoylphorbol 13-acetate. 
Biochem. J. £l2: 125-131. 
Burnham, D.B., Munowitz, P., Thorn, N. & Williams, J.A. 
(1985) Protein kinase activity associated with 
pancreatic zymogen granules. Biochem. J. 227: 743-751. 
Burnham, D.B., Sung, C.K., Munowitz, P. & Williams, J.A. 
(1988) Regulation of protein phosphorylation in 
pancreatic acini by cyclic AMP-mediated secretagogues: 
interaction with carbamylcholine. Biochim. Biophys. 
Acta 969: 33-39. 
161 
Burnham, D.B. & Williams, J.A. (1982) Effects of carbachol, 
cholecystokinin, and insulin on protein phosphorylation 
in isolated pancreatic acini. J. Biol. Chem. 257: 
10523-10528. 
Burnham, D.B. & Williams, J.A. (1984) Activation of protein 
kinase activity in pancreatic acini by calcium and 
cAMP. Am. J. Physiol. 246: G500-G508. 
Butcher, F.R. & Putney, J.W. Jr. (1980) Regulation of 
parotid gland function by cyclic nucleotides and 
calcium. Adv. cyclic Nucleotide Res. 13: 215-249. 
Buxeda, R.J., Nickels, J.T., Jr., Belunis, C.J. & Carman, 
G.M. (1991) Phosphatidylinositol 4-kinase from 
Saccharomyces cerevisiae: kinetic analysis using Triton 
X-100/Phosphatidylinositol-mixed micelles. J. Biol. 
Chem. 266: 13859-13865. 
Campbell, C.R., Fishman, J.B. & Fine, R.E. (1985) Coated 
vesicles contain a phosphatidylinositol kinase. J. 
Biol. Chem. 260: 10948-10951. 
Case, R.M. (1978) Synthesis, intracellular transport and 
discharge of exportable proteins in the pancreatic 
acinar cell and other cells. Biol. Rev. 53: 211-354. 
Carpenter, G. (1987) Receptors for epidermal growth factor 
and other polypeptide mitogens. Ann. Rev. Biochem. 56: 
881-914. 
Carpenter, C.L. & Cantley, L.C. (1990) Phosphoinositide 
kinases. Biochemistry 29: 11147-11156. 
Carpenter, G. & Cohen, S. (1979) Epidermal growth factor. 
Ann. Rev. Biochem. 48: 193-216. 
Carter, H.R. & Smith, A.D. (1987) Resolution of the 
phosphoinositide-specific phospholipase C isolated from 
porcine lymphocytes into multiple species: partial 
purification of two isoenzymes. Biochem. J. 244: 639-
645. 
Castagna, M., Takai, Y., Kaibuchi, K., Sane, K., Kikkawa, u. 
& Nishizuka, Y. (1982) Direct activation of calcium­
activated, phospholipid-dependent protein kinase by 
tumor-promoting phorbol esters. J. Biol. Chem. 257: 
7847-7851. 
Cenatiempo, Y. , Mangeat, P. & Marchis-Mouren, G. (1975) 
Purification and properties of cyclic AMP dependent and 
independent protein kinases from rat pancreas. 
Biochimie 57: 865-873. 
162 
Chahwala, S.B., Fleischman, L.F. & Cantley, L. (1987) 
Kinetic analysis of guanosine 5'-0-(3-thiotriphosphate) 
effects on phosphatidylinositol turnover in NRK cell 
homogenates. Biochemistry 26: 612-622. 
Chandrasekar, B. & Korc, M. (1991) Basic fibroblast growth 
factor is a calcium-mobilizing secretagogue in rat 
pancreatic acini. Biochem. Biophys. Res. Commun. 177: 
166-170. 
Channen, J.Y. & Leslie, c.c. (1990) A calcium-dependent 
mechanism for associating a soluble arachidonoyl­
hydrolyzing phosholipase A2 with membrane in the 
macrophage cell line RAW 264.7. J. Biol. Chern. 265: 
5409-5413. 
Clark, N.G. & Dawson, R.M.C. (1981) Alkaline 0--N 
transacylation: A new method for the quantitative 
deacylation of phospholipids. Biochem. J. 195: 301-
306. 
Cocco, L., Gilmour, R.S., Ognibene, A., Letcher, A.J., 
Manzoli, F.A. & Irvine, R.F. (1987) synthesis of 
polyphosphoinositides in nuclei of Friend cells: 
evidence for polyphosphoinositide metabolism inside the 
nucleus which changes with cell differentiation. 
Biochem. J. 248: 765-770. 
Cochet, c. & Chambaz, E.M. (1986) Catalytic properties of a 
purified phosphatidylinositol-4-phosphate kinase from 
rat brain. Biochem. J. £12: 25-31. 
Cochet, c. , Filhol, 0., Payrastre, B., Hunter, T. & Gill, G. 
(1991) Interaction between the epidermal growth factor 
receptor and phosphoinositide kinases. J. Biol. Chern. 
266: 637-644. 
Cockcroft, s., Taylor, J.A. & Judah, J.D. (1985 a) 
Subcellular localization of inositol lipid kinases in 
rat liver. Biochim. Biophys. Acta 845: 163-170. 
Cockcroft, S., Barrowman, M.M. & Gomperts, B.D. (1985 b) 
Breakdown and synthesis of polyphosphoinositides 1n 
fMetLeuPhe-stimulated neutrophils. FEBS Lett. 181: 
259-263. 
Collen, M.J., Sutliff, V.E., Guo-Zong, P. & Gardner, 
J.D. (1982) Postreceptor modulation of action of VIP and 
secretin on pancreatic enzyme secretion by 
secretagogues that mobilize cellular calcium. Am. J. 
Physiol. �: G423-428. 
163 
Co1odzin, M., & Kennedy, E.P. (1965) Biosynthesis of 
diphosphoinositide in brain. J. Biol. Chem. 240: 3771-
3780. 
Creba, J.A., Downes, C.P., Hawkins, P.T., Brewster, G., 
Michell, R.H., and Kirk, C.J. (1983) Rapid breakdown 
of phosphatidylinositol 4-phosphate and phosphatidyl­
inositol 4,5-bisphosphate in rat hepatocytes stimulated 
by vasopressin and other calcium-mobilizing hormones. 
Biochem. J. �: 733-747. 
Crooke, S.T. & Bennett, C.F. (1989) Mammalian 
phosphoinositide-specific phospholipase c isoenzymes. 
Cell Calcium 10: 309-323. 
Dawson, R.M. (1954) The measurement of 32P labelling of 
individual kephalins and lecithin in a small sample ·of 
tissue. Biochim. Biophys. Acta 11: 374-379. 
de Chaffoy de Courcelles, D., Roevens, P. & Van Belle, H. 
(1984) 1-oleoyl-2-acetyl-glycerol (OAG) stimulates the 
formation of phosphatidylinositol 4-phosphate in intact 
human platelets. Biochem. Biophys. Res. Commun. 1£2: 
589-595. 
Dehaye, J-P, Winand, J., Poloczek, P. & Christophe, J. 
(1984) Characterization of muscarinic cholinergic 
r�ceptors on rat pancreatic acini by N-
[ H]methylscopolamine binding: their relationship with 
calcium 45 efflux and amylase secretion. J. Biol. 
Chem. 259: 294-300. 
Dehaye, J-P, Gillard, M., Poloczek, P., Stievenart, M., 
Winand, J. & Christophe, J. (1985) Effects of 
forskolin on adenylate cyclase activity and amylase 
secretion in the rat exocrine pancreas. J. Cyclic 
Nucleotide Res. 1Q: 269-280. 
Del Vecchio, R.L. & Pilch, P.F. (1991) Phosphatidylinositol 
4-kinase is a component of glucose transporter (GLUT 
4)-containing vesicles. J. Biol. Chem. 266: 13278-
13283. 
Dembinski, A. Gregory, H., Konturek, S.J. & Polanski, M. 
(1982) Trophic action of epidermal growth factor on 
the pancreas and gastroduodenal mucosa in rats. J. 
Physiol. (London) 325: 35-42. 
Dennis, E.A. (1983) Phospholipases in: The Enzymes (Boyer, 
P.O., ed.) vol. 16, pp. 307-353, Academic Press, New 
York. 
164 
Douglas, W.W. (1968) Stimulus-secretion coupling: the 
concept and clues from chromaffin and other cells. Br. 
J. Pharmacol. 2i: 451-474. 
Douglas, w.w. & Rubin, R.P. (1961) The role of calcium in 
the secretory response of the adrenal medulla to 
acetylcholine. J. Physiol. 159: 40-57. 
Downes, C.P., Hawkins, T. & Stephens, L. (1989) 
Identification of the stimulated reaction in intact 
cells, its substrate supply and the metabolism of 
inositol phosphates; In: Inositol lipids in cell 
signalling (Michell, R.H., Drummond, A.H. & Downes, 
C.P. (eds.) pp. 3-38, Academic Press, London. 
Doyle, C.M. & Jamieson, J.D. (1978) Development of 
secretagogue response in rat pancreatic acinar cells. 
Dev. Biol. 65: 11-27. 
Drust, D.S. & Martin, T.F. (1985) Protein kinase C 
translocates from cytosol to membrane upon hormone 
activation: effects of thyrotropin-releasing hormone in 
GH3 cells. Biochem. Biophys. Res. Commun. 128: 531-537. 
Eberhard, D.A., Cooper, C.L., Low, M.G. & Holz, R.W. (1990) 
Evidence that the inositol phospholipids are necessary 
for exocytosis: loss of inositol phospholipids and 
inhibition of secretion in permeabilized cells caused 
by a bacterial phospholipase c and removal of ATP. 
Biochem. J. �: 15-25. 
Eggman, L.D. & Hokin, L.E. (1960) The relationshi� between 
secretory activity and the incorporation of 3 P into 
phosphoinositide and phosphatidic acid in salivary 
glands and pigeon esophageal mucosa in vitro. J. Biol. 
Chem. 235: 2569-2571. 
Ekholm, R., Zelander, T. & Edlund, Y. (1962) The 
ultrastructural organization of the rat exocrine 
pancreas. I. Acinar cells. J. Ultrastruct. Res. 2: 61-
72. 
El Mestikawky, s. , Glowinski, J. & Hamon, M. (1983) 
Tyrosine hydroxylase activation in depolarized 
dopaminergic terminals-involvement of ca2-dependent 
phosphorylation. Nature (London) 302: 830-832. 
Endemann, G., Dunn, S.N. & Cantley, L.C. (1987) Bovine 
brain contains two types of phosphatidylinositol 
kinase. Biochemistry 26: 6845-6852. 
Eng, S.P. & Lo, c.s. (1990) Mastoparan increases membrane­
bound phosphatidylinositol kinase and phosphatidyl­
inositol 4-monophosphate kinase activities in madin­
darby canine kidney cells. Life Sci. 46: 273-279. 
Farese, R.V., Larson, R.E. & Sabir, M.A. (1982a) ca2+­
dependent and ca2+-independent effects of pancreatic 
secretagogues on phosphatidylinositol metabolism. 
Biochim. Biophys. Acta 710: 391-399. 
165 
Farese, R.V., Larson, R.E. & Sabir, M.A. (1982b) ca2+­
dependent and ca2+-independent mechan�sms for 
phosphatidylinositol hydrolysis and 3 P-labeling during 
cholinergic stimulation of the rat submaxillary gland 
in vitro. Arch. Biochem. Biophys. 219: 204-208. 
Farese, R.V. Sabir, M.A. & Larson, R.E. (1981) Effects of 
dibutyryl cyclic AMP and theophylline on rat pancreatic 
phospholipids in vitro. Biochim. Biophys. Acta 665: 
463-470. 
Freedman, S.D. & Jamieson, J.D. (1982) Hormone-induced 
protein phosphorylation. I. Relationship between 
secretagogue action and endogenous protein 
phosphorylation in intact cells from the exocrine 
pancreas and parotid. J. Cell Biol. 95: 903-908. 
Ganong, B.R. (1990) Bimodal lipid substrate dependence of 
phosphatidylinositol kinase. Biochemistry 29: 6904-
6910. 
Ganong, B., Loomis, C.R., Hannun, Y.A. & Bell, R.M. (1986) 
Specificity and mechanism of protein kinase C 
activation by sn-1,2-diacylglycerols. Proc. Natl. Acad. 
Sci. (USA) .!l]_: 1184-1188. 
Ganong, B.R. & Lu, C-M. (1989) Application of nonionic 
polyoxyethylene detergents in studies of 
phosphatidylinositol kinase. Anal. Biochem. 179: 66-
71. 
Gardner, J.D. & Jackson, M.J. (1977) Regulation of amylase 
release from dispersed pancreatic acinar cells. J. 
Physiol. 270: 439-454. 
Gardner, J.D. & Jensen, R.T. (1986) Receptors and cell 
activation associated with pancreatic enzyme secretion. 
Ann. Rev. Physiol. 48: 103-117. 
Gardner, J.D. & Jensen, R.T. (1987) Secretagogue receptors 
on pancreatic acinar cells; In: Physiology of the 
Gastrointestinal Tract (Johnson, L.R. ed.), 2nd 
edition, pp. 1109-1127. Raven Press, New York. 
Giraud, F., Gascard, P. & Sulpice, J.C. (1988) Stimulation 
of polyphosphoinositide turnover upon activation of 
protein kinases in human erythrocytes. Biochim. 
Biophys. Acta 968: 367-378. 
166 
Goldschmidt-Clermont, P.J., Machesky, L.M., Baldassare, J.J. 
& Pollard, T.D. (1990) The actin-binding protein 
profilin binds to Ptdins(4,5)P2 and inhibits its 
hydrolysis by phospholipase c. Science 247: 1575-1578. 
Goldschmidt-Clermont, P.J., Kim, J-W, Machesky, L.M., Rhee, 
S.G. & Pollard, T.D. (1991) Regulation of 
phospholipase c-gl by profilin and tyrosine 
phosphorylation. Science 251: 1231-1233. 
Hajra, A.K., Seguin, E.B. & Agranoff, B.W. (1968) Rapid 
labeling of mitochondrial lipids by labeled 
orthophosphate and adenosine triphosphate. J. Biol. 
Chem. �: 1609-1616. 
Halenda, S.P. & Rubin, R.P. (1982) Phospholipid turnover in 
isolated rat pancreatic acini: consideration of the 
relative roles of phospholipase A2 and phospholipase C. 
Biochem. J. �: 713-721. 
Hall, z.w. (1987) Three of a kind: the beta-adrenergic 
receptor, the muscarinic acetylcholine receptor, and 
rhodopsin. Trends Neurosci. 10: 99-101. 
Hannun, Y.A., Loomis, C.R. & Bell, R.M. (1985) Activation 
of protein kinase c by triton X-100 mixed micelles 
containing diacylglycerol and phosphatidylserine. J. 
Biol. Chem. 260: 10039-10043. 
Harden, T.K., Stephens, L., Hawkins, P.T. & Downes, C.P 
(1987) Turkey erythrocyte membranes as a model for 
regulation of phospholipase c by guanine nucleotides. 
J. Biol. Chem. �: 9057-9061. 
Harwood, J.L. & Hawthorne, J.N. (1969) The properties and 
subcellular distribution of phosphatidylinositol kinase 
in mammalian tissues. Biochim. Biophys. Acta 171: 75-
88. 
Hellman, B., Wallgren, A. & Petersson, B. (1962) 
Cytological characteristics of the exocrine pancreatic 
cells with regard to their position in relation to the 
islets of Langerhans. Acta Endocrinol. (Copenh.) 22: 
465-473. 
Helms, J.B., Jan de Vries, K. & Wirtz, K.W.A. (1991) 
Synthesis of phosphatidylinositol 4,5-bisphosphate in 
the endoplasmic reticulum of chinese hamster ovary 
cells. J. Biol. Chern. 266: 21368-21374. 
167 
Hepler, J.R., Nakahata, N., Levenberg, T.W., Diguiseppi, J., 
Herman, B., Earp, H.S. & Harden, T.K. (1987) Epidermal 
growth factor stimulates the raped accumulation of 
inositol (1,4,5)-trisphosphate and a rise in cytosolic 
calcium mobilized from intracellular stores in A431 
cell. J. Biol. Chern. 262: 2951-2956. 
Hermodsson, L.H. (1965) The ultrastructure of exocrine 
pancreas cells as related to secretory activity: an 
electron microscopical study of exocrine pancreas cells 
from cats stimulated by secretin and pancreozymin. 
Almqvist and Wiksells: Uppsala. p. 9-139. 
Hirata, Y. & Orth, D.N. (1979) Epidermal growth factor 
(urogastrone) in human tissues. J. Clin. Endocrinol. 
Metab. 48: 667-672. 
Hirata, Y. Uchihashi, M., Nakajima, M., Fujita, T. & 
Matsukura, S. (1982) Immunoreactive human epidermal 
growth factor in human pancreatic juice. J. Clin. 
Endocrinol. Metab. 54: 1242-1245. 
Hockberger, P.E. & Swandulla, D. (1987) Direct ion channel 
gating: a new function for intracellular messengers. 
Cell Mol. Neurobiol. �: 229-236. 
Hokin, L.E. (1966) Effects of calcium omission on 
acetylcholine-stimulated amylase secretion and 
phospholipid synthesis in pigeon pancreas slices. 
Biochim. Biophys. Acta 115: 219-221. 
Hokin, L.E. & Hokin, M.R. (1955) Effects of acetylcholine 
on the turnover of phosphoryl units in individual 
phospholipids of pancreas slices and brain cortex 
slices. Biochim. Biophys. Acta 18f: 102-110. 
Hokin, L.E. & Hokin, M.R. (1958) Phosphoinositides and 
protein secretion in pancreas slices. J. Biol. Chern. 
�: 805-810. 
Hokin, L.E. & Hokin, M.R. (1958) Acetylcholine and the 
exchange of inositol and phosphate in brain 
phosphoinositides. J. Biol. Chern. �: 818-821. 
Hokin, L.E. & Hokin, M.R. (1960} Studies on the carrier 
function of phosphatidic acid in sodium transport. I. 
The turnover of phosphatidic acid and phosphoinositide 
in the avial salt gland on stimulation of secretion. 
J. Gen. Physiol. 44: 61-85. 
Hokin, L.E. & Sherwin, A.L. (1957) Protein secretion and 
phosphate turnover in the phospholipids in salivary 
glands in vitro. J. Physiol. Lond. 135: 18-29. 
168 
Hokin, M.R. & Hokin, L �· (1953) Enzyme secretion and the 
incorporation of 3 P into the phospholipids of pancreas 
slices. J. Biol. Chem. 203: 967-977. 
Hokin, M.R. & Hokin, L.E. (1959) The synthesis of 
phosphatidic acid from diglyceride and adenosine 
triphosphate in extracts of brain microsomes. J. Biol. 
Chem. �: 1381-1386. 
Hokin, M.R. & Hokin, L.E. (1964) Interconversions of 
phosphatidylinositol and phosphatidic acid involved in 
the response to acetylcholine in the salt gland; In: 
Metabolism and Physiological Significance of Lipids 
(Dawson, R.M.C. & Rhodes, D.N. eds.) pp. 423-434, John 
Wiley & Sons, New York. 
Hokin, M.R., Hokin, L.E., Saffran, M., Schally, A.V. & 
Zimmermann, B.U. (1958} Phospholipids and the 
secretion of adrenocorticotropin and of 
corticosteroids. J. Biol. Chem. �: 811-813. 
Hokin-Neaverson, M.R. (1974} Acetylcholine causes a net 
decrease in phosphatidylinositol and a net increase in 
phosphatidic acid in mouse pancreas. Biochem. Biophys. 
Res. Commun. 58: 763-768. 
Hokin-Neaverson, M. & Sadeghian, K. (1984} Lithium-induced 
accumulation of inositol 1-phosphate during 
cholecystokinin octapeptide- and acetylcholine­
stimulated phosphatidylinositol breakdown in dispersed 
mouse pancreas acinar cells. J. Biol. Chem. 259: 4346-
4352. 
Holian, 0. , Bombeck, C.T. & Nyhus, L.M. (1980) Hormonal 
stimulation of cAMP-dependent protein kinase in rat 
pancreas. Biochem. Biophys. Res. Commun. 95: 553-
561. 
Holland, K.M., Homann, M.J., Belunis, C.J. & Carman, G.M. 
(1988) Regulation of phosphatidylinositol kinase 
activity in Saccharomyces cerevisiae. J. Bacterial. 
170: 828-833. 
Hollander, F. & Birnbaum, D. (1952) The role of carbonic 
anhydrase in pancreatic secretion. Trans. NY Acad. 
Sci. 15: 56-58. 
Holub, B.J. (1978) Differential utilization of 1-palmitoyl 
and 1-stearoyl homologues of various unsaturated 1,2-
diacyl-sn-glycerols for phosphatidylcholine and 
phosphatidylethanolamine synthesis in rat liver 
microsomes. J. Biol. Chern. 253: 691-696. 
169 
Hootman, S.R. & Williams, J.A. (1987) Stimulation-secretion 
coupling in the pancreatic acinus; In: Physiology of 
the Gastrointestinal Tract (Johnson, L.R. ed.) 2nd 
edition, pp. 1129-1146, Raven Press, New York. 
Hou, W-M, Zhang, Z-L & Tai, H-H (1988) Purification and 
characterization of phosphatidylinositol kinase from 
porcine liver microsomes. Biochim. Biophys. Acta 959: 
67-75. 
Husebye, E.S. & Flatmark, T. (1988) Phosphatidylinositol 
kinase of bovine adrenal chromaffin granules: kinetic 
properties and inhibition by low concentrations of 
calcium. Biochim. Biophys. Acta 968: 261-265. 
Husebye, E.S., Letcher, A.J., Lander, D.J. & Flatmark, T. 
(1990) Purification and kinetic properties of a 
membrane-bound phosphatidylinositol kinase of the 
bovine adrenal medulla. Biochim. Biophys. Acta 1042: 
330-337. 
Imai, A. & Gershengorn, M.C. (1986) Phosphatidylinositol 
4,5-bisphosphate turnover is transient while 
phosphatidylinositol turnover is persistent in 
thyrotropin-releasing hormone-stimulated rat pituitary 
cells. Proc. Natl. Acad. Sci. (USA) al: 8540-8544. 
Imai, A., Rebecchi, M.J. & Gershengorn, M.C. (1986) 
Differential regulation by phosphatidylinositol 4,5-
bisphosphate of pituitary plasma-membrane and cytosolic 
phosphoinositide kinases. Biochem. J. 240: 341-
348. 
Irvine, R.F., Letcher, A.J., Heslop, J.P. & Berridge, M.J. 
(1986) The inositol trisjtetrakisphosphate pathway­
demonstration of Ins(1,4,5)P 3 3-kinase activity in 
animal tissues. Nature (London) 320: 631-634. 
Irvine, R.F. & Moor, R.M. (1987) Inositol(l,3,4,5)tetrakis­
phosphate-induced activation of sea urchin eggs 
requires the presence of inositol trisphosphate. 
Biochem. Biophys. Res. Commun. 146: 284-290. 
Ishizuka, T., Ito, Y., Kajita, K., Miura, K., Nagao, s. , 
Nagata, K-I & Nozawa, Y. (1987) Redistribution of 
protein kinase c in pancreatic acinar cells stimulated 
with caerulein or carbachol. Biochem. Biophys. Res. 
Commun. 144: 551-559. 
!washita, S., Mitsui, K., Shoji-Kasai, Y & Senshu-Miyaike, 
M. (1990) cAMP-mediated modulation of signal 
transduction of epidermal growth factor (EGF) receptor 
systems in human epidermal carcinoma A431 cells: 
depression of EGF-dependent diacylglycerol production 
and EGF receptor phosphorylation. J. Biol. Chern. 265: 
10702-10708. 
Jaanus, S.D. & Rubin, R.P. (1974) Analysis of the role of 
cyclic adenosine 3',5'-monophosphate in catecholamine 
release. J. Physiol. £12: 465-476. 
170 
Jahn, R. & Soling, H.D. (1983) Phosphorylation of the 
ribosomal protein S6 in response to secretagogues in 
the guinea pig exocrine pancreas, parotid, and lacrimal 
gland. FEBS Lett. 153: 71-76. 
Jenkins, G.H., Subrahmanyam, G. & Anderson, R.A. (1991) 
Purification and reconstitution of phosphatidylinositol 
4-kinase from human erythrocytes. Biochim. Biophys. 
Acta 1080: 11-18. 
Jergil, B. & Sundler, R. (1983) Phosphorylation of 
phosphatidylinositol in rat liver Golgi. J. Biol. 
Chern. 258: 7968-7973. 
Joh, T., Itoh, M., Yasue, N., Miyamoto, T., Iwai, A., 
Matsusako, K., Endoh, K., Takeuchi, T., Moriyama, A., 
Kato, T. & Tanaka, R. (1989). A sensitive enzyme 
immunoassay system of rat epidermal growth factor in 
biological fluids and tissue extracts. Acta 
Endocrinol. (Copenh.) 120: 616-623. 
Jones, L.M. & Michell, R.H. (1974) Breakdown of 
phosphatidylinositol provoked by muscarinic 
stimulation in rat parotid-gland fragments. 
J. �= 583-590. 
cholinergic 
Biochem. 
Kai, M., White, G.L. & Hawthorne, J.N. (1966) The 
phosphatidylinositol kinase of rat brain. Biochem. J. 
101: 328-337. 
Kasai, K., Ohmori, T. Koizumi, N., Hosoya, T., Hiraiwa, M. 
Emote, T., Hattori, Y. & Shimoda, S.I. (1989} 
Regulation of thyroid peroxidase activity by 
thyrotropin, epidermal growth factor and phorbol ester 
in porcine thyroid follicles cultured in suspension. 
Life Sci. 45: 1451-1459. 
Kate, H., Uno, I. , Ishikawa, T. & Takenawa, T. (1989) 
Activation of phosphatidylinositol kinase and 
phosphatidylinositol-4-phosphate kinase by cAMP in 
Saccharomyces cerevisiae. J. Biol. Chem. 264: 3116-
3121. 
Kempen, H.J.M., De Pont, J.J.H.H.M. & Bonting, S.L. (1977) 
Rat pancreatic adenylate cyclase. V. Its presence in 
isolated rat pancreatic acinar cells. Biochim. 
Biophys. Acta 496: 521-531. 
Khalaf, L.J., & Laychock, S.G. (1992) Phosphatidylinositol 
availability and polyphosphoinositide synthesis in 
pancreatic islet cell membranes. Biochem. Pharmacal. 
12: 1303-1310. 
Kikkawa, U. & Nishizuka, Y. (1986) The role of protein 
kinase c in transmembrane signalling. Annu. Rev. Cell 
Biol. �: 149-178. 
Kikkawa, U., Kishimoto, A. & Nishizuka, Y. (1989) The 
protein kinase C family: heterogeneity and its 
implications. Annu. Rev. Biochem. 58: 31-44. 
Kirk, C.J., Creba, J.A., Downes, C.P. & Michell, R.H. (1981 
a) Hormone-stimulated metabolism of inositol lipids 
and its relationship to hepatic receptor function. 
Biochem. Soc. Trans. �: 377-379. 
Kirk, C.J., Michell, R.H. & Hems, D.A. (1981 b) 
Phosphatidylinositol metabolism in rat hepatocyes 
stimulated by vasopressin. Biochem. J. 194: 155-165. 
171 
Knecht, M. & catt, K.J. (1983) Modulation of cAMP-mediated 
differentiation in ovarian granulosa cells by epidermal 
growth factor and platelet-derived growth factor. J. 
Biol. Chem. 258: 2789-2794. 
Komabayashi, T., McKinney, J.S. & Rubin, R.P. (1990) 
Regulation by diacylglycerol of calcium-evoked amylase 
secretion from intact and permeabilized pancreatic 
acinar cells. Cell Calcium 11: 501-506. 
Korc, M., Matrisian, L.M. & Magun, B.E. (1984) 
calcium regulates epidermal growth factor 
in rat pancreas and cultured fibroblasts. 
Acad. Sci. (USA) 81: 461-465. 
Cytosolic 
endocytosis 
Proc. Natl. 
172 
Korc, M., Matrisian, L.M., Planck, S.R. & Magun, B.E. (1983) 
Binding of epidermal growth factor in rat pancreatic 
acini. Biochem. Biophys. Res. Commun. 111: 1066-1073. 
Kraft, A.S. & Anderson+ W.B. (1983) Phorbol esters increase the amount of ca2 , phospholipid-dependent protein 
kinase associated with plasma membrane. Nature 
(London) 301: 621-623. 
Kurosawa, M. & Parker, c.w. (1986) A phosphatidylinositol 
kinase in rat mast cell granules. J. Immune. 136: 616-
622. 
Lambert, M., Camus, J. & Christophe, J. (1973) Pancreozymin 
and caerulein stimulate in vitro protein 
phosphorylation in the rat pancreas. Biochem. Biophys. 
Res. Commun. 52: 935-942. 
Lambert, M., Camus, J. & Christophe, J. (1974) 
Phosphorylation of protein components of isolated 
zymogen granule membranes from the rat pancreas. FEBS 
Lett. 49: 228-232. 
Langerhans, P. (1903) Beitrage zur Mikroskopischen Anatomie 
der Bauchspeilcheldruse; In: Inaug. Diss. Berlin, 
(1869), cited by Opie, E.L.; Histology of the Pancreas, 
In: Diseases of the pancreas pp. 67-88, J.B. Lippincott 
Co., Philadelphia. 
Lapetina, E.G. & Michell, R.H. (1972) Stimulation by 
acetylcholine of phosphatidylinositol labelling: 
subcellular distribution in rat cerebral-cortex slices. 
Biochem. J. 126: 1141-1147. 
Larose, L., Dumont, Y., Asselin, J., Morisset, J. & Poirier, 
G.G. (19�1) Muscarinic receptor of rat pancreatic 
acini: [ H]QNB binding and amylase secretion. Eur. J. 
Pharmacal. 76: 247-254. 
Lassing, I. & Lindberg, U. (1988) Specificity of the 
interaction between phosphatidylinositol-4,5-
bisphosphate and the profilin-actin complex. J. Cell. 
Biochem. 37: 255-267. 
Lefebvre, Y.A., White, D.A. & Hawthorne, J.N. (1976) 
Diphosphoinositide metabolism in bovine adrenal 
medulla. Can. J. Biochem. 54: 746-753. 
Levine, R.R. & Birdsall, N.J.M. (1989) Subtvoes of 
muscarinic receptors IV. Trends Pharmacol. Sci. 10 
(suppl.). Elsevier Press, United Kingdom. 
173 
Lewis, D.S. & Ronzio, R.A. (1979) An assessment of the role 
of protein kinase and zymogen granule phosphorylation 
during secretion by the rat exocrine pancreas. 
Biochim. Biophys. Acta 583: 422-433. 
Li, Y-S, Porter, F.D., Hoffman, R.M. & Deuel, T.F. (1989) 
Separation and identification of two 
phosphatidylinositol 4-kinase activities in bovine 
uterus. Biochem. Biophys. Res. Commun. 160: 202-209. 
Ling, L.E., Schulz, J.T. & Cantley, L.C. (1989) 
Characterization and purification of membrane­
associated phosphatidylinositol-4-phosphate kinase from 
human red blood cells. J. Biol. Chern. 264: 5080-5088. 
Lips, D.L., Majerus, P.W., Gorga, F.R., Young, A.T. & 
Benjamin, T.L. (1989) Phosphatidylinositol 3-phosphate 
is present in normal and transformed fibroblasts and is 
resistant to hydrolysis by bovine brain phospholipase c 
II. J. Biol. Chern. 264: 8759-8763. 
Logsdon, C.D. (1986) Stimulation of pancreatic acinar cell 
growth by CCK, epidermal growth factor and insulin. 
Am. J. Physiol. Gastroint. Liver Physiol. 14: G487-
G494. 
Logsdon, C.D. & Williams, J.A. (1983a) Epidermal growth 
factor binding and biologic effects on mouse pancreatic 
acini. Gastroenterol. 85: 339-345. 
Logsdon, C.D. & Williams, J.A. (1983b) Pancreatic acini in 
short-term culture: regulation by EGF, carbachol, 
insulin, and corticosterone. Am. J. Physiol. 244: 
G675-G683. 
Logsdon, C.D. & Williams, J.A. (1983c) Epidermal growth 
factor: intracellular ca2+ inhibits its association 
with pancreatic acini and A431 cells. FEBS Lett. 164: 
335-339. 
Low, M.G., Carroll, R.C. & Weglicki, W.B. (1984) Multiple 
forms of phosphoinositide-specific phospholipase c of 
different relative molecular masses in animal tissues: 
evidence for modification of the platelet enzyme by 
ca2+-dependent proteinase. Biochem. J. 221: 813-820. 
Low, M.G., Carroll, R.C. & Cox, A.C. (1986) 
Characterization of multiple forms of phosphoinositide­
specific phospholipase C purified from human platelets. 
Biochem. J. £21: 139-145. 
Lundberg, G.A. & Jergil, B. (1988) Generation of 
Ptdins(4,5)P2 proceeds through an intracellular route 
in rat hepatocytes. FEBS Lett. 240: 171-176. 
174 
Macara, I.G. (1986) Activation of 45ca2+ influx and 22Na+;H+ 
exchange by epidermal growth factor and vanadate in 
A431 cells is independent of phosphatidylinositol 
turnover and is inhibited by phorbol ester and 
diacylglycerol. J. Biol. Chern. 261: 9321-9327. 
Machesky, L.M., Goldschmidt-Clermont, P.J. & Pollard, T.D. 
(1990) The affinities of human platelet and 
Acanthamoeba profilin isoforms for 
polyphosphoinositides account for their relative 
abilities to inhibit phospholipase C. Cell Regul. �: 
937-950. 
Malaisse-Lagae, F., Ravazzola, M., Robberecht, P., 
Vandermeers, A., Malaisse, W.J. & Orci, L. (1975) 
Exocrine pancreas: evidence for topographic partition 
of secretory function. Science 190: 795-797. 
Margolis, B.L., Bonventre, J.V., Kremer, S.G., Kudlow, J.E. 
& Skorecki, K.L. (1988) Epidermal growth factor is 
synergistic with phorbol esters and vasopressin in 
stimulating arachidonate release and prostaglandin 
production in renal glomerular mesangial cells. 
Biochem. J. 249: 587-592. 
Massague, J. (1982) Epidermal growth factor-like 
transforming growth factor. II. Interaction with 
epidermal growth factor receptor in human placenta and 
membranes and A431 cells. J. Biol. Chern. 258: 13614-
13620. 
Matozaki, T. & Williams, J.A. (1989) Multiple sources of 
1,2-diacylglycerol in isolated rat pancreatic acini 
stimulated by cholecystokinin: involvement of 
phosphatidylinositol bisphosphate and 
phosphatidylcholine hydrolysis. J. Biol. Chern. 264: 
14729-14734. 
McMurray, W.C. & Dawson, M.C. (1969) 
reactions within the liver cell. 
108. 
Phospholipid exchange 
Biochem. J. 112: 91-
Merritt, J.E. & Rubin, R.P. (1985) Pancreatic amylase 
secretion and cytoplasmic free calcium: effects of 
ionomycin, phorbol dibutyrate and diacylglycerols alone 
and in combination. Biochem. J. 230: 151-159. 
175 
Merritt, J.E., Taylor, c.w., Rubin, R.P. & Putney, J.W. Jr. 
(1986) Evidence suggesting that a novel guanine 
nucleotide regulatory protein couples receptors to 
phospholipase c in exocrine pancreas. Biochern. J. 236: 
337-343. 
Michell, R.H. (1975) Inositol phospholipids and cell 
surface receptor function. Biochirn. Biophys. Acta 
415: 81-147. 
Michell, R.H. & Hawthorne, J.N. (1965) The site of 
diphosphoinositide synthesis in rat liver. Biochern. 
Biophys. Res. Cornrnun. 21: 333-338. 
Michell, R.H., Hawthorne, J.N., Coleman, R. & Karnovsky, 
M.L. (1970) Extraction of polyphosphoinositides with 
neutral and acidified solvents: a comparison of guinea­
pig brain and liver, and measurements of rat liver 
inositol compounds which are resistant to extraction. 
Biochirn. Biophys. Acta 210: 86-91. 
Missiaen, L., Wuytack, F., Raeyrnaekers, L., De Srnedt, H. & 
Casteels, R. (1989} Polyarnines and neomycin inhibit 
the purified plasma-membrane ca2+ pump by interacting 
with associated polyphosphoinositides. Biochern. J. 
261: 1055-1058. 
Morisset, J., Larose, L. & Korc, M. (1989) Epidermal growth 
factor inhibits rat pancreatic cell proliferation, 
causes acinar cell hypertrophy, and prevents caerulein­
induced desensitization of amylase release. 
Endocrinol. 124: 2693-2698. 
Moritz, A., De Graan, P.N.E., Gispen, W.H. & Wirtz, K.W.A. 
(1992) Phosphatidic acid is a specific activator of 
phosphatidylinositol-4-phosphate kinase. J. Biol. 
Chern. 267: 7207-7210. 
Motta, P., Andrews, P.M., Cararnia, F. & Correr, S. (1977) 
Scanning electron-microscopy of dissociated pancreatic 
acinar cell surfaces. Cell Tissue Res. 176: 493-504. 
Muallern, S., Pandol, S.J. & Beeker, T.G. (1988) Two 
components of hormone-evoked calcium release from 
intracellular stores of pancreatic acinar cells. 
Biochern. J. 255: 301-307. 
Muller, E., Hegewald, H., Jaroszewicz, K., Curnrne, 
Hoppe, H. & Frunder, H. (1986} Turnover of 
phosphornonoester groups and cornpartrnentation 
polyphosphoinositides in human erythrocytes. 
J. 235: 775-783. 
G.A. 
of 
Biochern. 
Muller, W.A., Steinman, R.M. & Cohn, Z.A. (1980) The 
membrane proteins of the vacuolar system. II. 
Bidirectional flow between secondary lysosomes and 
plasma membrane. J. Cell. Biol. 86: 304-314. 
Nakagawa, Y., Gammichia, J., Purushotham, K.R., Schneyer, 
C.A. & Humphreys-Beher, M.G. (1991) Epidermal growth 
factor activation of rat parotid gland adenylate 
cyclase and mediation by a GTP-binding regulatory 
protein. Biochem. Pharmacol. 42: 2333-2340. 
176 
Olsson, H., Persson, A. & Jergil, B. (1991) Purification of 
liver membranes highly enriched in phosphatidylinositol 
kinase. Cell. Signal. 2: 353-359. 
Orchard, J.L., Davis, J.S., Larson, R.E. & Farese, R.V. 
(1984) Effects of carbachol and pancreozymin 
(cholecystokinin-octapeptide) on polyphosphoinositide 
metabolism in the rat pancreas in vitro. Biochem. J. 
217: 281-287. 
Oron, Y., Sharoni, Y. Lefkovitz, H. & Selinger, Z. (1978) 
Phosphatidylinositol kinase and diphosphoinositide 
kinase in the rat parotid gland; In: Cyclitols and 
phosphoinositides (Wells, w. & Eisenberg, F. eds.) pp. 
383-397, Academic Press, New York. 
O'Shea, J.J., Harford, J.B. & Klausner, R.D. (1986) 
Identification and characterization of the 
phosphatidylinositol kinase in membranes of murine T­
lymphocytes. J. Immunol. 122: 971-976. 
O'Shea, J.J., Suarez-Quian, C.A., Swank, R.A. & Klausner, 
R.D. (1987) The inhibitory effect of cyclic AMP on 
phosphatidylinositol kinase is not mediated by the 
cAMP-dependent protein kinase. Biochem. Biophys. Res. 
Commun. 146: 561-567. 
Palade, G.E., Siekevitz, P. & Caro, L.G. (1962) Structure, 
chemistry and function of the pancreatic exocrine cell; 
In: Ciba Found. Symp. Exocrine Pancreas (de Reuck, 
A.V.S. & Cameron, M.P. eds.) pp. 23-55, Churchill 
Press, London. 
Palmer, S. Hawkins, P.T., Michell, R.H. & Kirk, C.�2 (1986) The labelling of polyphosphoinositides with [ PJPi and 
the accumulation of inositol phosphates in vasopressin­
stimulated hepatocytes. Biochem. J. 238: 491-499. 
Paulus, H. & Kennedy, E.P. (1960) 
of inositol monophosphatide. 
1311. 
The enzymatic synthesis 
J. Biol. Chem. �: 1303-
177 
Payrastre, B., Plantavid, M., Breton, M. Chambaz, E. & Chap, 
H. (1990) Relationship between phosphoinositide kinase 
activities and protein tyrosine phosphorylation in 
plasma membranes from A431 cells. Biochem. J. 272: 
665-670. 
Payrastre, B., van Bergen en Henegouwen, P.M.P, Breton, M., 
den Hartigh, J.C., Plantavid, M., Verkleij, A.J. & 
Boonstra, J. (1991) Phosphoinositide kinase, 
diacylglycerol kinase, and phospholipase c activities 
associated to the cytoskeleton: effect of epidermal 
growth factor. J. Cell Biol. 115: 121-128. 
Payrastre, B., Nievers, M., Boonstra, J., Breton, M., 
Verkleij, A.J. & van Bergen en Henegouwen, P.M.P. 
(1992) A differential location of phosphoinositide 
kinases, diacylglycerol kinase, and phospholipase C in 
the nuclear matrix. J. Biol. Chern. 267: 5078-5084. 
Peppelenbosch, M.P., Tertoolen, L.G.J. & de Laat, S.W. 
(1991) Epidermal growth factor-activated calcium and 
potassium channels. J. Biol. Chern. 266: 19938-19944. 
Peralta, E.G., Ashkenazi, A., Winslow, J.W., Ramachandran, 
J. & Capon, D.J. (1988) Differential regulation of 
phosphatidylinositol hydrolysis and adenylyl cyclase by 
muscarinic receptor subtypes. Nature (London) d21: 
434-437. 
Peterson, O.H. (1982) Stimulation excitation coupling in 
plasma membranes of pancreatic acinar cells. Biochim. 
Biophys. Acta 6944: 163-184. 
Phillips, J.H. (1973) Phosphatidylinositol kinase: a 
component of the chromaffin-granule membranes. 
Biochem. J. �: 579-587. 
Pike, L.J. & Eakes, A.T. (1987) Epidermal growth factor 
stimulates the production of phosphatidylinositol 
monophosphate and the breakdown of 
polyphosphoinositides in A431 cells. J. Biol. Chern. 
262: 1644-1651. 
Pike, M.C., Bruck, M.E., Arndt, c. & Lee, c-s. (1990) 
Chemoattractants stimulate phosphatidylinositol-4-
phosphate kinase in human polymorphonuclear leukocytes. 
J. Biol. Chern. 265: 1866-1873. 
178 
Po1ascik, T., Godfrey, P.P. & Watson, S.P. (1987) Neomycin 
cannot be used as a selective inhibitor of inositol 
phospholipid hydrolysis in intact and semi­
permeabilized human platelets: aminoglycosides activate 
semi-permeabilized platelets. Biochem. J. �: 815-
819. 
Porter, F.D., Li, Y-S & Deuel, T.F. (1988) Purification and 
characterization of a phosphatidylinositol 4-kinase 
from bovine uteri. J. Biol. Chern. 263: 8989-8995. 
Profrock, A., Schnefel, S. & Schulz, I. (1991a) Receptors 
for insulin interact with Gi-proteins and for epidermal 
growth factor with G·- and Gs-proteins in rat 
pancreatic acinar ceils. Biochem. Biophys. Res. 
Commun. 175: 380-386. 
Profrock, A., Piiper, A., Eckhardt, L. & Schulz, I. (1991b) 
Epidermal growth factor inhibits both 
cholecystokinin octapeptide-induced inositol 1,4,5-
trisphosphate production and [Ca2+Ji increase in rat 
pancreatic acinar cells. Biochem. Biophys. Res. 
Commun. 180: 900-906. 
Putney, J.W. Jr., Burgess, G.M., Halenda, S.P., McKinney, 
J �· & Rubin, R.P. (1983) Effects of secretagogues on 
[3 P]phosphatidylinositol 4,5-bisphosphate metabolism 
in the exocrine pancreas. Biochem. J. 212: 483-488. 
Putney, J.W. Jr. (1986) A model for receptor-regulated 
calcium entry. Cell Calcium 2: 1-12. 
Quist, E., Satumtira, N. & Powell, P. (1989) Regulation of 
polyphosphoinositide synthesis in cardiac membranes. 
Arch. Biochem. Biophys. 271: 21-32. 
Rana, R.S. & MacDonald, M.J. (1986) Phosphatidylinositol 
kinase in rat pancreatic islets: subcellular 
distribution and sensitivity to calcium. Horm. 
Metabol. Res. 18: 659-662. 
Rasmussen, H. (1981) Calcium and cAMP as synarchic 
messengers. John Wiley & Sons, New York. 
Reich, J.G. (1968) Analogue computer analysis of tracer 
flow patterns through the glycolytic and related 
pathway in erythrocytes and other intact metabolic 
systems. Eur. J. Biochem. �: 395-403. 
Rhee, S.G, Suh, P-G, Ryu, S-H & Lee, S.Y. (1989) Studies of 
inositol phospholipid-specific phospholipase c. 
Science 244: 546-550. 
Robberecht, P., Deschodt-Lanckman, M., Lammens, M., DeNeef, 
P. & Christophe, J. (1977) In vitro effects of 
secretin and vasoactive intestinal polypeptide on 
hydrolase secretion and cyclic AMP levels in the 
pancreas of five animal species: a comparison with 
caerulein. Gastroenterol. Clin. Biol. l: 519-525. 
179 
Robberecht, P., Waelbroeck, M., Noyer, M., Chatelain, P., De 
Neef, P., Konig, w. & Christophe, J. (1982) 
Characterization of secretin and vasoactive intestinal 
peptide receptors in rat pancreatic plasma membranes 
using the native peptides, secretin (7-27) and five 
secretin analogues. Digestion £1: 201-210. 
Roger, P.P., Breton, M.F., Dumont, J.E. & Pavlovic-Hournac, 
M. (1991) Epidermal growth factor and phorbol ester 
actions on the TSH induced down regulation of the 
isoenzyme I (PKA I) of cyclic AMP-dependent protein 
kinases in dog thyroid cell primary cultures. Cell 
Signal. �: 145-151. 
Rosenzweig, S.A., Miller, L.J. & Jamieson, J.D. (1983) 
Identification and localization of cholecystokinin 
binding sites on rat pancreatic plasma membranes and 
acinar cells: a biochemical and autoradiographic study. 
J. Cell Biol. 96: 1288-1297. 
Rubin, R.P. (1984) Stimulation of inositol trisphosphate 
accumulation and amylase secretion by caerulein in 
pancreatic acini. J. Pharmacol. Exp. Ther. 231: 623-
627. 
Rubin, R.P., Godfrey, P.P., Chapman, D.A. & Putney, J.W. Jr. 
(1984) Secretagogue-induced formation of inositol 
phosphates in rat exocrine pancreas: implications for a 
messenger role for inositol trisphosphate. Biochem. J. 
£12: 655-659. 
Rubin, R.P., Hundley, T.R. & Adolf, M.A. (1992) Regulation 
of diacylglycerol levels in carbachol-stimulated 
pancreatic acinar cells: relationship to the breakdown 
of phosphatidylcholine and metabolism to phosphatidic 
acid. Biochim. Biophys. Acta 1133: 127-132. 
Rubin, R.P., Thompson, R.H. & Laychock, S.G. (1990) 
Characterization of phospholipase A2 and 
acyltransferase activities in purif1ed zymogen granule 
membranes. Biochim. Biophys. Acta 1045: 245-251. 
Rubin, R.P., Withiam-Leitch, M. & Laychock, S.G. (1991) 
Modulation of phospholipase A2 activity in zymogen 
granule membranes by GTP[S); evidence for GTP-binding 
protein regulation. Biochem. Biophys. Res. Commun. 
122: 22-26. 
Rutten, W.J. De Pont, J.J.H.H.M. & Bonting, S.L. (1972) 
Adenylate cyclase in the rat pancreas: properties and 
stimulation by hormones. Biochirn. Biophys. Acta 274: 
201-213. 
180 
Ryu, S.H., Cho, K.S., Lee, K-Y, Suh, P-G & Rhee, S.G. (1987) 
Purification and characterization of two 
immunologically distinct phosphoinositide-specific 
phospholipase c from bovine brain. J. Biol. Chern. 262: 
12511-12518. 
Sahai, A., Smith, K.B., Panneerselvarn, M. & Salomon, D.S. 
(1982) Activation of calcium and phospholipid­
dependent protein kinase by epidermal growth factor 
(EGF) in A431 cells: attenuation by 12-0-
tetradecanoylphorbol-13-acetate (TPA). Biochern. 
Biophys. Res. Cornrnun. 109: 1206-1214. 
Saltiel, A.R., Fox, J.A., Sherline, P., Sahyoun, N. & 
Cuatrecasas, P. (1987) Purification of 
phosphatidylinositol kinase from bovine brain myelin. 
Biochern. J. 241: 759-763. 
Santiago-Calve, E., Mula, s. , Redman, C.M., Hokin, M.R. & 
Hokin, L.E. (1964) The chromatographic separation of 
polyphosphoinositides and studies on their turnover in 
various tissues. Biochirn. Biophys. Acta 84: 550-562. 
Schacht, J. (1978) Purification of polyphosphoinositides by 
chromatography on immobilized neomycin. J. Lipid 
Research 19: 1063-1067. 
Schafer, R., Christian, A-L & Schulz, I. (1988) Photoaffin 
ity labeling with GTP-r-azidoanilide of a cholera 
toxin-sensitive 40 kDa protein from pancreatic acinar 
cells. Biochern. Biophys. Res. Cornrnun. 155: 1051-1059. 
Schlessinger, J. (1987) Allosteric regulation of the 
epidermal growth factor receptor kinase. J. Cell Biol. 
103: 2067-2072. 
Schneider, Y-J, Tulkens, P., de Duve, c. & Trouet, A. (1979) 
Fate of plasma membrane during endocytosis. II. 
Evidence for recycling (shuttle) of plasma membrane 
constituents. J. Cell Biol. 82: 466-474. 
Schulz, I. (1987) Electrolyte and fluid secretion in the 
exocrine pancreas; In: Physiology of the 
Gastrointestinal Tract (Johnson, L.R. ed.) 2nd edition, 
pp. 1147-1171, Raven Press, New York. 
Scott, J.D. (1991) Cyclic nucleotide-dependent protein 
kinases. Pharmac. Ther. 50: 123-145. 
Segel, I.H. (1976) Biochemical Calculations (2nd edition) 
pp. 208-323, John Wiley and Sons, New York. 
Serunian, L.A., Haber, M.T., Fukui, T., Kim, J.W., Rhee, 
S.G., Lowenstein, J.M. & Cantley, L.C. (1989) 
Polyphosphoinositides produced by phosphatidylinositol 
3-kinase are poor substrates for phospholipase C from 
rat liver and bovine brain. J. Biol. Chern. 264: 
17809-17815. 
181 
Sewell, W.A. & Young, J.A. (1975) Secretion of electrolytes 
by the pancreas of the anaesthetized rat. J. Physiol. 
(London) 252: 379-396. 
Seyfred, M.A. & Wells, W. (1984) Subcellular site and 
mechanism of vasopressin-stimulated hydrolysis of 
phosphoinositides in rat hepatocytes. J. Biol. Chern. 
259: 7666-7672. 
Singh, M. (1982) Role of cyclic adenosine monophosphate in 
amylase release from dissociated rat pancreatic acini. 
J. Physiol. 221: 547-555. 
Smith, c.o. & Chang, K-J (1989) Regulation of brain 
phosphatidylinositol-4-phosphate kinase by GTP 
analogues. J. Biol. Chern. 264: 3206-3210. 
Smith, C.D. & Wells, W.W. (1983) 
liver nuclear envelopes. II. 
vitro lipid phosphorylation. 
9373. 
Phosphorylation of rat 
Characterization of in 
J. Biol. Chern. 258: -g368-
Soderling, T.R., Corbin, J.D. & Park, C.R. (1973) 
Regulation of adenosine 3',5'-monophosphate-dependent 
protein kinase. II. Hormonal regulation of the adipose 
tissue enzyme. J. Biol. Chern. 248: 1822-1829. 
Spat, A., Bradford, P.G., McKinney, J.S., Rubin, R.P. & 
Putney, J.W. Jr. (1986) A saturable receptor for 32P­
inositol-1,4,5-trisphosphate in hepatocytes and 
neutrophils. Nature (London) 319: 514-516. 
Steinman, R.M., Mellman, I.S., Muller, W.A. & Cohn, Z.A. 
(1983) Endocytosis and the recycling of plasma 
membrane. J. Cell Biol. 96: 1-27. 
Streb, H., Bayerdorffer, E., Haase, w. , Irvine, R.F. & 
Schulz, I. (1984) Effect on inositol 1,4,5-
trisphosphate on isolated subcellular fractions of rat 
pancreas. J. Membr. Biol. 81: 241-253. 
Streb, H., Heslop, J.P., Irvine, R.F. & Berridge, M.J. 
(1985) Relationship between secretagogue-induced ca2+ 
release and inositol phosphate production in 
permeabilized pancreatic acinar cells. J. Biol. Chem. 
260: 7309-7315. 
Streb, H., Irvine, R.F., Berridge, M.J. & Schulz, I. (1983) 
Release of ca2+ from a nonmitochondrial intracellular 
store in pancreatic acinar cells by inositol 1,4,5-
trisphosphate. Nature (London) 306: 67-69. 
Stubbs, E.B. Jr., Kelleher, J.A. & Sun, G.Y. (1988) 
Phosphatidylinositol kinase, phosphatidylinositol-4-
phosphate kinase and diacylglycerol kinase activities 
in rat brain subcellular fractions. Biochim. Biophys. 
Acta 958: 247-254. 
Sugimoto, Y., Whitman, M., Cantley, L.C. & Erikson, R.L. 
(1984) Evidence that the Rous sarcoma virus 
transforming gene product phosphorylates 
phosphatidylinositol and diacylglycerol. Proc. Natl. 
Acad. Sci. (USA) 81: 2117-2121. 
182 
Susa, M., Olivier, A.R., Fabbro, D. & Thomas, G. (1989) EGF 
induces biphasic S6 kinase activation: late phase is 
protein kinase C-dependent and contributes to 
mitogenicity. Cell 57: 817-824. 
Svoboda, M., Robberecht, P., Camus, J., Deschodt-Lanckman, 
M. & Christophe, J. (1978) Subcellular distribution 
and response to gastrointestinal hormones of adenylate 
cyclase in the rat pancreas: partial purification of a 
stable plasma membrane preparation. Eur. J. Biochem. 
69: 185-193. 
Taylor, M.V., Metcalfe, J.C., Hesketh, T.R., Smith, G.A. & 
Moore, J.P. (1984) Mitogens increase phosphorylation of 
phosphoinositides in thymocytes. Nature (London) 312: 
462-465. 
Thomas, A.P., Alexander, J. & Williamson, J.R. (1984) 
Relationship between inositol polyphos�hate production 
and the increase of cytosolic free ca2 induced by 
vasopressin in isolated hepatocytes. J. Bio1. Chem. 
259: 5574-5584. 
Tooke, N.E., Hales, C.N. & Hutton, J.C. (1984) ca2+­
sensitive phosphatidylinositol 4-phosphate metabolism 
in a rat beta-cell tumour. Biochem. J. 219: 471-480. 
183 
Trifaro, J.M. (1969) The effect of ca2+ omission on the 
secretion of caJ�cholamines and the incorporation of orthophosphate- P04 into nucleotides and phospholipids 
of bovine adrenal medulla during acetylcholine 
stimulation. Mol. Pharmacal. 2: 420-431. 
Trifaro, J.M. & Dworkind, J. (1971) Phosphorylation of 
membrane components of adrenal chromaffin granules by 
adenosine triphosphate. Mol. Pharmacol. 2: 52-65. 
Trifaro, J.M. & Dworkind, J. (1975) Phosphorylation of the 
membrane components of chromaffin granules: synthesis 
of diphosphatidylinositol and presence of 
phosphatidylinositol kinase in grnaule membranes. can. 
J. Physiol. Pharmacol. 21: 479-492. 
Trimble, E.R., Bruzzone, R., Biden, T.J., Meehan, C.J., 
Andreu, D. & Merrifield, R.B. (1987) Rapid increases in 
inositol 1,4,5-trisphosphate, inositol 1 , 3,4,5-
tetrakisphosphate and cytosolic free ca 2 T in agonist­
stimulated pancreatic acini of the rat: effect of 
carbachol, caerulein and secretin. Proc. Natl. Acad. 
Sci. (USA) .ll_±: 3146-3150. 
Uromow, T. & Wieland, O.H. (1986) Stimulation of 
phosphatidylinositol 4-phosphate phosphorylation in 
human placenta membranes by GTPgS. FEBS Lett. 207: 
253-257. 
Uromow, T. & Wieland, O.H. (1990a) Purification and partial 
characterization of phosphatidylinositol-4-phosphate 
kinase from rat liver plasma membranes: further 
evidence for a stimulatory G-protein. Biochim. 
Biophys. Acta 1052: 152-158. 
Uromow, T. & Wieland, O.H. (1990b) A small G-protein 
involved in phosphatidylinositol-4-phosphate kinase 
activation. FEBS Lett. �: 15-17. 
van Bergen en Henegouwen, P.M., Defize, L.H., de Kroon, J. , 
van Damme, H., Verkleij, A.J. & Boonstra, J. (1989) 
Ligand-induced association of epidermal growth factor 
receptor to the cytoskeleton of A431 cells. J. Cell 
Biochem. 39: 455-465. 
Van Dongen, C.J., Zwiers, H. & Gispen, W.H. (1984) 
Purification and partial characterization of the 
phosphatidylinositol 4-phosphate kinase from rat 
brain. Biochem. J. �: 197-203. 
van Rooijen, L.A.A., Rossowska, M. & Bazan, N.G. (1985) 
Inhibition of phosphatidylinositol-4-phosphate kinase 
by its product phosphatidylinositol-4,5-bisphosphate. 
Biochem. Biophys. Res. Commun. 126: 150-155. 
184 
Vandermeers, A., Vandermeers-Piret, M.C., Rathe, J., Dehaye, 
J-P, Winand, J. & Christophe, J. {1984) 
Phosphorylation of 3 particulate proteins in rat 
pancreatic acini in response to vasoactive intestinal 
peptide (VIP), secretin and cholecystokinin (CCK-8). 
Peptides 2: 359-365. 
Verhoeven, A.J.M., Tysnes, 0-B, Aarbakke, G.M., Cook, C.A. & 
Holmsen, H. (1987 a) Turnover of the phosphomonoester 
groups of polyphosphoinositol lipids in unstimulated 
human platelets. Eur. J. Biochem. 166: 3-9. 
Verhoeven, A.J.M., Tysnes, 0-B, Horvli, 0., Cook, C.A. & 
Holmsen, H. (1987 b) Stimulation of phosphate uptake 
in human platelets by thrombin and collagen. J. Biol. 
Chem. 262: 7047-7052. 
Vogel, S. & Hoppe, J. (1986) Polyamines stimulate the 
phosphorylation of phosphatidylinositol in membranes 
from A431 cells. Eur. J. Biochem. 154: 253-257. 
Wahl, M.I., Sweatt, J.D. & carpenter, G. (1987) Epidermal 
growth factor (EGF) stimulates inositol trisphosphate 
formation in cells which overexpress the EGF receptor. 
Biochem. Biophys. Res. Commun. 142: 688-695. 
Walaas, S.I. & Greengard, P. {1991) Protein phosphorylation 
and neuronal function. Pharmacal. Rev. ±2: 299-349. 
Walker, D.H., Dougherty, N. & Pike, L.J. (1988) 
Purification and characterization of a 
phosphatidylinositol kinase from A431 cells. 
Biochemistry £1: 6504-6511. 
Walker, D.H. & Pike, L.J. (1987) Phosphatidylinositol 
kinase is activated in membranes derived from cells 
treated with epidermal growth factor. Proc. Natl. 
Acad. Sci. (USA) 84: 7513-7517. 
Walker, D.H. & Pike, L.J. (1990) Stimulation of purified 
phosphatidylinositol 4-kinase by cobra venom 
cardiotoxin. Biochim. Biophys. Acta 1055: 295-298. 
Weiss, S.J., McKinney, J.S. & Putney, J.W. (1982) 
Regulation of phosphatidate synthesis by secretagogues 
in parotid acinar cells. Biochem. J. 204: 587-592. 
Wetzger, R., Klinger, R., Hsuan, J., Fry, M.J., Kauffrnann­
Zeh, A., Muller, E., Frunder, H. & Waterfield, M. 
(1991) Purification and characterization of 
phosphatidylinositol 4-kinase from human erythrocyte 
membranes. Eur. J. Biochern. 200: 179-185. 
Whitman, M., Downes, C.P., Keeler, M., Keller, T. & Cantley 
L. (1988) Type I phosphatidylinositol kinase makes a 
novel inositol phospholipid, phosphatidylinositol-3-
phosphate. Nature (London) �: 644-646. 
Whitman, M., Kaplan, D.R., Roberts, T.M. & Cantley, L. 
(1987) Evidence for two distinct phosphatidylinositol 
kinases in fibroblasts. Biochern. J. £12: 165-174. 
185 
Williams, J.A., Korc, M., and Dormer, R.L. (1978) Action of 
secretagogues on a new preparation of functionally 
intact, isolated pancreatic acini. Am. J. Physiol. 
£l2: E517-E524. 
Wilson, D.B., Bross, T.E., Hofmann, S.L. & Majerus, 
(1984) Hydrolysis of polyphosphoinositides by 
sheep seminal vesicle phospholipase c enzymes. 
Biol. Chern. 259: 11718-11724. 
P.W. 
purified 
J. 
Wooten, M.W. & Wrenn, R.W. (1984) Phorbol ester induces 
intracellular translocation of phospholipidjca2+­
dependent protein kinase and stimulates amylase 
secretion in isolated pancreatic acini. FEBS Lett. 
171: 183-186. 
Wrenn, R.W. (1983) Phospholipid-sensitive calcium-dependent 
protein kinase and its endogenous substrate proteins in 
rat pancreatic acinar cells. Life Sci. 1£: 2385-2392. 
Wrenn, R.W. (1984) Phosphorylation of a pancreatic zymogen 
granule membrane protein by endogenous 
calcium/phospholipid-dependent protein kinase. 
Biochirn. Biophys. Acta 775: 1-6. 
Wrenn, R.W., Katoh, N. & Kuo, J.F. (1981) Stimulation by 
phospholipid of calcium-dependent phosphorylation of 
endogenous proteins from mammalian tissues. Biochirn. 
Biophys. Acta 676: 266-269. 
Yarnakawa, A., Nishizawa, M., Fujiwara, K.T., Kawai, s. , 
Kawasaki, H., Suzuki, K. & Takenawa, T. (1991) 
Molecular cloning and sequencing of eDNA encoding the 
phosphatidylinositol kinase from rat brain. J. Biol. 
Chern. 266: 17580-17583. 
186 
Yamakawa, A. & Takenawa, T. (1988) Purification and 
characterization of membrane-bound phosphatidylinositol 
kinase from rat brain. J. Biol. Chem. �: 17555-
17560. 
Yamamoto, K. & Lapetina, E.G. (1990) Protein kinase C­
mediated formation of phosphatidylinositol 3,4-
bisphosphate in human platelets. Biochem. Biophys. 
Res. Commun. 168: 466-472. 
Yanigihara, N. , Tank, A.W. & Weiner, N. (1984) Relationship 
between activation and phosphorylation of tyrosine 
hydroxylase by 56 mM K+ in PC12 cells in culture. Mol. 
Pharmacol. 26: 141-147. 
187 
